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Kurzfassung 
 
In den meisten Organismen kodieren 25%-30% des Genoms für Membranproteine. Sie 
spielen eine wichtige Rolle für die Zellfunktion, und ihre Bedeutung wird verstärkt durch 
die Tatsache, dass viele Medikamente an Membranproteinen angreifen. Paradoxerweise 
entfallen lediglich 1,7% der hinterlegten Proteinstrukturen in der protein databank (PDB) 
auf experimentell ermittelte Strukturen von Membranproteinen. Dies ist hauptsächlich 
auf  die  schwierige  Handhabung,  bedingt  durch  ihren  amphipathischen  Charakter, 
zurückzuführen. Das geringe Vorkommen in natürlichen Geweben macht die heterologe 
Überexpression  dieser  Gene  zu  einer  Notwendigkeit.  Diese  Arbeit  zielte  darauf  ab, 
verschiedene  sekundär  aktive  Transportproteine  für  strukturelle  und  funktionelle 
Untersuchungen heterolog zu produzieren und alternative Strategien zu etablieren, um 
die Hürden im Zusammenhang mit der heterologen Überexpression zu überwinden. 
 
Vier  Mitglieder  der  Schwermetall-transportierenden  cation diffusion  facilitator  (CDF) 
Familie aus S.  typhimurium und A. aeolicus wurden heterolog in E. coli produziert und 
durch  einen  in  vivo  Komplementationsassay  unter  Zuhilfenahme  des  Zink-Transport 
defizienten E. coli Stammes GG48 funktionell charakterisiert. Von diesen vier Proteinen 
konnte  Aq_2073  aus  A.  aeolicus  im  präparativen  Maßstab  mit  einer  beachtlichen 
Ausbeute  und  Reinheit  hergestellt  werden,  um  strukturelle  Untersuchungen 
durchzuführen.  Nach  umfangreichen  Stabilitätsuntersuchungen  mit  verschiedenen 
Detergenzien,  pH-Werten  und  Temperaturen  wurden  2D  sowie  3D-
Kristallisationsversuche unternommen. Zusätzlich wurden mehrere C-terminal verkürzte 
Konstrukte  hergestellt,  welche  ebenfalls  für  Kristallisationsversuche  genutzt  wurden. 
Diese ergaben in 3D-Kristallisationsversuchen erste nadelähnliche Kristalle oder in 2D-
Kristallisationsversuchen  Vesikel  mit  kristallinen  Stellen,  aber  keine  offensichtlichen 
Kristalle. Das Protein besaß eine signifikant  höhere Schmelztemperatur in Gegenwart 
von Cadmiumionen wie durch differential scanning calorimetry (DSC) gezeigt wurde.  
 
Ein weiterer Transporter, STM3880 aus der potassium uptake permease (KUP) Familie 
aus  S.  typhimurium,  wurde  in  E.  coli  heterolog  exprimiert,  durch 
Affinitätschromatographie gereinigt, in  künstliche Liposomen rekonstituiert und durch                                                                                                                  KURZFASSUNG 
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elektrophysiologische  Untersuchungen  mit  Festphasen-gestützten  Membranen  (solid 
supported membranes; SSM) funktionell charakterisiert. 
 
Um  alternative  Expressionsstrategien  zu  etablieren,  wurden  Proteine  von  vier 
verschiedenen Familien zellfrei unter kontinuierlichem Austausch (continuous  exchange 
cell  free  expression;  CECF)  produziert.  Diese  Methode  schien  geeignet,  um  den 
zellbasierten  Ansatz  zu  komplementieren.  Zielproteine  der  resistence  to 
homoserine/threonine (RhtB) Familie, die in vivo keine Expression zeigten, konnten so 
hergestellt  und  gereinigt  werden.  STM1781  aus  der  sulfate  permease  (SulP)  Familie 
konnte  zellfrei  hergestellt,    gereinigt  und  hinsichtlich  seiner  Stabilität  charakterisiert 
werden, wohingegen die zellbasierte Produktion in starkem Abbau resultierte. PF0780 
der  multidrug/oligosaccharidyl-lipid/polysaccharide  flippase  (MOP)  Familie  wurde 
ebenfalls zur Homogenität gereinigt und zeigte eine vergleichbare Stabilität zum in vivo 
produzierten Protein. Des Weiteren wurde der Effekt einer Fusion des Maltose bindenden 
Proteins (MBP) am N-Terminus auf die Produktion und Membranintegration bei drei 
verschiedenen  Proteinen  untersucht.  Die  Analyse  ergab  eine  verringerte  Ausbeute  in 
Anwesenheit des MBPs, wenn sich beide Termini des Proteins im Cytoplasma befanden.  
 
In dieser Arbeit konnten verschiedene sekundär aktive Transporter erfolgreich hergestellt 
und  entsprechende  Reinigungsprotokolle  etabliert  werden,  die  darauf  abzielen 
strukturelle  und  funktionelle  Untersuchungen  im  Rahmen  eines  structural  genomics 
Projektes durchzuführen. Es zeigte sich, dass die Einbindung alternativer Strategien wie 
die  Anwendung  zellbasierter  und  zellfreier  Expressionssysteme,  die  Gesamtanzahl 
herstellbarer Proteine steigert und damit die Erfolgsaussichten derart angelegter Projekte 
verbessert. 
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Zusammenfassung 
 
Membranproteine  sind  oft  sehr  komplex,  haben  viele  verschiedene  Funktionen  und 
spielen  eine  Schlüsselrolle  bei  Prozessen  wie  Signaltransduktion,  Zellwachstum  und 
Differenzierung, Transport und Stoffwechsel. Zusätzlich wird ihre Bedeutung dadurch 
verstärkt, dass viele der heutigen Medikamente an Membranproteinen angreifen. Trotz 
ihrer steigenden Bedeutung entfallen lediglich 1,7% der in der protein databank (PDB) 
hinterlegten  Proteinstrukturen  auf  experimentell  ermittelte  Strukturen  von 
Membranproteinen.  Auf  eine  ähnliche  Situation  stieß  man  in  den  1970er  Jahren  bei 
löslichen  Proteinen.  Technologischer  Fortschritt  im  Bereich  der  Methoden  zur 
Strukturaufklärung führte zu einer fast exponentiell steigenden Zahl gelöster Strukturen. 
Jedoch ist die Handhabung von Membranproteinen, bedingt durch ihre Topologie, die 
den ineffizienten Transport und die Insertion  in zelluläre Membranen beeinflusst, die 
toxischen  Effekte  der  heterologen  Expression  für  den  Wirtsorganismus  und  ihre 
Instabilität, schwierig. Da die Menge von Membranproteinen die in natürlichen Geweben 
bis auf wenige Ausnahmen vorkommen, nicht ausreicht, um sie aufzureinigen, ist eine 
heterologe Überexpression notwendig. In den vergangenen Jahren legten verschiedene 
structural genomics Projekte ihren Schwerpunkt nicht nur darauf Membranproteine zu 
produzieren,  sondern  auch  darauf,  effiziente  Methoden  zur  Überexpression  zu 
entwickeln.  
 
Diese  Arbeit  zielte  darauf  ab,  verschiedene  sekundär  aktive  Transportproteine  für 
strukturelle und funktionelle Untersuchungen heterolog zu produzieren und alternative 
Strategien, wie die zellfreie Expression und Maltose-Bindeprotein-Fusionen (MBP), zu 
etablieren, um die Hürden im Zusammenhang mit der heterologen Überexpression zu 
überwinden. Zu diesem Zweck wählte ich, auf Grundlage verfügbarer bioinformatischer 
Daten  der  Transporter  protein  analysis  database  (TransportDB; 
www.membranetransport.org), 14 sekundär aktive Transporter aus sieben verschiedenen 
Familien  der  drei  Organismen  Salmonella  typhimurium,  Aquifex  aeolicus  und 
Pyrococcus furiosus, aus. Es sollten solche Transporter ausgewählt werden, von denen 
keine atomare Proteinstruktur mit atomarer Auflösung verfügbar war und die noch wenig 
untersucht wurden.                                                                                                      ZUSAMMENFASSUNG 
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Ich  began  mit  vier  Proteinen  der  Schwermetall-transportierenden  cation  diffusion 
facilitator  (CDF)  Familie,  von  denen  jeweils  zwei  aus  Salmonella  typhimurium  und 
Aquifex  aeolicus,  stammten.  Die  Klonierungs-  und  Expressionsversuche  mit  drei 
verschiedenen Vektoren, die jeweils in zwei verschiedenen Versionen vorlagen, welche 
sich  in  der  Position  des  tags  unterschieden,  ergab,  dass  die  CDF-Familie  eine  gut 
exprimierbare Familie derstellt. Alle Konstrukte exprimierten gut in den entsprechenden 
E. coli Wirtsorganismen. Funktionelle Komplementationsstudien mit dem Zink-Export 
defizienten E. coli Stamm GG48 zeigten, dass STM0758 aus S. typhimurium die Zink-
Defizienz  komplementieren  kann.  Jedoch  erfordern  strukturelle  Untersuchungen  
ausreichende Mengen an stabilem und gereinigtem Protein. Diesbezüglich stellte  sich 
Aq_2073 aus A. aeolicus als vielversprechendster Kandidat heraus. 
 
Aq_2073 wurde in den araBAD Operon basierten Vektor pBAD, der einen N-terminalen 
deca-His tag und einem C-terminalem STREP-II tag enthält kloniert, in E. coli Top10 
Zellen  exprimiert  und  mittels  immobilisierter  Metallionen-Affinitätschromatographie 
(IMAC) zur Homogenität gereinigt. Das finale Reinigungsprotokoll ergab eine Ausbeute 
von 2,5 mg Protein pro einem Liter Kulturvolumen.  
 
Der nächste Schritt war die Charakterisierung des Proteins hinsichtlich seiner Stabilität, 
da  Membranproteine  auf  Grund  ihrer  amphiphilen  Natur  oft  unter  unvorteilhaften 
Bedingungen  aggregieren,  was  die  Kristallisation  ausschließt.  Aq_2073  wurde 
umfangreich  in  verschiedenen  Detergenzien  und  bei  unterschiedlichen  pH-Werten 
untersucht, wobei das Gelfiltrationsprofil als Maßstab für eine korrekte Faltung und die 
Stabilität  diente.  Es  konnte  gezeigt  werden,  dass  das  Protein  in  einer  Vielzahl  von 
Detergenzien  und  Detergenz-Gemischen,  einschließlich  bestimmter  harscher 
Detergenzien  wie  N-dodecylphoscholine  (FOS12)  and  N,N-dimethyldodecylamin-N-
oxid  (LDAO),  homogen  war.  Interessanterweise  zeigte  sich,  dass  in  einer  Reihe 
verschiedener Maltoside die Stabilität des Proteins mit sich verkürzender Kettenlänge der 
Kohlenwasserstoffkette abnahm. Allerdings war das Protein im Wesentlichen stabil von 
pH 4 bis  pH  8,  selbst  nach  Lagerung über 15 Tage  bei  Raumtemperatur. Außerdem 
konnte  für  Aq_2073  eine  hohe  Schmelztemperatur  (Tm)  um  96  °C  in  einem 
physiologischen  pH-Bereich  mit  differential  scanning  calorimetry  (DSC)  gemessen                                                                                                      ZUSAMMENFASSUNG 
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werden.  Diese  Eigenschaften  zusammen  machten  Aq_2073  zu  einem  attraktiven 
Kandidaten für strukturelle Untersuchungen.  
 
Kristallisationsversuche wurden mit kommerziell erhältlichen Screens durchgeführt und 
resultierten  in  ersten  nadelähnlichen  Kristallen.  Jedoch  ergaben  umfangreiche 
Optimierungen  keine  weiteren  vielversprechenden  Bedingungen.  Daran  anschließend 
entwarf ich sechs N- und C-terminal verkürzte Versionen von Aq_2073, basierend auf 
Homologie-Modellen,  einschließlich  zweier  Konstrukte,  die  lediglich  aus  der 
vorhergesagten  löslichen  C-terminalen  Domäne  bestanden.  Drei  dieser  Konstrukte 
wurden zur Homogenität gereinigt, wobei die Kristallisationsversuche nicht erfolgreich 
waren. Die Bemühungen zur Strukturaufklärung von Aq_2073 waren nicht nur auf 3D-
Kristallisation  beschränkt,  sondern  wurden  auch  auf  2D-Kristallisation  erweitert  mit 
Hilfe von cryo-EM. Um hierbei Kristalle zu erhalten wurden verschiedene Detergenzien, 
Lipide,  Lipid-zu-Protein  Verhältnisse  (lipid protein  ratio; LPR),  Salzkonzentrationen, 
Temperaturen  und  Additive  mit  dem  Volllängenkonstrukt  und  mit  einem  C-terminal 
verkürzten Konstrukt (C1) von Aq_2073 getestet. Das beste Ergebnis, Vesikel optimaler 
Größe mit kristallinen Bereichen, wurde bei einem LPR von 0.5 in Gegenwart von E. coli 
total lipid extract, einer minimalen Salzkonzentration und Dialyse bei 30 °C erhalten. 
Die oligomere Struktur von Aq_2073 wurde durch komplementäre Techniken untersucht, 
wie  blue  native  Elektrophorese,  Größenausschlußchromatographie  und  chemischer 
Vernetzung.  Alle  Ergebnisse  deuten  auf  einen  oligomeren  Zustand  von  Aq_2073  in 
Detergenzlösung  hin, möglicherweise als Dimer und einen höheren Oligomerzustand. 
Bindungsstudien mit einer Vielzahl möglicher Substrate (Zink, Cadmium, Nickel und 
Eisen) durch DSC zeigte, dass Cadmium die Schmelztemperatur (Tm) um 10 °C steigerte.  
 
Die nächste Familie sekundär aktiver Transporter, mit der ich mich beschäftigte, war die 
potassium uptake permease (KUP) Familie. STM3880 aus S.  typhimurium wurde im 
pBAD Vektor mit einem C-terminalen deca-His-tag exprimiert. Mit Hilfe einer IMAC 
konnte eine ausreichende Menge an Protein für strukturelle Untersuchungen aufgereinigt 
werden. Jedoch blieb STM3880 offenkundig hinsichtlich seiner Stabilität problematisch. 
Weitreichende  Optimierungen  von  Detergenzien,  Salzen,  pH-Werten,  Additiven  und 
Kultivierungsbedingungen  genügten  nicht,  um  die  Langzeitstabilität  des  Proteins  zu 
verbessern, was eine Vorraussetzung für die Kristallisation ist. Die einzige Lösung war                                                                                                      ZUSAMMENFASSUNG 
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zügig  nach  der  Reinigung  weiter  zu  arbeiten.  STM3880  wurde  in  Liposomen 
rekonstituiert und durch SSM-Experimente funktionell charakterisiert. Lediglich bei pH 
6 führte ein Konzentrationssprung des Substrats (KCl) von 1 mM zu einem messbaren 
Strom, was darauf schließen lässt, dass das Protein wahrscheinlich nur bei niedrigerem 
pH-Wert aktiv ist. Während der Arbeit stieß ich auf Membranproteine, die bedingt durch 
ihre  toxischen  Effekte,  unzureichender  Ausbeute  und  proteolytischen  Abbau  in 
zellbasierten  Systemen  schwierig  heterolog  herzustellen  waren.  Um  diese  Proteinen 
trotzdem untersuchen und kristallisieren zu können, entschied ich mich für das E. coli 
S30-Extrakt basierte zellfreie Expressionssystem, das nicht nur die Möglichkeit bietet, 
Probleme mit der zellbasierten heterologen Expression zu umgehen, sondern auch die 
Reaktionsbedingungen zu kontrollieren. Der in vivo hergestellte Transporter PF0780 der 
MOP-Transporter Familie aus P. furiosus lieferte gut beugende Kristalle. Ich etablierte 
zellfreie  Produktionsprotokolle,  sowohl  in  Abwesenheit  (PCF-Modus),  als  auch  in 
Gegenwart von Detergenz (DCF-Modus). Das im PCF-Modus hergestellte Protein wurde 
zur  Homogenität  gereinigt  und  wies  eine  gute  Langzeitstabilität  auf,  wie  durch 
analytische  Größenauschlußchromatographie  gezeigt  wurde.  Kristallisation  wurde  mit 
PF0780,  welches  im  PCF-Modus  produziert  wurde,  versucht.  Blue  native 
Gelelektrophorese  zeigte,  dass  das  zellfrei  produzierte  Protein  in  einem  oligomeren 
Zustand  vorliegt.  Da  jedoch  das  im  DCF-Modus  hergestellte  Protein  eine  geringere 
Reinheit und Stabilität zeigte, ist der PCF-Modus als Expressionsmethode für weitere 
strukturelle und funktionelle Untersuchungen vorzuziehen. 
 
Erste  funktionelle Charakterisierungen  von  STM3476, einem  Transporter der  formate 
nitrite  transporter  (FNT)  Familie  aus  S.  typhimurium,  zeigten  Hinweise  für  einen 
Nitrittransport.  Ich  versuchte  STM3476  zellfrei  für  funktionelle  und  strukturelle 
Untersuchungen zu produzieren. Sowohl der PCF- als auch der DCF-Modus wurden  mit 
verschiedenen Detergenzien für eine maximale Ausbeute getestet. Mit Hinblick auf die 
endgültige Ausbeute wurde der Einfluss der Temperatur im PCF-, im DCF-Modus und 
während  der  Solibilisierung  des Präzipitats untersucht. Sowohl  im PCF-  als  auch  im 
DCF-Modus verringerte sich die Ausbeute mit sinkender Temperatur nahezu linear. Im 
Gegensatz  dazu  stellte  sich  bei  der  Solubilisierung  des  Präzipitats  bei  verschiedenen 
Temperaturen (4 °C, 20 °C, 30 °C) mit zwei verschiedenen Detergenzien heraus, dass der 
Art des Detergenz eine wichtigere Rolle zukam als der Temperatur.                                                                                                      ZUSAMMENFASSUNG 
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Zwei  weitere  Transporter,  STM1781  aus  der  sulfate  permease  (SulP)  Familie  und 
STM3959  aus  der  Aminosäuretransportierenden  resistence  to  homoserine/threonine 
(RhtB)  Familie,  beide  aus  S.  typhimurium,  wurden  im  PCF-Modus  hergestellt.  Im 
zellbasierten  Expressionssystem  wurde  STM1781  stark  abgebaut,  während  STM3959 
überhaupt  nicht  produziert  wurde.  Das  im  PCF-Modus  hergestellte  STM1781  wurde 
ohne Abbau aufgereinigt und an einem Smart-System hinsichtlich seiner Stabilität durch 
analytische  Größenausschlußchromatographie  mit  einer  Superdex  200  Säule  in 
Gegenwart  der  Detergenzien n-Dodecyl-β-D-Maltosid  (β-LM) und FOS12 untersucht. 
Der Transporter STM3959 hingegen wurde im PCF-Modus hergestellt und in Gegenwart 
von β-LM aufgereinigt. Jedoch besaß dieses Protein keine Langzeitstabilität.  
 
An  drei  ausgewählten  Transportern  wurde  der  Einfluss  von  MBP-Fusionen  auf  die 
Expression  und  Membranintegration  von  Membranproteinen  getestet.  STM0365  und 
STM3959 wurden, sowohl mit als auch ohne MBP-Fusion, unter dem Detektionslimit 
enhalten. Andererseits führte die MBP-Fusion bei STM0758, einem Mitglied der CDF 
Familie,  dessen  beide  Termini  im  Cytoplasma  erwartet  werden,  zu  einer  3-5  fachen  
Verringerung in der Produktion und Membranintegration, je nach Position des His-tags. 
Eventuell behinderte die Positionierung des MBPs am N-Terminus eines Proteins, das 
beide Enden im Cytoplasma hat, die korrekte Insertion in die Membran und führte somit 
zu  einer  verringerten  Produktion.  Diese  Beobachtung  unterstützt  ebenfalls  die  für 
STM0758 vorhergesagte Topologie mit beiden Termini im Cytoplasma. 
 
In  dieser  Arbeit  konnten  einige  sekundär  aktive  Transporter  erfolgreich  heterolog 
produziert und entsprechende Reinigungsprotokolle etabliert werden, um strukturelle und 
funktionelle  Untersuchungen  im  Rahmen  eines  structural  genomics  Projektes 
durchzuführen. Es zeigte sich ebenfalls, dass die Einbindung alternativer Strategien, wie 
die  Anwendung  zellbasierter  und  zellfreier  Expressionssysteme,  die  Gesamtanzahl 
herstellbarer Proteine steigert und damit die Erfolgsaussichten derart angelegter Projekte 
verbessert.                                                                                                                          ABSTRACT 
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Abstract 
 
Genes  coding  for  membrane  proteins  make  up  25%-30%  of  the  genome  in  most 
organisms.  Membrane  proteins  play  an  important  role  in  cell  functioning  and  their 
importance is enhanced by the fact that a large number of drugs are targeted at membrane 
proteins.  Paradoxically,  experimentally  determined  structures  of  membrane  protein 
correspond to only about 1.7% of protein structures deposited in the protein data bank 
(PDB). This is largely due to the fact that membrane proteins are difficult to deal with 
owing to their amphipathic nature. The low abundance of membrane proteins in native 
tissue makes heterologous overexpression of these genes a necessity. This thesis work 
aimed at heterologous production of several secondary active transporter proteins for 
structural  and  functional  characterizations  and  establishing  alternative  strategies  to 
overcome the obstacles associated with heterologous overproduction. 
 
Four members of the heavy metal transporting cation diffusion facilitator (CDF) family 
from S. typhimurium and A. aeolicus were heterologously overproduced in E. coli and 
functionally characterized by an in vivo complementation assay using the zinc transport 
deficient E. coli GG48 strain. Out of these four, Aq_2073 from A. aeolicus was produced 
in large scale with substantial yield and purity sufficient to carry out structural studies. 
After  extensive  stability  studies  with  different  detergents,  pHs  and  temperatures,  the 
protein was subjected to 3D and 2D crystallization trials. Several C- terminal truncated 
constructs were made and the simultaneous crystallization screenings were carried out. 
These resulted in initial needle like crystals in 3D crystallization trials or optimum sized 
vesicles with crystalline patches in 2D crystallization trials but no obvious crystal. The 
protein showed significant increase in melting temperature in the presence of cadmium, 
when tested by differential scanning calorimetry. 
 
Another transporter, STM3880 of the potassium uptake permease (KUP) family from S. 
typhimurium,  was  heterologously  overproduced  in  E.  coli,  purified  by  affinity 
chromatography, reconstituted into artificial liposome and functionally characterized by 
solid supported membrane based electrophysiology. 
In  order  to  establish  alternative  expression  strategies,  continuous  exchange  cell  free 
expression (CECF) of proteins from four different families was carried out. This method                                                                                                                          ABSTRACT 
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found  to  be  aptly  complementing  the  cell-based  production  approach.  Targets  from 
resistance  to  homoserine/threonine  (RhtB)  family  not  expressing  in  vivo  could  be 
expressed and purified using CECF. STM1781 of the sulfate permease (SulP) family was 
expressed,  purified  and  characterized  for  stability  while  the  cell-based  production 
resulted  in  extensive  degradation.  PF0780  of  multidrug/oligosaccharidyl-
lipid/polysaccharide flippase (MOP) family was also purified to homogeneity and the 
stability was comparable to in vivo produced protein. Moreover, the effect of maltose 
binding protein (MBP) fusion at N-terminus on production and membrane integration 
was  tested  with three  selected  targets.  The  analysis  revealed  decreased  yields  in  the 
presence of MBP if the protein had both termini in the cytoplasm. 
 
This  work  succeed  in  heterologously  overproducing  and  establishing  purification 
protocols for several secondary active transporters aiming at structural and functional 
characterization in a structural genomics framework. It also showed that integration of 
alternative  strategies,  like  employing  both  cell-based  and  cell-free  heterologous 
expression systems, expands the overall expression space coverage and in turn increases 
the chance of success of a structural genomics styled project. 
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Summary 
 
Membrane proteins are often very complex, function in many different ways and play 
key  roles  in  processes  including  signal  transduction,  cell  growth  and  differentiation, 
transport and metabolism. In addition, their importance is enhanced by the fact that a 
large  number  of  today’s  drugs  are  targeted  at  membrane  proteins.  Despite  this  high 
significance, experimentally determined structures of membrane protein correspond to 
only about 1.7% of protein structures deposited in the protein data bank (PDB). A similar 
situation was encountered for soluble proteins in 1970s. Technological advancement in 
the  methods  for  structure determination led  to an almost  exponential  increase  in the 
number of solved structures. However, membrane proteins are difficult to deal with due 
to  their  topology  which  affects  the  inefficient  transport  and  insertion  in  cellular 
membranes, the toxic effect of recombinant membrane proteins on host cells, and their 
instability. As the abundance of membrane proteins in native tissue with few exceptions 
is  insufficient  for  purification,  heterologous  overexpression  is  a  necessity.  In  recent 
years,  several  structural  genomics  projects  put  emphasis  not  only  to  overproduce 
membrane  proteins  but  also  to  develop  efficient  methods  for  membrane  protein 
production.  
 
This  thesis  work  aimed  at  heterologously  overproducing  several  secondary  active 
transporter  proteins  for  structural  and  functional  characterizations  and  establishing 
alternative strategies, namely, cell-free expression and Maltose binding protein (MBP) 
fusion to overcome the obstacles associated with heterologous overproduction. For this 
purpose, I selected 14 secondary active transporter proteins of 7 different families from 3 
different  source  organisms,  namely,  Salmonella  typhimurium,  Aquifex  aeolicus  and 
Pyrococcus  furiosus  based  on  available  bioinformatics  information  provided  by 
Transporter protein analysis database (TransportDB; www.membranetransport.org). The 
criteria were to select those secondary active transporter families which lack an atomic 
resolution structure and are not sufficiently studied as evident from the literature. 
I started off with four heavy metal transporting cation diffusion facilitator (CDF) family 
proteins,  two  each  from  Salmonella  typhimurium  and  Aquifex aeolicus.  Cloning  and 
expression screening with three different vectors having two different versions based on 
tag positions revealed that the CDF family is a well expressing family. All the constructs                                                                                                                           SUMMARY 
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expressed well in respective E. coli host cells. Functional complementation studies with 
zinc  export  deficient  E.  coli  strain  GG48  showed  STM0758  from  S.  typhimurium 
complementing the zinc deficiency function. However, structural studies with membrane 
proteins need sufficient amount of stable and purified protein. In this regard, Aq_2073 
from A. aeolicus turned out to be the most suitable one. 
 
Aq_2073, cloned in araBAD operon based pBAD vector with N-terminal deca His-tag 
and  C-terminal  STREP-II  tag,  was  expressed  in  E.  coli  Top10  cells  and  purified  to 
homogeneity by immobilized metal affinity chromatography (IMAC). The purification 
protocol for Aq_2073 was established providing a final yield around 2.5 mg from 1 L 
culture volume.  
 
The next step was to characterize the protein for its stability as membrane proteins often 
aggregate in unfavorable conditions precluding crystallization owing to their amphiphilic 
nature. Aq_2073 was characterized extensively in different detergents and pHs taking the 
gel filtration profile as a benchmark for correct folding and stability. The protein was 
found to be homogeneous in  a  range  of  detergents and detergent  mixtures  including 
certain  strong  detergents  like  N-dodecylphoscholine  (FOS12)  and  N,N-
dimethyldodecylamin-N-oxid (LDAO). Interestingly, when tested in a series of maltoside 
detergents differing in alkyl chain length, the stability went down with decreasing carbon 
chain length. However, the protein was substantially stable at pH 4 to pH 8 and even 
after  15 days  of  storage  at  room  temperature.  In  addition,  Aq_2073  showed  a  high 
melting  temperature  (Tm),  around  96  °C,  at  a  physiological  pH  range  in  differential 
scanning  calorimetry  (DSC)  measurement.  These  characteristics  altogether  made 
Aq_2073 an attractive target for structural studies.  
 
Crystallization trials were performed with commercially available screens and resulted in 
initial needle like crystals. However, extensive optimization of this initial condition failed 
to  generate  any  further  promising  crystals.  Subsequently,  I  designed  six  N-  and  C-
terminally truncated versions of Aq_2073 based on homology alignment, including two 
constructs made only of the predicted soluble C-terminal domain. Three of these were 
purified to homogeneity and subjected to crystallization trials without any success. The 
structural endeavor of Aq_2073 was not only limited to 3D crystallization screens but                                                                                                                           SUMMARY 
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also extended  to 2D crystallization  using  cryo-EM.  Different  lipids,  detergents,  lipid 
protein ratios (LPR), salt concentrations, temperatures and additives were screened, both 
with full length and a C-terminal truncated version (C1) of Aq_2073, to generate 2D 
crystals. The best result, an optimum sized vesicle with crystalline patches, was obtained 
with E. coli total lipid extract at LPR 0.5 with minimum salt concentration and dialysis at 
30 °C. 
 
The oligomeric structure of Aq_2073 was studied by complementary techniques like blue 
native  electrophoresis,  size  exclusion  chromatography  and  chemical  crosslinking.  All 
results indicated that Aq_2073 exists as an oligomer in detergent solution, possibly in 
equilibrium between a dimer and a higher oligomeric state. Binding studies with a range 
of putative substrates (zinc, cadmium, nickel and ferrous) by DSC showed that cadmium 
could increase the melting temperature (Tm) by 10 °C. 
 
The next family of secondary active transporters I worked on was the potassium uptake 
permease family (KUP). STM3880 of KUP family from S. typhimurium was expressed in 
the pBAD vector with a C-terminal deca His-tag. The protein was purified using IMAC 
to sufficient quantity for structural studies. However, STM3880 remained notoriously 
difficult in terms of stability. Extensive optimization with detergents, salts, pHs, additives 
and culturing conditions were not enough to increase the long term stability of this target 
which is the prerequisite for crystallization. The only solution was to work fast after 
purification.  Purified  STM3880  was  reconstituted  in  liposomes  and  functionally 
characterized  by  solid  supported  membrane  (SSM)  experiments.  Only  at  pH  6,  a 
substrate  (KCl)  concentration  jump  of  1  mM  produced  a  detectable  current  which 
indicated that the protein is probably active only at low pH. 
 
In due course of my thesis work, I came across with membrane protein targets which 
were difficult to hetorologously overproduce in cell-based systems because of their toxic 
effect, insufficient  yield, or extensive proteolytic degradation. I opted for E. coli S30 
extract  based  cell-free  expression  system  which  not  only  offers  the  possibilities  to 
overcome the problems associated with cell-based heterologous overexpression but also 
to  control  the  reaction  conditions.  In  addition,  it  was  also  necessary  to  establish 
alternative  production  protocols  for  attractive  targets  which  already  generated  either                                                                                                                           SUMMARY 
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diffracting  crystals  or  functional  data  and  test  the  crystallizibility  and  functional 
reproducibility of the cell-free produced protein. 
 
In vivo produced PF0780, the multidrug/oligosaccharidyl-lipid/polysaccharide flippase 
(MOP)  family  transporter  from  P.  furiosus  generated  well  diffracting  crystals.  I 
established a cell-free production protocol of PF0780, both in the absence of detergent 
(PCF mode) and in the presence of detergent (DCF mode). The PCF produced protein 
was purified to homogeneity and showed long term stability when analyzed by analytical 
gel filtration chromatography. Crystallization was attempted with PCF produced PF0780. 
Blue native gel electrophoresis showed the cell-free produced protein to be oligomeric in 
nature.  However,  DCF  mode  production  resulted  in  decreased  purity  and  yield, 
establishing  PCF mode production  as  the  preferred  method for further  structural and 
functional studies. 
 
Initial  functional  characterization  of  STM3476, the  formate  nitrite  transporter  (FNT) 
family  protein  from  S.  typhimurium  showed  evidence  of  nitrite  transport.  I  tried  to 
produce STM3476 by cell-free expression for functional and structural characterizations. 
Both  PCF  and  DCF  mode  production  were  carried  out  with  detergent  screening  for 
maximum yield. The effect of the reaction temperature in terms of final yield was studied 
on PCF production, DCF production  and  the  solubilization of PCF produced protein 
precipitates in presence of detergents. Both in PCF and DCF mode production, the yield 
went  down  linearly  with  the  decrease  in  temperature.  However,  solubilization  of 
precipitates (PCF mode) at different temperatures (4 °C, 20 °C and 30 °C) with two 
different detergents revealed that the detergent type played a more prominent role than 
the temperature. 
Two more transporters, STM1781 of sulfate permease (SulP) family and STM3959 of 
amino acid transporting resistance to homoserine/threonine (RhtB) family, both from S. 
typhimurium, were produced in PCF mode. In the cell-based heterologous expression 
system, STM1781 was heavily degraded while STM3959 was not expressed at all. PCF 
produced  STM1781  protein  was  purified  without  degradation  and  characterized  for 
stability using n-dodecyl-β-D-maltoside (βLM) and FOS12 detergents by analytical gel 
filtration  using  superdex  200  column  in  SMART  system.  Similarly,  PCF  produced                                                                                                                           SUMMARY 
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STM3959 protein of RhtB family was purified in the presence of βLM. However, the 
protein lacks long term stability. 
 
The effect of MBP fusion on production and membrane integration of the membrane 
protein was tested with three selected transporters. STM0365 and STM3959 of the RhtB 
family were expressed under the detection limit both with and without MBP fusion. On 
the other hand, production and membrane integration upon MBP fusion of STM0758, a 
CDF family protein predicted to have both termini inside the cytoplasm, was lowered by 
3 to 5 times depending on the His tag positions. Probably, the placement of MBP on the 
N-terminus of a protein having its ends in the cytoplasm interfered with correct insertion 
into the membrane and resulted in reduced production. This observation also supported 
the predicted topology of STM0758 with both ends in the cytoplasm. 
 
This  work  succeed  in  heterologously  overproducing  and  establishing  purification 
protocols for several secondary active transporters aiming at structural and functional 
characterization in a structural genomics framework. It also showed that integration of 
alternative  strategies,  like  employing  both  cell-based  and  cell-free  heterologous 
expression systems, expands the overall expression space coverage and in turn increases 
the chance of success of a structural genomics styled project. 
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Abbreviations 
 
2D     2 Dimensional 
3D     3 Dimensional 
βME    β-Mercaptoethanol 
ABC     ATP Binding Cassette 
AP     Alkaline phosphatase enzyme 
APS     Ammonium persulphate 
ATP     Adenosine triphosphate 
BCA     Biscinchonic acid 
BCIP     5-Bromo-4-chloro-3-indolyl phosphate 
BNPAGE  Blue native polyacrilamide gel electrophoresis  
BSA     Bovine serum albumin 
CBB     Commassie brilliant blue dye 
CECF    Continuous exchange cell free 
CMC     Critical micellar concentration 
DCF    Detergent cell free reaction mode 
DSC    Differential scanning calorimetry 
DMSO   Dimethyl sulphoxide 
DNA     Deoxyribonucleic acid 
DTT     Dithiothritol 
EDTA    Ethylenediaminetetraacetic acid 
EM     Electron microscopy 
ETL       E. coli lipid total extract 
GFP     Green fluorescent protein 
GPCR    G protein coupled receptor 
HEPES   N-(2-Hydroxyethyl)-piperazine-N'-2-ethanesulfonic acid 
His     Histidine 
IMAC    Immobilized metal ion chromatography 
IMP    Integral membrane protein 
IPTG    isopropyl-β-1-thiogalactoside 
kD     kilo Dalton 
LPR    Lipid protein ratio                                                                                                               ABBREVIATIONS 
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MME    mono methyl ether 
NBT     Nitrobluetetrazolium 
NMR     Nuclear magnetic resonance 
ORF     Open reading frame 
PCF    Precipitate cell free reaction mode 
PDB     The protein data bank 
PEG     Polyethylene glycol 
polyHis   Poly histidine 
PVDF    Polyvinylidene difluoride 
RPM     Revolutions per minute 
RT    Room temperature 
SEC    Size exclusion chromatography 
SDS     Sodium dodecyl sulphate 
SDS-PAGE   Sodium dodecyl sulphate polyacrilamide gel electrophoresis 
SSM    Solid supported membrane 
TEV protease Tobacco Etch Virus protease 
TEMED   N,N,N,’N,’- tetramethylethylenediamine 
Tm    Melting temperature 
TRIS     Trishydroxymethylaminoethane 
 
 
Transporter protein families 
CDF     Cation diffusion facilitator family 
FNT    Formate nitrite transporter family 
MOP    Multidrug/oligosaccharidyl-lipid/polysaccharide flippase superfamily 
KUP    Potassium uptake permease family 
SulP    Sulfate permease family 
RhtB    Resistance to homoserine/threonine family 
 
 
 
 
                                                                                                               ABBREVIATIONS 
  c 
Detergents 
βLM     n-dodecyl-β-D-maltoside 
DM    n-decyl-β-D-maltoside 
UM    n-undecyl-β-D-maltoside 
NM    n-nonyl-β-D-maltoside 
Fos-12   N-dodecylphoscholine 
Fos-11   N-undecylphoscholine 
C10E5    Penteethylene glycolmonodecyl ether 
C12E9     dodecyl nonaoxyethylene ether 
OG     n-octyl-β-D-glucoside 
OTG    n-octyl-ß-D-thioglucoside 
NG     n-nonyl-β-D-glucoside 
LDAO   N,N-dimethyldodecylamin-N-oxid 
LMPC   1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine 
LMPG   1-myristoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] 
LPPG    1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] 
Brij35    Polyoxyethylene-(23)-lauryl-ether (C12 ⁄ 23)  
Brij-56   Polyoxyethylene-(10)-cetyl-ether (C16 ⁄ 10)  
Brij-58   Polyoxyethylene-(20)-cetyl-ether (C16 ⁄ 20)  
Brij-72   Polyoxyethylene-(2)-stearyl-ether (C18 ⁄ 2)  
Brij-78   Polyoxyethylene-(20)-stearyl-ether (C18 ⁄ 20)  
Brij-98   Polyoxyethylene-(20)-oleyl-ether (C18-1 ⁄ 20)  
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1.1 Biological membrane 
 
Membrane formation was a key step towards the formation of individual life. All living 
organisms are confined to a limited volume and surrounded by a surface border. The 
construction of that  border represents  one of the most  fundamental  considerations in 
biological organization. This outer shell is built to keep the interior contents from leaking 
out into the surrounding environment. The chemical processes of cellular life generally 
take place in an aqueous solution and the intracellular constituents of cells are largely 
molecules which are readily soluble in water. Similarly, the environment surrounding 
cells is an aquous one. A biological membrane composed of fatty molecules separate 
inside and outside (Alberts et al. 1994). This biological membrane or plasma membrane 
is almost invariably a bilayer  consisting of amphiphilic phospholipid molecules (Fig. 
1.1).  However,  membranes  are  not  merely  a  passive  barrier.  They  include  arrays  of 
proteins  specialized  for  facilitating  various  cellular  processes,  such  as  transporting 
metabolites and ions, sensing extracellular signals and energy transduction (Nelson and 
Cox 2000). 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Cross section of biological membrane showing different components. 
Source: http://www.apsu.edu/thompsOnj. For details see references. 
 
 
1.2 Integral membrane proteins (IMP) and their biogenesis 
 
Integral membrane proteins (IMPs) hold a critical role in the cell factory. They are of 
paramount  importance  for  a  wide  variety  of  cellular  processes.  In  the  completely 
sequenced genomes, the fraction of genes coding for membrane proteins is estimated to 
be about 25% (Lundstrom 2006). IMPs are composed of either helices (helical protein) or 
β sheets (β barrel protein). Though the helical types are predominant among IMPs, β 
barrel proteins are mostly found in outer membranes of gram negative bacteria. Apart                                                                                                                INTRODUCTION 
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from that,  membranes of  cyanobacteria,  mycobacteria, chloroplasts  and  mitochondria 
also have β barrel proteins. The firm attachment of IMPs to membranes is the result of 
mainly hydrophobic interactions between membrane lipids and hydrophobic domains of 
the proteins. 
Biogenesis  of  most  α  helical  proteins  appears  to  follow  a  partly  conserved  co-
translational pathway (reviewed in details by White and von Heijne 2004; Luirink et al. 
2005). In E. coli targeting involves a relatively simple signal recognition particle (SRP) 
and its cognate receptor SR (SRP Receptor). Insertion into the plasma membrane occurs 
via the Sec translocon, often with the involvement of some other associated proteins like 
YidC, Oxa1 and Alb3 (Fig. 1.2) 
 
Figure 1.2: Biogenesis of E. coli inner membrane 
proteins.  Step  1:  SRP  binds  to  a  particularly 
hydrophobic  targeting  peptide  in  nascent  proteins  at 
L23  near  the  nascent  chain  exit  site  on  the  large 
subunit  of  the  ribosome.  Step  2:  FtsY  binds  to  the 
ribosome-SRP complex and supports targeting to the 
inner  membrane  through  its  affinity  for  lipids  and, 
possibly,  the  Sec-translocon  component  SecY.  The 
nascent  protein  is  transferred  to  the  Sec/YidC-
translocon  or  to  a  YidC  insertase.  Step  3:  The 
transmembrane segments move laterally into the lipid 
bilayer and the membrane protein folds and assembles 
into the native (often oligomeric) structure. Malfolded 
membrane  proteins  are  identified  and  degraded 
(quality control). Reproduced from Luirink et al. 2005. 
 
1.3 Secondary active transporters 
 
In  terms  of  energy coupling mechanisms, two classes  of  membrane  transporters, the 
primary  active  and  secondary  active  transporters  are  abundant  in  all  known  species 
across different domains of life. Primary active transporters convert light or chemical 
energy  into  electrochemical  energy,  such  as  solute  concentration  gradients  plus  an 
electric voltage across membranes. The majority of the primary systems belong to the 
ATP  binding  cassette  (ABC)  superfamily.  On  the  other  hand  secondary  active 
transporters use the free energy stored in ion and/or solute gradients to drive the transport 
of another ion or solute across the cytoplasmic or internal membranes of biological cells. 
They are widely spread through all kingdoms of life; they are found in all biological cells 
and can probably be found for every low molecular weight compound in nature (Sobczak                                                                                                                INTRODUCTION 
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and  Lolkema,  2005).  Three  different  mechanisms  of  secondary  active  transports  are 
recognized  (Fig.  1.3),  uniport,  symport  and  antiport.  In  uniport  a  single  substrate  is 
transported along the electrochemical gradient while in symport two different substrates 
are transported in the same direction. The antiporters transport two different substrates in 
the opposite direction. However, some transporters may actually obey a mixture of these 
modes,  such  as  the  glutamate  transporter  which  translocates  glutamate  together  with 
three Na
+ ions and a proton and also in exchange of K
+( Broeer and Wagner 2003). 
 
Figure 1.3: Three types of secondary 
active  transport.  Uniport:  single 
substrate  transported  along  (electro) 
chemical  gradient.  Symport: 
concomitant  translocation  of  two 
substrates,  metabolites,  ions  or 
mixture. Antitransport: translocation of 
two substrates in opposite directions.  
S: substrate  gradient,  MP:  membrane 
potential,  Na
+:  Sodium  ion  gradient, 
H
+:  proton  gradient.  .  Reproduced 
from Broeer and Wagner 2003. 
 
The high abundance of secondary active transporters is reflected in the great diversity of 
their coding sequences. The transporter classification system (TC system) developed in 
the Saier lab (Saier 2000) is based on sequence homology and lists some 550 transporter 
families based on 3000 protein sequences (http://www.tcdb.org/).  
 
1.4 Represented families of secondary active transporters 
 
1.4.1 Cation diffusion facilitator family (CDF) 
 
The members of the cation diffusion facilitator (CDF) family serve as major metal efflux 
proteins. The primary substrate of the CDF transporters is zinc, but they also transport 
cobalt, nickel, cadmium and ferrous ions
 along with a proton or potassium ion in antiport 
fashion (Guffanti et al. 2002; Nies 2003). CzcD of Ralstonia metallidurans CH34, the 
archaetype of the family, was reported to mediate resistance to cobalt, cadmium
 and zinc 
in R. metallidurans while only zinc
 and cadmium in E. coli (Anton et al. 1999; 2004). 
The E. coli protein ZitB was reported to function as an antiporter in vivo, exchanging 
zinc
 for potassium ion,
 while YiiP showed evidence of an iron efflux function along with 
zinc (Grass et al. 2001; Lee et al. 2002; Grass et al. 2005). The human homologues of 
CDF transporters are called ZnT (SLC30). There are at least 9 ZnT transporters (Znt1-                                                                                                               INTRODUCTION 
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ZnT9) found in human cells which exhibit unique tissue specific expression, differential 
responsiveness to dietary zinc deficiency and excess and differential responsiveness to 
physiologic stimuli via hormones and cytokines (Liuzzi 2004). Most CDF transporters 
have 6 putative transmembrane segments and function as antiporters. Fig. 1.4 depicts the 
sequence alignment of known CDF transporters with the selected targets for this thesis 
work. The CDF members show the highest level of amino acid residue conservation in 
transmembrane  helix  II.  Paulsen  and  Saier  (1997)  proposed  a  CDF  family  specific 
signature sequence which begins with a fully conserved serine and continues just past a 
fully conserved aspartate. 
S X (ASG) (LIVMT)2 (SAT) (DA) (SGAL) (LIVFYA) (HDN) X3DX2(AS) 
 
[X = any residue; alternative residues at any one position are in parentheses] 
 
Recently, an atomic structure of YiiP, CDF protein from E. coli, has been published (Lu 
and Fu 2007, Lu et al. 2009). It is a homodimer held together in a parallel orientation 
through four zinc ions at the interface of the cytoplasmic domains (CTD), whereas the 
two transmembrane segments (TMS) swing out to yield a Y-shaped structure. In each 
protomer, the CTD  adopts  a  metallochaperone like  protein  fold;  the  TMS  features  a 
bundle of six transmembrane helixes and a tetrahedral zinc binding site  located in a 
cavity that is open to both, the membrane outer leaflet and the periplasm (Fig. 1.5). Site 
directed fluorescence resonance energy transfer (FRET) and mutation activity analysis 
suggested that zinc binding triggers hinge movements of two transmembrane domains. 
Highly conserved salt bridges interlock the transmembrane helices at the dimer interface, 
where  they  are  well  positioned  to  transmit  zinc  induced  interdomain  movements  to 
reorient transmembrane helices, thereby modulating coordinating geometry of the active 
site for zinc transport. 
The active site of zinc transport (Site A, one of three sites in each YiiP protomer) consists 
of four coordinating residues which facilitate preferred tetrahedral coordination for Zn(II) 
and Cd(II), but not for other divalent cations, such as Fe(II), Ni(II) and Co(II). This failed 
to explain the iron tolerance of a mutant E. coli strain overexpressing YiiP (Grass et al. 
2005). Moreover, the role of protons in zinc transport by CDF transporters still remains 
obscure.  Clearly  more  structural  and  functional  efforts  are  required to  find  out  how 
exactly these broad substrate specific CDF transporters work. 
                                                                                                                INTRODUCTION 
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Figure 1.4: Sequence alignment of selected CDF transporters for this thesis work and other 
known transporters. Zinc binding sites of YiiP are marked with black dots and CDF signature 
sequence with a box (Lu and Fu 2007, Lu et al. 2009). 
 
 
 
 
Yiip            --------MNQSYGRLVSRAAIAATAMASLLLLIKIFAWWYTGSVSILAALVDSLVDIGA 52 
STM0758         MAHSHSHADSHLPKDNNARRLLFAFIVTAGFMLLEVVGGILSGSLALLADAGHMLTDAAA 60 
ZitB(YbgR)      MAHSHSHTSSHLPEDNNARRLLYAFGVTAGFMLVEVVGGFLSGSLALLADAGHMLTDTAA 60 
Aq_1073         -----------MEREKSLKVLAFSFLLIFLFAFIEFLGGLLTNSLALLSDAGHMLTDAVS 49 
CzcD            MGAGHSHD----HPGGNERSLKIALALTGTFLIAEVVGGVMTKSLALISDAAHMLTDTVA 56 
ZnT8            HSGSKPTEKGANEYAYAKWKLCSASAICFIFMIAEVVGGHIAGSLAVVTDAAHLLIDLTS 113 
ZnT3            HRDPLPPPGLTPERLHARRQLYAACAVCFVFMAGEVVGGYLAHSLAIMTDAAHLLADVGS 115 
STM4061         --------MNQTYGRLVSRAAIAATAMASALLLIKIFAWWYTGSVSILAALVDSLVDIAA 52 
Aq_2073         --------------MKKHHWALVSFGFNIFQSLIKLVGGLLTGSLSLIGDAIHSLSDATA 46 
 
Yiip            SLTNLLVVRYSLQPADDNHSFGHGKAESLAALAQSMFISGSALFLFLTGIQHLISPTPMT 112 
STM0758         LLFALLAVQFSRRPPTVRHTFGWLRLTTLAAFVNAIALVVITLLIVWEAIERFYTPR-PV 119 
ZitB(YbgR)      LLFALLAVQFSRRPPTIRHTFGWLRLTTLAAFVNAIALVVITILIVWEAIERFRTPR-PV 119 
Aq_1073         LSIALVAQYLALKVKTKRTTYGLYRLEVLAALVNGVFLLGLIGYIILEAIHRFENPE-PV 108 
CzcD            LAIALAAIAIAKRPADKKRTFGYYRFEILAAAFNALLLFGVAIYILYEAYLRLKSPP-QI 115 
ZnT8            FLLSLFSLWLSSKPPSKRLTFGWHRAEILGALLSILCIWVVTGVLVYLACERLLYPDYQI 173 
ZnT3            MMGSLFSLWLSTRPATRTMTFGWHRSETLGALASVVSLWMVTGILLYLAFVRLLHSDYHI 175 
STM4061         SLTNLLVVRYSLQPADDEHTFGHGKAESLAALAQSMFISGSALFLFLTSIQNLIKPTPMN 112 
Aq_2073         SLIAFLSIKFS-EIKSERFPYGLYKLENIGAIVIAFFLLFTAWEIIQRALKGEININ-FE 104 
 
Yiip            DPGVGVIVTIVALICTIILVSFQRWVVRRT----------------------QSQAVRAD 150 
STM0758         AGNLMMVIAVAGLLANLFAFWILHRGSDEK-----------------------NLNVRAA 156 
ZitB(YbgR)      EGGMMMAIAVAGLLANILSFWLLHHGSEEK-----------------------NLNVRAA 156 
Aq_1073         KP-QMIYIAFAGLIVNLVVGYILLKHSEE------------------------NINIKSA 143 
CzcD            ESTGMFVVAVLGLIINLISMRMLSSGQSS------------------------SLNVKGA 151 
ZnT8            QATVMIIVSSCAVAANIVLTVVLHQRCLGHNHKEVQAN----------------ASVRAA 217 
ZnT3            EGGAMLLTASIAVCANLLMAFVLHQAGPPHSHGSRGAEYAPLEEGPEEPLPLGNTSVRAA 235 
STM4061         DPGVGIGVTVIALICTIILVTFQRWVVRKT----------------------QSQAVRAD 150 
Aq_2073         NLPIGIGVTVLSLVLSLTLSFLERRAGKKLN----------------------SPTLIAD 142 
 
Yiip            MLHYQSDVMMNGAILLALGLSWYG--WHRADALFALGIGIYILYSALRMGYEAVQSLLDR 208 
STM0758         ALHVMGDLLGSVGAIVAALIIIWT-GWTPADPILSILVSVLVLRSAWRLLKDSVNELLEG 215 
ZitB(YbgR)      ALHVLGDLLGSVGAIIAALIIIWT-GWTPADPILSILVSLLVLRSAWRLLKDSVNELLEG 215 
Aq_1073         LLHVATDTLGSVAAIIAGIAIVFW-KFYLADPILSVAVALLILPSAYSVIKETVNVLLEV 202 
CzcD            YLEVWSDLLGSVGVIAGAIIIRFT-GWAWVDSAIAVLIGLWVLPRTWILLKSSLNVLLEG 210 
ZnT8            FVHALGDLFQSISVLISALIIYFKPEYKIADPICTFIFSILVLASTITILKDFSILLMEG 277 
ZnT3            FVHVLGDLLQSFGVLAASILIYFKPQYKAADPISTFLFSICALGSTAPTLRDVLRILMEG 295 
STM4061         MLHYQSDVMMNGAILIALGLSWYG--WHRADALFALGIGIYILYSALRMGYEAVQSLLDR 208 
Aq_2073         SYHTLTDAFSSFLVLISLSSYYFG---INIERYVAVAVALIIVYTAFELLKEQIGAILDI 199 
   
Yiip            ALPDEERQEIIDIVT-SWPGVSGAHDLRTRQSGP-TRFIQIHLEMEDSLPLVQAHMVADQ 266 
STM0758         APVSLDINALQRHLSREIPEVRNVHHVHVWMVGE-KPVMTLHAQVIP--PHDHD-ALLER 271 
ZitB(YbgR)      APVSLDIAELKRRMCREIPEVRNVHHVHVWMVGE-KPVMTLHVQVIP--PHDHD-ALLDQ 271 
Aq_1073         APSHINTEELEKELL-NLQGVKGVHDLHVWSITPGTEVLTVHVVVED--TSICN-DILKE 258 
CzcD            VPDDVDLAEVEKQIL-ATPGVKSFHDLHIWALTSGKASLTVHVVNDT--AVNPEMEVLPE 267 
ZnT8            VPKSLNYSGVKELIL-AVDGVLSVHSLHIWSLTMNQVILSAHVATAA--SRDSQ-VVRRE 333 
ZnT3            TPRNVGFEPVRDTLL-SVPGVRATHELHLWALTLTYHVASAHLAIDS--TADPE-AVLAE 351 
STM4061         ALPDAERQEIIDIVT-SWPGVSGAHDLRTRQSGP-TRFIQIHLEMEDNLPLVQAHFVADQ 266 
Aq_2073         SADKETVEKIKRIIL-SFPEVSEVKRLLVRNAGG-RLFIDAVITINT-DDFIKSHAIADE 256 
 
Yiip            VEQAILRRFP-GSDVIIHQDPCSVVPREGKRSMLSS------------------------ 301 
STM0758         IQDFLMHEYH-IAHATIQMEYQVCHGPDCH--LN-QTSSGHVHHH--------------- 312 
ZitB(YbgR)      IQHYLMDHYQ-IEHATIQMEYQPCHGPDCH--LN-EGVSGHSHHHH-------------- 313 
Aq_1073         VEK-IAHKYG-IKHTTVQLEKEGYACAECCPLLSPQGLKFHHHHHHGHEHEH-------- 308 
CzcD            LKQMLADKFD-ITHVTIQFELAPCEQADAAQHFNASPALVGSKSLAAGGN---------- 316 
ZnT8            IAKALSKSFT-MHSLTIQMESPVDQDPDCLFCEDPCD----------------------- 369 
ZnT3            ASSRLYSRFG-FSSCTLQVEQYQPEMAQCLRCQEPPQA---------------------- 388 
STM4061         VEQAILQRFP-GSDVIIHQDPCSVVPREGRKFELV------------------------- 300 
Aq_2073         IERKIMKEIPNVDMVFIHYEPCCVKKGTSVAVLAKDGVVARSFKDVDKIIIFKENEGNPE 316                                                                                                                INTRODUCTION 
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Figure 1.5: YiiP Structure. (A) YiiP homodimer (yellow and cyan for each protomer) viewed 
from  the  membrane plane.  Magenta  spheres  represent  bound  zinc  ions  in  zinc-binding sites, 
which are marked by red circles. Red arrows indicate the directions of Zn(II) exit from the two 
active  sites.  Grey  lines  indicate  the  possible  membrane  boundaries.(B)  Schematic  model  for 
autoregulation.  TM3-TM6  pairs  and  four-helix  bundles  are  coloured  in  yellow  and  cyan, 
respectively. Open boxes represent the charge interlock located at the pivotal point of the hinge-
like motions (Lu et al. 2009). 
 
1.4.2 Formate nitrite transporter (FNT) family 
 
The FNT family is a group of integral membrane proteins that are, on average, between 
256  and  285  residues  in  length  and  are  predicted  to  possess  6–8  transmembrane 
segments. They are found widely in prokaryotes. In addition, 64 species of eukaryotes, 
including yeast, fungi, and protists, possess genes encoding FNT proteins but no clear 
homologues have been observed in the genomes of higher plants or metazoans. Although 
very few of these transporters have been characterized biochemically, FNT proteins are 
believed  to  enable  the  specific  transport  of  formate  and/or  nitrite.  Prokaryotic  FNT 
proteins that have been characterized include FocA and NirC of E. coli that have been 
implicated in the transport of formate and nitrite, respectively (Suppman and Sawers 
1994, Saier et al. 1999; Clegg et al. 2002). 
Several reports suggested FNT proteins to function as  higher oligomers (Falke et  al. 
2009; Beckham et al. 2009). Very recently, two atomic structures of FocA from E. coli 
and Vibrio cholerae, have been published back to back. These structures revealed FocA 
to  form  a  symmetric  pentamer,  with  each  protomer  consisting  of  6  transmembrane 
segments (Fig. 1.6). Despite a lack of sequence homology, the overall structure of the 
FocA protomer closely resembles that of aquaporin and strongly argues that FocA is a                                                                                                                INTRODUCTION 
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channel, rather than a transporter. Unlike aquaporin, FocA is impermeable to water but 
allows the passage of formate (Wang et al. 2009; Waight et al. 2010).  
According to Waight et al. (2010), the positively  charged surface of the cytoplasmic 
funnel helps to concentrate formate ions in a preselection process. The selectivity filter of 
the formate channel begins at the cytoplasmic slit. At the inner site, both oxygen atoms of 
the formate form a hydrogen bond with the N atom of histidine 208, and the formate 
makes van der Waals contact with the slit, suggestive of a coin in a slot, except that the 
coin cannot tilt or rotate due to the hydrogen bonds. The binding of the inner formate ion 
in turn facilitates the binding of the outer formate ion by forming a hydrogen bond with 
the  latter. Once the  first formate ion passes the cytoplasmic  slit,  it  goes through the 
remaining  part  of  the  selectivity  filter  fairly  smoothly.  There  is  probably  little 
electrostatic  interaction  with  the  periplasmic  half of the pore due  to  its  hydrophobic 
surface; the size of the 2.3 Å central restriction ring fits with the dimensions of the 
formate.  After  the  formate  ion  reaches  the  exit  of  the  filter,  the  negatively  charged 
periplasmic funnel rapidly repels it into the extracellular space. 
 
 
 
 
 
 
Figure 1.6: Structure of FocA. (A) Ribbon representation of the FocA pentamer of E. coli, 
shown in two perpendicular views. Note the pore in the centre of the pentameric assembly (black 
circle) and the axial passage in each of the five protomers (magenta circles). (B) Pentameric 
structure  of  FocA  from  Vibrio  cholerae  determined  at  2.13  Å  resolution;  viewed  from  the 
periplasm. Reproduced from Wang et al. 2009 and Waight et al. 2010. 
 
1.4.3 Multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) flippase superfamily 
 
The MOP exporter superfamily consists of four previously recognized families: (a) the 
ubiquitous multi-drug and toxin  extrusion (MATE) family; (b) the prokaryotic poly-
saccharide transporter (PST) family; (c) the eukaryotic oligosaccharidyl-lipid flippase 
(OLF)  family  and  (d)  the  bacterial  mouse  virulence  factor  family  (MVF).  These 
transporters are all homologous and are, therefore, related by common descent. Since, I 
had chosen a MATE family transporter from Pyrococcus furiosus for this thesis work,                                                                                                                INTRODUCTION 
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only this family will be discussed in details. MATE transporters typically possess 12 
transmembrane  segments.  NorM  from  Vibrio  parahaemolyticus  was  the  first 
characterized MATE family transporter. It functions as a sodium drug antiporter (Morita 
et al. 1998). One of the most important properties of a MATE transporter is its substrate 
specificity.  From  the  published  data  regarding  drug  susceptibility  tests,  almost  all 
MATE-family transporters can recognize fluoroquinolones as transport substrates, such 
as  norfloxacin.  Among  cationic  dyes,  acriflavine  and  ethidium  are  pumped  out  via 
several MATE transporters. Substrates for the MATE transporters identified up to now 
are various and have unrelated chemical structures (Kuroda and Tsuchiya 2009). Though 
initially believed to be solely a sodium drug antiporter, MATE family proteins are also 
reported to function as H
+/drug antiporter (He et al. 2004; Su et al. 2005). Bacterial 
species that have developed clinical resistance to antimicrobial agents are increasing in 
numbers and have become a serious problem in hospitals. MATE family transporters 
could easily become an important drug target. The most desired step towards this, is a 
three dimensional structure. Only an atomic structure could answer the broad substrate 
specificity and ubiquity of this scantly characterized MATE family transporter. 
 
1.4.4 Potassium uptake permease (KUP) family 
 
Proteins of the KUP family include the KUP (TrkD) protein of E. coli and homologues in 
both  Gram-positive  and  Gram-negative  bacteria.  High  affinity  (20   M)  K
+  uptake 
systems (Hak1) of the yeast Debaryomyces occidentalis as well as of Neurospora crassa, 
and  several  homologues  in plants  have  been  characterized. Arabidopsis thaliana  and 
other plants possess multiple KUP family paralogues. The E. coli protein is 622 amino 
acyl residues long and has 12 putative transmembrane spanners (440 residues) with a 
requisite hydrophilic, C-terminal domain of 182 residues, localized at the cytoplasmic 
side of the membrane. Deletion of most of the hydrophilic domain reduces but does not 
abolish KUP transport activity. The function of the C-terminal domain is not known. The 
E. coli KUP protein is believed to be a secondary active transporter. Uptake is blocked by 
protonophores  such  as  CCCP  (but  not  arsenate),  and  evidence  for  a  proton  symport 
mechanism has been presented (Zakharyan and Trchounian 2001). The N. crassa protein 
was earlier shown to be a K
+:H
+ symporter, establishing that the KUP family consists of 
secondary active transporters. The yeast high affinity (KM = 1 µM) K
+-transporter Hak1                                                                                                                INTRODUCTION 
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is 762 amino acid residues long with 12 putative transmembrane segments. Like the E. 
coli KUP protein, it possesses a C-terminal hydrophilic domain, probably localized at the 
cytoplasmic side of the membrane. Hak1 may be able to accumulate K
+ 10
6-fold against 
a concentration gradient. The plant high and low affinity K
+ transporters can complement 
K
+ uptake defects in E. coli. The generalized transport reaction for members of the KUP 
family is: 
       
1.4.5 Resistance to homoserine/threonine (RhtB) family 
 
About 100 sequenced proteins, derived from Gram-negative and Gram-positive bacteria 
as  well  as  from  archaea,  comprise  the  RhtB  family,  but  few  of  these  proteins  are 
functionally characterized (Vrljic et al. 1999). E. coli possesses five paralogues, and a 
large region of one of them (YahN of E. coli) exhibits significant sequence similiarity to 
YggA of E. coli, an established member of the LysE family. The PSI-BLAST program 
groups the L-Lysin exporter (LysE) family, the RhtB family and the cadmium resistance 
(CadD)  family  together.  These  proteins  are  all  of  about  the  same  size  and  possess 
apparently  the  same  topology,  further  suggesting  a  common  evolutionary  origin 
(www.tcdb.org).  The  first  two  members  of  the  RhtB  family  to  be  characterized 
functionally  were  the  RhtB  and  RhtC  permeases  of  E.  coli  (Aleshin  et  al.  1999; 
Zakataeva et al. 1999). YfiK of E. coli exports cysteine, O-acetylserine and azaserine 
(Franke et al. 2003). The YeaS (LeuE) homologue exports leucine and several other 
neutral, hydrophobic amino acids (Kutukova et al. 2005). Aleshin et al. (1999) reported a 
partial alignment of recognized bacterial and archael members of the RhtB and LysE 
families, but not the CadD family. Vrljic et al. (1999) reported phylogenetic trees for all 
three families of the LysE superfamily (LysE, RhtB and CadD). The transport reaction 
presumably catalyzed by members of the RhtB family is: 
   
1.4.6 The sulfate permease (SulP) family 
 
The SulP family is a large and ubiquitous family with over 200 sequenced members 
derived from archaea, bacteria, fungi, plants and animals. Many organisms  including 
K
+ (out) + energy ￿ ￿ ￿ ￿ K
+ (in) 
amino acid (in) + nH
+ (out)  amino acid (out) + nH
+ (in)                                                                                                                INTRODUCTION 
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Bacillus subtilis, Synechocystis sp., Saccharomyces cerevisiae, Arabidopsis thaliana and 
Caenorhabditis elegans possess multiple SulP family paralogues. Many of these proteins 
are  functionally  characterized,  and  most  are  inorganic  anion  uptake  transporters  or 
anion:anion exchange transporters. Some transport their substrate(s) with high affinities, 
while others transport it or them with relatively low affinities. Many function by SO4
2-
:H
+ symport, but SO4
2-:HCO3
-, or more generally, anion:anion antiport has been reported 
for several homologues. The bacterial proteins vary in size from 434 residues to 573 
residues with  only  a  few exceptions. The eukaryotic proteins  vary  in  size  from 611 
residues to 893 residues with a few exceptions. Thus, the eukaryotic proteins are usually 
larger  than  their  prokaryotic  homologues.  These  proteins  exhibit  10-13  putative 
transmembrane α-helical segments (TMSs) depending on the protein. The generalized 
transport reactions catalyzed by SulP family proteins are: 
 
1.5 Heterologous overproduction of membrane protein 
 
Transport proteins are usually present at low levels and constitute 0.1% of the total cell 
membrane protein  (Lundstrom 2006). This is  a key  bottleneck  when  considering  the 
structural studies of transporters which demands milligram quantities of purified protein. 
Moreover,  use  of  natural  resources  excludes  the  possibility  of  genetically  modifying 
proteins  to  improve their  stability  and  facilitate  their easy  detection and purification. 
With the advance  of  genome sequencing,  a  whole  lot of  other  transporter  targets of 
potential therapeutic importance, from diverse domains of life, are queuing up. But one 
could imagine how tedious and costly it might be to isolate transporters from natural 
sources. So, the obvious alternative is to heterologously overproduce the recombinant 
target  protein  from  diverse  source  organisms  in  a  suitable  expression  host.  The 
heterologously overproduced membrane proteins are more homogeneous compared to 
proteins  isolated  from  the  native  source.  Both  the  necessity  and  feasibility  of 
overexpression  are  evident  from  the  steadily  growing  number  of  high  resolution 
structures  of  helical  membrane  proteins  obtained  through  overexpression 
(http://blanco.biomol.uci.edu/Membrane_ Proteins_xtal.html). In the last few years, there 
were several reports of heterologous overproduction of membrane proteins and many of                                                                                                                INTRODUCTION 
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them were in highthroughput fashion (Dobrovetsky and Lu 2005; Eshaghi et al. 2005; 
Korepanova et al. 2005; Surade et al. 2006; Psakis et al. 2007; Gordon et al. 2008). 
 
1.5.1 Choice of target: source organism 
 
Sequence data of genomics projects and the availability of genomic DNA have made it 
possible to  clone  almost any  transporter protein.  As a result, multiple members of a 
protein  family  of  interest  can  be  selected  from  different  source  organisms  for 
overexpression and crystallization (Goeddel 1990; Chang and Roth 2001; Locher et al. 
2002; Surade et al. 2006). Among the members of the chosen protein family, transporters 
that  have  been  biochemically  and  functionally  characterized  are  worth  considering, 
because such information may help crystallization experiments. 
The work for this thesis is also a part of structural genomics project where more than 240 
transporters belonging to 40 different families were selected from three different source 
organisms. The detailed characteristics and the reasons for the choice of these organisms 
are tabulated below. 
 
Table 1.1 Details of the three selected source organisms for this work 
Parameter  Aquifex aeolicus VF5  Pyrococcus 
furiosus DSM 
3638 
Salmonella 
typhimurium LT2 
First isolation  Underwater volcanoes, 
hot springs 
Heated marine 
sediments 
Pig intestinal fluid 
Ambient 
temperature (ºC) 
85-95  70-103 (100)  27-40 (35.5) 
Size (µm)  2-6  0.8-1.5  0.5-3 
Sequencing center  Diversa corporation & 
University of Illinois at 
UC 
University of Utah 
and University of 
Maryland 
Washington University 
Consortium 
Year of annotation 
at CMR 
January-December 
2000 
June 2002  November 2001 
Genome 
size(Mbp) 
1.55  1.91  4.95 
GC content (%)  43.47  40.76  52.23 
Primarily 
annotated genes 
1522  2065  4553 
Structures in PDB
# 
(with genus) 
312  749  204 
Reason for 
selection 
Hyperthermophilic 
bacterium 
Hyperthermophilic 
archaeon 
Pathogenic, mesophilic 
bacterium 
CMR : Comprehensive microbial resource, PDB : Protein data bank, # as of Feb. 18,2010 
Source : http://cmr.jcvi.org/tigr-scripts/CMR/CmrHomePage.cgi                                                                                                                INTRODUCTION 
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1.5.2 Expression vectors and tags 
 
Heterologous overexpression of membrane protein genes/cDNAs greatly depends on the 
choice of expression vectors. An ideal vector should have a tightly regulated, moderately 
strong promoter and should have a wide range of usable inducer concentrations. Tight 
regulation prevents leaky expression, which can lead to in vivo proteolysis or even cell 
death when a toxic membrane protein is produced. To meet the needs of this project, 
three  vectors,  pBAD,  pTTQ18  and  pQE  were  chosen  to  overproduce  membrane 
transporters in vivo. 
The  pBAD  vectors  from  Invitrogen,  containing  the  arabinose  araBAD  operon,  are 
particularly  suitable  for  overproduction  of  membrane  proteins  (Guzman  et  al.  1995; 
Surade et al. 2006). The promoter is repressed 1200 fold and can be  induced by L-
arabinose at concentrations upto 0.2%. This vector was used to overproduce a wide range 
of membrane proteins (Auer et al. 2001; Li et al. 2001; Surade et al. 2006), showing its 
general applicability. The pTTQ18 vector uses the moderately strong tac promoter. It has 
been used to successfully overproduce membrane proteins, with a yield of upto 1-2mg /L 
by Ward et al. (1999; 2000; 2001). Finally the pQE vector (Qiagen), which uses the 
stronger  T5  promoter,  has  two  lac  operator  binding  sites,  which  prevent  expression 
without inducer. 
For the convenience of highthroughput cloning, all vectors were modified to have the 
identical multiple cloning sites as well as one of two sets of tags (A2 or C3). Fig.1.7 
depicts the final protein product with different tags. 
 
 
 
 
 
 
Figure 1.7: Schematic representation of final protein products. A2 has an N-terminal deca 
His- tag preceded by a TEV cleavage site. C3 has an N-terminal STREP-II tag and a C-terminal 
deca His-tag followed by a TEV cleavage site. 
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1.5.3 Choice of the expression host: E. coli  
 
By  far,  E.  coli  is  the  preferred  expression  host  for  heterologous  overexpression  of 
membrane protein genes, where the production level could go up to 50% of the total 
cytoplasmic protein (Ward et el. 1999). Convenient features, like well studied genetics, 
low cost, growth to relatively high density and availability of a large number of cloning 
and expression vectors, make E. coli invaluable. Moreover, the availability of different 
promoters for expression provides a wide range of choices for heterologous production. 
Because  of  the  well  studied  genetics  and  physiology,  a  range  of  E.  coli  strains  are 
available for expression. As changing strains  could affect the expression by 2-5 fold 
(Auer et al. 2001), one should try different strains at the beginning. Several strains with 
protease deficiencies  or  with  extra  codons  are  available.  E.  coli  host  strain  carrying 
plasmids (pRARE) encoding rare tRNAs are used to express genes from thermophilic 
archaea (Wakagi et al. 1998; Kanaya et al. 1999). Auxotrophic mutants of E. coli, like 
B834  (methionine  auxotroph),  allow  efficient  labeling  of  target  protein  with 
selenomethionine,  a  feature  that  facilitates  structure  determination  by  the 
multiwavelength anomalous diffraction method. While pET and pQE based vectors could 
be expressed in BL21(DE3) strain or C43(DE3) strain or NM554 strain,  pBAD vectors 
require the host cell to be deficient in arabinose metabolism, like TOP10 cell. For this 
work, NM5554 and BL21(DE3) for pTTQ18 and pQE vectors while TOP10 for pBAD 
vector were chosen. 
 
1.5.4 Bottlenecks affecting heterologous overexpression and remedies 
   
1.5.4.1 Overexpression, targeting and folding 
Prokaryotic membrane proteins are usually overexpressed in E. coli while eukaryotic 
membrane  proteins  have  been  overexpressed  in  Lactococcus  lactis  and  various 
eukaryotic systems. Heterologous overexpression of target protein can be hampered by 
different synthesis, targeting, insertion and folding characteristics in the overexpression 
host (Tate 2001). Incompatibility of factors involved in the processing of heterologously 
expressed  membrane  proteins  (discussed  earlier  in  the  membrane  protein  biogenesis 
section) indicates a general problem (Goder et al. 2004; Bowie 2005). In addition, the                                                                                                                INTRODUCTION 
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availability of endogenous factors necessary for biogenesis of membrane protein could 
turn out to be the limiting factor for heterologous overexpression (Valent et al. 1995). 
Optimizing the overexpression condition by lowering the culture temperature or inducer 
concentration or choosing a different promoter might be beneficial. A recent study in 
yeast indicates that culture condition not only influence the amount of produced protein 
but also its membrane integration (Bonander et al. 2005). Wang and co-workers (Chen et 
al. 2003) reported increased overproduction of the E. coli CorA protein in E. coli when 
coexpressed  with  cytoplasmic  DnaK-DnaJ  chaperone  system.  Moreover,  yields  of 
functionally overproduced membrane proteins can also be increased by adding ligands to 
the culture medium which assists folding and stabilization of the overproduced protein 
(Weiss et al. 1998; Andre et al. 2006). 
 
1.5.4.2 Membrane space and accommodation of foreign structures 
The membrane space required to accommodate overproduced proteins represents another 
bottleneck.  The  accumulation  of  foreign  structures  in  a  membrane  can  induce  stress 
responses  and  activate  proteolytic  systems  of  the  overexpressing  hosts  (Kihara et  al. 
1995; Griffith et al. 2003). An attractive remedy is to use an expression system which has 
a larger membrane surface area or by nature has a high biogenesis capacity for membrane 
proteins  and  sufficient  space  in  the  membrane  to  accommodate  the  overexpressed 
materials  (Eroglu  et  al.  2002).  Roy  et  al.  (2008)  from  our  lab  reported  functional 
overproduction of several GPCRs in Rhodobacter sphaeroides, employing the fact that R.  
sphaeroides  provides  more  membrane  surface per  cell  compared  to other  expression 
hosts. 
 
1.5.4.3 Lipid composition 
Membranes  from  prokaryotes,  yeasts  or  higher  eukaryotes  differ  in  their  lipid 
composition,  which  might lead  to problems  with  the  heterologous overproduction of 
functional  membrane  proteins  (Opekarova  and  Tanner  2003).  For  example,  the 
mammalian  presynaptic  serotonin  transporter  is  functionally  obtained  only  in  the 
presence of cholesterol (Tate 2001), while the E. coli protein LacY absolutely requires 
the  lipid  phosphatidylethanolamine  for proper folding (Bogdanov  et  al.  1996; 1999).
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1.5.4.4 Stability of messenger RNA 
Gene expression levels are mainly determined by the efficiency of transcription, mRNA 
stability (rate of decay) and the frequency of mRNA translation. The average half life of 
mRNA  in  E.  coli  at  37  ºC  ranges  from  seconds  to  maximally  20  minutes  and  the 
expression rate depends directly on the inherent mRNA stability (Rauhut and Klug 1999; 
Regnier and Arraiano 2000). A mRNA fragment encoding the C-terminal region of an E. 
coli  Fo  ATPase  subunit  was  stabilized  by  fusion  to  the  sequence  encoding  green 
fluorescent protein (GFP) (Arechaga et al. 2003). E. coli strains containing a mutation in 
the  gene  encoding  RNaseE  (rne131  mutation)  are  available  for  the  enhancement  of 
mRNA stability in recombinant expression systems (Invitrogen BL21 star strain). 
   
1.5.4.5 Toxicity of target protein 
Toxicity of heterologously produced protein in the host cell poses a major hindrance in 
highthroughput protein production, especially  in a structural genomics set up. E. coli 
strain C42(DE3) and C43(DE3), derived from E. coli strain BL21(DE3), are best known 
for their ability to mitigate the toxic effect of overexpressing membrane protein and also 
increasing the protein level (Miroux et al. 1996; Eshaghi et al. 2005; Drew et al. 2006). 
Additionally, the newly developed cell-free expression system  for membrane protein, 
discussed in details in the following pages, is an attractive alternative. 
 
1.5.4.6 Poor expression and N terminal fusion partner; MBP fusion 
While  the  N-terminal  ends  of  membrane  proteins  show  a  strong  preference  for  the 
cytoplasm (Wallin et al. 1995; Daley et al. 2005), their translocation efficiency during 
biogenesis hampers the overexpression, specially the ones that have to translocate across 
the membrane (Monne et al. 2005). N-terminal soluble protein fusion partners, such as 
glutathione S-transferase, NusA, green fluorescent protein (GFP) and maltose binding 
protein (MBP) are routinely tested for their ability to improve the expression of poorly 
expressed membrane proteins. MBP fusion strategy was employed for some of the targets 
in the present study to check its effect on production level and also to gain insight of their 
topology. 
MBP is localized in the periplasmic space of E. coli and possesses a signal peptide which 
is cleaved off during translation of MBP across the membrane. The C-terminal fusion of 
MBP is usually performed without the periplasmic signal peptide (first 26 amino acid                                                                                                                INTRODUCTION 
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residues), while the N-terminal fusion is described for both periplasmic full-length MBP 
and cytoplasmic MBP lacking the signal sequence (Spangfort et al. 1996; Korepanova et 
al.  2007).  The  successful  application  of  MBP  fusion  for  the  expression  of  22  low 
molecular  weight  (less  than  4  transmembrane  helices)  membrane  proteins  from 
Mycobacterium  tuberculosis  was  recently  demonstrated  (Korepanova  et  al.  2007). 
Several human G-protein coupled receptors (GPCR) were functionally overproduced in 
E. coli as fusions with full length MBP (Grisshammer et al. 1994; Grisshammer et al. 
2002; Weiss and Grisshammer 2002; White et al. 2004; Yelisseev et al. 2007). In contrast 
to many other solubility tags, MBP has the additional benefit of being an affinity tag 
(Esposito and Chatterjee 2006; Cabanne et al. 2009). 
To  evaluate the effect of full  length  MBP (with signal  peptide) on the  heterologous 
expression of secondary active transporters, MBP was fused to the N-terminus of three 
prokaryotic membrane transporters belonging to 2 different families. N- and C-terminal 
His-tag fusions were tested, in parallel, to compare the effect of tags. The constructs are 
schematically represented in Fig 1.8. 
 
 
   
   
   
     
 
 
 
 
Figure 1.8: Constructs used for MBP fusion. A and C are the conventional constructs while B 
and D are corresponding MBP fusion constructs with MBP is inserted at the N-terminus. 
 
 
1.6 Cell-free production of membrane protein 
 
Low  natural  abundance  is the biggest obstacle  for working  with membrane proteins. 
Moreover, in vivo overexpression is notoriously problematic, often resulting in low yield, 
cell toxicity, protein aggregation and misfolding. Isolation and purification of the protein                                                                                                                INTRODUCTION 
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from  the  membrane  and  subsequent  reconstitution  are  not  easy.  Cell-free  expression 
systems  are  increasingly  being  considered as a  viable  alternative  for overcoming the 
above obstacles. The cell-free systems offer, in principle: (i) the possibility to eliminate 
toxic effects of recombinant protein to the cell, (ii) flexibility, as conditions like pH, 
redox potential or buffer system could easily be altered, (iii) open nature, as nearly any 
compound can be added at any time point directly to the reaction chamber, (iv) reduced 
proteolytic degradation and enhanced functional folding by addition of protease inhibitor 
or chaperones, respectively, (v) stabilization by  addition of substrates or ligands, (vi) 
generation  of  an  artificial  hydrophobic  environment  in  the  cell-free  reaction  for  the 
production of membrane proteins (Spirin and Swartz 2008). 
 
1.6.1 Development of coupled transcription translation system 
 
Cell-free expression systems are reconstituted reactions based on cellular extracts that 
recapitulate  the  transcription-translational  capabilities  of  a  cell  in  vitro.  The  first 
demonstration of DNA-dependent incorporation of amino acids into synthesized proteins 
as well as the first evidence for the coupled transcription-translation process in bacterial 
cell-free  systems  were  made  by  Nirenberg’s  group  in  the  beginning  of  the  1960s 
(Matthaei and Nirenberg 1961; Byrne et al. 1964). In 1967, Zubay and colleagues made 
significant improvements (DeVries and Zubay 1967; Lederman and Zubay 1967) and 
introduced an efficient bacterial coupled transcription-translation system for expression 
of  exogenous  DNA.  The  next  important  step  in  the  development  of  cell-free  gene 
expression was the combination of a cell extract with a  specific bacteriophage RNA 
polymerase (T7 or SP6) that used a phage-specific promoter for transcription. According 
to  Spirin  and  Swartz  (2008),  this  system  could  rather  be  called  “combined”  than 
“coupled”  transcription-translation  system,  due  to  lack  of  temporal  and/or  spatial 
coupling between the transcription and translational machinery.  
 
1.6.2 Types and modes of reaction 
 
In batch mode, performed in a fixed volume of a test tube, the conditions change during 
incubation as a result of the consumption of substrates and the accumulation of products. 
Translation stops as soon as any essential substrate is exhausted or any product or by-                                                                                                               INTRODUCTION 
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product reaches an inhibiting concentration, usually after 20–60 minutes of incubation 
(Fig  1.9A).  In  the  continuous  exchange  cell  free  (CECF)  system,  the  reaction  is 
performed under conditions of persistent supply of the consumable substrates, such as, 
amino  acids,  nucleoside  triphosphates  and  energy-regenerating  compounds  and  with 
removal  of  the  reaction  products,  mainly  inorganic  phosphates  and  nucleoside 
monophosphates (Fig. 1.9B).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9: Cell-free expression system, types and modes. (A) Batch reaction. (B) Continuous 
exchange cell-free reaction. (C) Dialysis set up used for reaction. 1: RM, 2: FM, 3: Dialysis 
membrane. (D) Mode of reactions, PCF, DCF and LCF (Schneider et al. 2010). 
 
For this purpose, a porous (dialysis) membrane  is used to retain the high-molecular-
weight  components  of  the  protein-synthesizing  machinery  (ribosomes,  mRNA,  etc.) 
within  a  defined  reaction  compartment.  The  membrane  separates  the  reaction 
compartment  (RM:  reaction  mix)  from  another  compartment  containing  a  feeding 
solution  (FM:  feeding  mix)  with  a  reservoir  of  low-molecular-weight  components 
(substrates) for the reaction (Fig. 1.9C). Cell-free production of membrane proteins can 
be performed in three different modes: (i) protein can be obtained as precipitate (PCF) 
and then resolubilized and purified in a suitable detergent, (ii) produced in soluble form 
with detergent micelles in the reaction mix (DCF) or (iii) synthesized in the presence of 
preformed  liposomes  (LCF)  and  isolated  from  the  reaction  mix  by  density  gradient 
centrifugation (Fig. 1.9D). 
 
A  B  C 
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1.6.3 E. coli S30 extract 
 
The  cell  extract  preparation  is  one  of  the  key  steps  in  obtaining  successful  and 
reproducible results using the cell-free protein synthesis. Currently up to 10mg of protein 
per mL of reaction mix by CECF mode is reported (Spirin and Swartz 2008). The most 
important aspect in making the extract is to choose the right strain. The E. coli strains 
that lack major RNases, such as MRE600, A19 were routinely used (Zubay 1973; Pratt 
1984). Several BL21 derived strains, containing extra copies of genes for minor tRNAs, 
such as BL21 codon-plus, Rosetta or lacking RNAse, such as, BL21-Star(DE3) are also 
used routinely (Ahn et al. 2005; Chumpolkulwong et al. 2006).  
 
1.6.4 Plasmid construct and template quality 
 
T7 RNA polymerase is mostly used for transcription because of its high specificity and 
strong  activity.  So,  standard  T7  promoter  based  vectors  such  as  pET  (Novagen)  or 
pIVEX (Roche Bioscience) are used commonly. An efficient T7 terminator should be 
included to reduce non productive consumption of nucleotides while the low yield can be 
countered with an efficiently translated expression tag, such as T7 tag at the N-terminal 
end. An extended poly (His)10 tag at the C-terminus not only helps for efficient binding 
during purification but also to verify the full length expression. The schematic drawing of 
the pET construct used for this thesis work is shown in the Fig. 1.10. A high quality of 
template DNA at a concentration of ≥0.15 µg µl
-1 is of extreme importance. 
 
 
  
 
 
 
 
 
 
 
Figure 1.10: Schematic representation of  the important sequences of pET based construct 
used for this thesis work. 
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1.6.5 Mg
2+, phosphate and K
+ 
 
Divalent  magnesium  cations  are  essential  for  many  biological  reactions,  particularly 
those involving nucleotides. Consequently, the total added Mg
2+ concentration is one of 
the  most  influential  factors  in  the  cell-free  reaction  mixture.  Because  the  free  Mg
2 
interacts with many cell-free reaction components, it is often beneficial to optimize Mg
2+ 
for each lot of cell extract and cell-free reagents to obtain maximal protein synthesis. For 
most prokaryotic reactions, total Mg
2+ concentrations range from about 8 to 20 mM. 
Stabilizing  free  Mg
2+  is  particularly  challenging  when  high  energy  phosphate  bond 
donors such as phosphoenol pyruvate (PEP) and creatine phosphate are used (Spirin and 
Swartz 2008). One final consideration that is often taken for granted is the necessity of 
having sufficient phosphate available. Typically, excess phosphate comes either from the 
energy  source  or  the  nucleotides.  However,  with  systems  using  nonphosphorylated 
energy  sources (such as  glucose), 10 mM phosphate is required for maximal protein 
production (Calhoun and Swartz, 2005). Additional reaction components for prokaryotic 
systems  include  potassium  and  ammonium  acetate,  potassium  glutamate  at  high 
concentrations (>200 mM) (Pratt 1984; Kim et al. 1996), and acetyl phosphate as an 
energy source (Ryabova et al. 1995). One common theme is that of using potassium as 
the dominant cation, an approach that mimics the intracellular milieu (Jewett and Swartz 
2004). 
 
1.6.6 Energy source 
 
Protein synthesis is the most energy intensive metabolic process. During this reaction, 
two  major  types  of  substrates  are being  used:  (i)  amino  acids  as  monomers  for  the 
synthesis  of  polypeptide  chains,  (ii)  nucleoside  triphosphates  (NTPs)  as  the  energy 
supply for translation factors, for aminoacyl-tRNA synthetases and also as monomers for 
the synthesis of mRNA. In CECF systems, the amino acids and energy substrates are 
constantly  supplied  and  the  products,  including  inorganic  phosphate  are  removed  by 
diffusion exchange to maintain a steady-state concentration. Nevertheless, even in the 
CECF systems, a supply and removal problem may still exist if the rate of exchange is 
not sufficient to keep up with both the coupled and uncoupled consumption of substrates 
and  production  of  side  products  in  the  reaction  mixture.  Owing  to  NTPase  and                                                                                                                INTRODUCTION 
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phosphatase activities in cell extracts, rapid and uncoupled hydrolysis of NTPs occurs in 
the incubation mixture (Kim and Swartz 2000; Kim and Choi 2001) in addition to their 
productive consumption during protein synthesis. So,  an  in  situ  NTP regeneration  is 
highly  advantageous,  if  not  essential  for  most  of  the  cell-free  systems.  In  bacterial 
systems, phosphoenol pyruvate is commonly used, but acetyl phosphate (AcP) (Ryabova 
et al. 1995) and creatine phosphate (Kigawa et al. 1999) are other options. According to 
Swartz and Spirin (2008), the combination of PEP and AcP ensured higher activity than 
PEP or AcP alone. 
 
1.6.7 Temperature 
 
The temperature of the reaction mixture for protein synthesis is one of the most important 
parameters  determining  the  correct  folding  of  newly  synthesized  polypeptides.  The 
temperature  optimum  for  co-translational  protein  folding  in  cell-free  systems  is  not 
necessarily  the  optimum  for  the  rate  of  synthesis.  Plausible  explanations  for  the 
temperature dependence of correct protein folding are: (i) T7 RNA polymerase, being 8 
times faster than the intrinsic transcriptase, breaks the transcription translation coupling. 
(ii) For co-translational protein folding, the elongation of a growing polypeptide at a 
higher temperature might be too fast, and the local secondary structure of the chain does 
not have sufficient time to form and thus might interfere with following section (Kommer 
et al. 2005; Iskakova et al. 2006). 
 
1.6.8 Detergents: for DCF mode and solubilization in PCF mode 
 
Detergents have to be added at concentrations above their critical micellar concentrations 
(CMCs) to become effective for the solubilization of IMPs. Several detergents such as 
sodium  deoxycholate,  sodium  cholate,  N-laurylsarcosine,  FOS12  and  β-OG  severely 
inhibit CF systems already at low concentrations and they are not suitable for the cell-
free production of soluble IMPs. However, most commonly employed relatively mild 
detergents, specially the Brij group of detergents, appear to be tolerated by CF systems at 
concentrations that exceed the proposed specific CMCs several times (Berrier et al. 2004; 
Klammt et al. 2005; Ishihara et al. 2005). Evaluation of the most effective detergent for                                                                                                                INTRODUCTION 
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the  CF  production  of  a  specific  IMP  should  be  one  of  the  primary  tasks  of  initial 
optimization screens. 
Protein precipitates obtained by PCF reactions usually solubilize rapidly upon addition of 
relatively mild detergents at a final concentration of 1–5% with gentle shaking at room 
temperature. In particular, LMPG, LPPG and FOS12 exhibit outstanding properties in the 
efficient solubilization of CF-produced precipitates of structurally different membrane 
proteins (Klammt et al. 2005).   
 
1.7 Biophysical methods to study membrane protein 
 
1.7.1 X ray crystallography 
 
X-ray crystallography is a method of determining the arrangement of atoms within a 
crystal, in which a beam of X-rays strikes  a crystal and diffracts  into many  specific 
directions. From the angles and intensities of these diffracted beams, a crystallographer 
can produce a three-dimensional picture of the density of electrons within the crystal. 
Three dimensional crystallization of membrane proteins is extremely difficult, as evident 
from the number of solved structures in PDB. This is largely due to their amphipathic 
nature. Deisenhofer and Michel (1985) first solved the crystal structure of the bacterial 
photosynthetic reaction center crystallized in the presence of a detergent. Since then, 
slow but steady development in the membrane protein crystallography can be observed. 
Apart from its amphipathic nature, obtaining sufficient amount of pure and homogeneous 
protein and finding the right detergent, pH, precipitant and temperature, add complexity 
to the whole process. 
Based on crystal formation, two types of membrane protein crystals are observed (Michel 
1983). Type I crystals are in principal ordered stacks of 2D crystals, which contain the 
ordered protein molecules within the membrane plane. In type II, 3D crystals can be 
formed by membrane proteins integrated in detergent micelles similar to soluble proteins. 
In these crystals contacts are made by the polar surfaces of the protein, which protrude 
from the detergent micelle. Mixed type I and II crystals are possible, although most 
membrane protein crystals belong to type II (Fig 1.11). 
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Figure 1.11: Type I and Type 
II  crystals  of  membrane 
protein. 
(reproduced from Michel 1983). 
 
 
 
 
 
There are several modifications one could try to get a well diffracting membrane protein 
crystal. In order to decrease the flexibility and to increase the hydrophilic protein- protein 
contacts, antibodies or their fragments against an epitope have been successfully used to 
generate crystals (Ostermeier et al. 1995; Dutzler et al. 2003; Hunte and Michel 2002). 
Engineering proteins by N or C-terminal truncation or generating a stable crystallizable 
core construct by controlled proteolysis, often reported to yield well diffracting crystals 
(Wang et al. 2009; Ressl et al. 2009; Lu et al. 2009). Size and shape of detergent micelles 
play an important role in crystal contact and careful optimization helps to improve the 
crystal quality (Kuo et al. 2003). 
The role of lipid in membrane protein crystallization is widely recognized. Lipids can 
facilitate  crystallization  not  only  by  stabilizing  the  protein  fold  and  the  association 
between  subunits  or  monomers,  but  also  by  lipid  mediated  lattice  contacts.  The 
importance of lipids in crystal formation is well known for cytochrome b6f and LacY 
structures (Zhang and  Cramer 2004;  Guan et  al.2006).  In  recent  years,  lipidic  phase 
crystallization  is  gaining popularity.  These  approaches,  including lipidic cubic phase, 
lipidic sponge phase, and bicelle crystallization methods, all immerse purified membrane 
protein within a lipid rich matrix before crystallization. This environment is hypothesized 
to  contribute  to  the  proteins  long-term  structural  stability  and  thereby  favour 
crystallization. Spectacular recent successes include the high-resolution structures of the 
β2-adrenergic G-protein-coupled receptor, the A2A adenosine G-protein-coupled receptor, 
and the mitochondrial voltage dependent anion channel (see Johansson et al. 2009 for 
review). 
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1.7.2 Electron crystallography  
 
Electron  crystallography  of  membrane  proteins  involves the  study of 2D crystals  by 
electron  cryo-microscopy  (cryo-EM)  and  image processing. In cryo-EM, samples are 
studied at cryogenic temperature (liquid nitrogen temperature) without being stained or 
fixed and hence in a more native environment. The limiting factor in obtaining structural 
information by electron crystallography is the 2D crystallization. This is accomplished by 
mixing  detergent-solubilized  membrane  proteins  with  detergent-solubilized  lipids 
followed by removal of the detergent, using only little lipid to induce the formation of 2D 
crystals upon reconstitution. Removal of the detergent can be achieved by dialysis of the 
protein/lipid mixture against detergent-free buffer though other methods exist. A number 
of  factors  critical  for  the  formation  of  2D  crystals  include  the  lipid  used  for 
reconstitution,  the  lipid-to-protein  ratio  (LPR),  and  the  composition  and  pH  of  the 
dialysis buffer. Less clear is the influence of other factors, such as the initial detergent 
concentration  of  the  sample,  a  preincubation  of  the  protein  with  the  lipid  prior  to 
detergent removal, and temperature cycles during reconstitution (Schmidt-Krey 2007; 
Raunser and Walz 2009). 
Compared to X-ray crystallography, electron crystallography used to be a low-resolution 
technique,  as  the  resolution of  density  maps  were  typically  limited  to  approximately 
3.5 Å, although recently, the structure of aquaporin-0 was determined to 1.9 Å resolution 
(Gonen  et  al.  2005).  Other  problems  associated  with  2D  crystallizations  are  poor 
reproducibility and lack of automation. However, requirement of less protein compared 
to  3D  crystallization  and  the  observation  of  the  structure  in  a  native  like  lipidic 
environment make 2D crystallization an attractive option along with 3D. 
 
1.7.3 Differential scanning calorimetry (DSC) 
 
DSC is a technique to study thermally induced conformational transitions of biological 
macromolecules.  Regarding  instrumentation,  the  differential  scanning  calorimeter 
basically consists of two cells, the reference and sample cell. Both cells can be heated at 
a constant rate programmed in such a way as to maintain an equal temperature in both 
cells throughout the scan. When a temperature induced equilibrium process takes place in 
the sample cell (like unfolding of a macromolecule), the DSC control system supplies the                                                                                                                INTRODUCTION 
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necessary additional heat to this cell by means of appropriate heaters in order to maintain 
the same temperature as the other cell. The data output from the DSC is usually this 
excess heat as a function of temperature. This excess heat in turn, is proportional to the 
difference of heat capacity (Cp) between the two cells and their contents (Sánchez-Ruiz 
and Mateo 1987). 
The  transition  is  recognized  as  a  sharp  endothermic  peak  centered  at  Tm  (melting 
temperature) and the maximum in Cp occurs directly at Tm. Integration of the Cp versus 
T curve yield the transition enthalpy ( H
0) and the shift in the baseline yields the  Cp 
(Fig. 1.12). The sharpness of the transition peak can be measured as the width at half-
peak height, and is an index of the cooperative nature of the transition (Bruylants et al. 
2005; Wright et al. 1977). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12: A typical DSC curve for two-state unfolding of a globular protein. 
Reproduced from Bruylants et al. 2005. 
 
 
Though scantly studied, there are few reports of membrane protein stability and ligand 
interaction, analyzed by DSC (Halsey et al. 1977; Kresheck et al. 1985; Rigell et al. 
1985; Epand et al. 2001). 
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1.8 Scope of this thesis 
 
Membrane transporters are involved in diverse functions, from nutrient uptake, antibiotic 
efflux, protein secretion, toxin production to oxidative phosphorylation and environment 
sensing. There are commercial and biomedical interests  in inhibiting the activities of 
some membrane transporters, optimizing the activities of others and employing them as 
transducers  of  electrical/chemical/mechanical  energy  for  nanotechnology.  A  detailed 
structural  and  functional  insight  of  membrane  transporters  is  essential  for  these 
endeavors.  However  membrane  transporters  are  mostly  low  abundant  in  their  native 
membrane.  Hence,  heterologous  overproduction  of  membrane  proteins  in  sufficient 
amounts is the absolute necessity for structural and functional studies. In recent years, 
structural  genomics  approaches  of  heterologously  overproducing  large  number  of 
proteins in medium or high-throughput manner for crystallographic studies have been 
promising. Moreover, it is also necessary to develop and establish new expression and 
purification protocols for membrane proteins to enrich the crystallization pipeline. 
The work of this thesis is part of a structural genomics project already running in our 
group. A set of 210 transporters from A. aeolicus, S. typhimurium and P. furiosus were 
selected  based  on  available  bioinformatics  data.  An  initial  pilot  scale  expression 
screening with 37 transporters was carried out to evaluate the use of orthologous targets, 
various expression vectors and different host systems in order to find out the appropriate 
conditions for maximum protein production. This study revealed the following (Surade et 
al.  2006):  (i)  A.  aeolicus  was  the  most  suitable  source  organism  for  production  of 
hyperthermophilic  proteins,  (ii)  E.  coli  was  able  to  express  a  higher  number  of 
heterologous prokaryotic transporters at higher levels than L. lactis, (iii) the pBAD vector 
was superior to others in terms of expressing the targets in higher amounts. 
For my thesis work, I had chosen targets from the original set of 210 secondary active 
transporters as described in the table 1.2. The main criteria for selecting the target family 
were  lack  of  a  published  structure  and  established  protocols  for  heterologous 
overproduction of at least one member of the family. However, in the course of my 
doctoral work structures from two of the families were published. 
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Table 1.2: Details of the selected targets 
S.No.  Protein ID
a  Source
b  Family
c  Function  nAA  MW 
(kD) 
nTM
d 
1  STM0758  ST  312  34.4  5 
2  STM4061  ST  300  32.97  6 
3  Aq_1073  AA  308  34  6 
4  Aq_2073  AA 
CDF  Heavy metal transport 
385  43.01  5 
5  STM3880  ST  KUP  Potassium transport  622  69.18  12 
6  STM4189  ST  PNaS  Inorganic phosphate transport  543  59.4  8 
7  STM0365  ST  210  23.03  6 
8  STM1270  ST  212  22.94  6 
9  STM2645  ST  195  21.29  6 
10  STM3959  ST  206  22.49  6 
11  STM3960  ST 
RhtB  Amino acids transport 
206  22.32  6 
12  STM3476  ST  FNT  Nitrate assimilation, transport  269  28.6  6 
13  STM1781  ST  SulP  Sulfate transport  553  58.6  11 
14  PF0708  PF  MOP  Multidrug transport  461  49.23  12 
a : according to www.membranetransport.org 
b:  ST-  Salmonella  typhimurium  LT2,  AA-  Aquifex  aeolicus  VF5,  PF-  Pyrococcus  furiosus 
DSM3638 
c:  CDF-  Cation  Diffusion  Facilitator,  KUP-  Potassium  Uptake  permease,  PNaS-  Phosphate 
Sodium  Symporter,  RhtB-  Resistance  to  Homoserine  Threonine,  FNT-  Formate-Nitrite 
Transporter,  SulP-  Sulfate  Permease,  MOP-  Multidrug/Oligosaccharidyl-lipid/Polysaccharide  
flippase  
d: Predicted by TMHMM (http://www.cbs.dtu.dk/services/TMHMM/) 
S.No. Serial number, nAA Number of Amino Acids, MW (kD) Molecular weight in Kilodalton, 
nTM number of trnasmembrane helices 
 
 
The  overall  aim  of  this  work  was  to  heterologously  overproduce  selected  secondary 
active transporters from three different source organisms, within the structural genomics 
framework already established in our group. After successful overproduction, they were 
subjected to characterization in terms of detergent compatibility and stability which in 
turn could facilitate the crystallization of the selected targets. The idea behind choosing 
multiple  targets  from  a  single  family  was  to  take  at  least  one  target  up  to  the 
crystallization stage. Alternative expression strategies, such as cell-free expression and 
MBP fusion, were also tried to generate sufficient amount of homogeneous protein for 
functional and structural studies.                                                                                                                INTRODUCTION 
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The specific aims of my project were: 
(i)  Successful expression of chosen transporters and purification to homogeneity 
(ii)  Characterization of the purified proteins in terms of detergent compatibility 
and stability 
(iii)  Crystallization of the purified protein  
(iv)  Functional characterization of the transporters 
(v)  Establishing  a  cell-free  production  and  purification  protocol  for  selected 
transporter targets, especially for those which were difficult to produce in vivo 
(vi)  Analysis of crystallizibility and functionality of cell-free produced protein 
 
The flow chart of Fig. 1.13, describes the road map followed for this thesis work. After 
initial expression screening, I tried to heterologously overproduce the target proteins in 
cell based system. A quality control step to ensure the stability, purity, integrity and 
homogeneity of the protein was followed by functional and structural characterizations. 
Upon encountering difficulties like no expression, degradation, low yield, poor stability 
or poor crystal in crystallization trials, alternative approaches like cell-free expression, 
MBP fusion or truncated construct designing were attempted to check whether these 
could overcome the obstacles. 
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Figure 1.13:  Schematic description of the road map followed for this thesis work. 
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2.1 Cation diffusion facilitator (CDF) family 
 
2.1.1 Target selection and in silico analysis 
 
The heavy metal transporting CDF family members typically possess 5-6 transmembrane 
segments with both N- and C-terminus oriented towards the cytoplasm. Both A. aeolicus 
and S. typhimurium have two members each of the CDF family, Aq_1073, Aq_2073 and 
STM0758, STM4061, respectively. The results of an in silico analysis of these selected 
four targets are summarized in Table 2.1 and their phylogenetic tree in Fig. 2.1.  
 
Table 2.1: In silico analysis of selected CDF transporters 
% Identity with 
b  Protein  Source 
organism 
TM 
a 
 
MW 
 (kD)  ZitB 
EC  YiiP 
EC  CzcD 
RM   Znt3 
HS  Znt8
 HS 
STM0758  ST  5  34.4  86  27  37  31  30 
STM4061  ST  6  32.9  24  92  25  19  21 
Aq_1073  AA  6  34  39  25  41  28  26 
Aq_2073  AA  5  43.01  25  25  34  N*  28 
ST: Salmonella typhimurium , AA: Aquifex aeolicus ; 
a Number of transmembrane segments as 
predicted by TMHMM server ; 
b Identity in percentage (%), as calculated by NCBI-BLAST 
Align tool with default settings ; N* No significant similarity
  
EC Escherichia coli, 
RM  Ralstonia metallidurans, 
HS Homo sapiens  
 
 
Figure 2.1:  Phylogenetic tree of selected CDF transporters along with their known 
homologues. The tree was drawn using ClustalW software. 
 
 
 
 
 
                                                                                                                              RESULTS 
  31
28kD- 
M
a
r
k
e
r
 
A
q
_
1
0
7
3
 
A
q
_
2
0
7
3
 
S
T
M
0
7
5
8
 
S
T
M
4
0
6
1
 
38kD- 
2.1.2 Expression screening of 4 members of CDF family 
 
The gene sequence of the four selected transporters of A. aeolicus and S. typhimurium are 
obtained  from  TransportDB  (http://www.membranetransport.org).  The  genes  were 
cloned into the pBAD, pTTQ18 and pQE vectors, each having 2 different constructs (A2 
and C3), resulting in 6 constructs altogether. These plasmids were transformed into the 
respective expression host cells and subjected to whole cell lysate expression screening 
and  visualization by  Western blot (Table 2.2  and Fig. 2.2). All  the  constructs could 
express the targets equally well, as determined by whole cell lysate screening. 
 
Table 2.2: Expression screening of CDF transporters, determined by Western blot 
++ and +++ represents relative expression level 
   
 
Figure 2.2 : Western blot of four CDF  
transporters, produced with pBADC3  
plasmids and developed using anti-  
His antibody. 
 
 
 
 
 
 
2.1.3 Functional complementation of 4 CDF transporters 
 
Heterologous overproduction of membrane proteins often  resulted  in a  nonfunctional 
inactive state. To check the functionality of the expressed CDF transporters, the E. coli 
Constructs  Tag position  Host cell  Aq_1073  Aq_2073  STM0758  STM4061 
A2  C-His  ++  ++  ++  ++  pBAD 
  C3  N-His, C-Strep 
TOP10 
++  +++  +++  ++ 
A2  C-His  ++  ++  ++  ++  pTTQ18 
  C3  N-His, C-Strep 
NM554 
++  +++  +++  ++ 
A2  C-His  ++  ++  ++  ++  pQE 
  C3  N-His, C-Strep 
NM554 
++  ++  ++  ++                                                                                                                              RESULTS 
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strain  GG48  ( zitB::CmzntA::Km)  was  employed  for  complementation  studies.  In 
GG48, the Zn translocating P-type ATPase ZntA and the CDF protein ZitB have been 
deleted, rendering it highly Zn sensitive (Grass et al. 2001). All four constructs were 
expressed in GG48 cells and could be detected migrating at the correct position in SDS-
PAGE as indicated by Western blot, developed using an anti-His antibody (Fig. 2.3A). 
For functional complementation, GG48 cells were transformed with pTTQ18C3 based 
constructs  of  STM0758,  STM4061,  Aq_1073  and  Aq_2073.  The  GG48  strain 
transformed  with  empty  vector  (pTTQ18C3)  was  taken  as  a  negative  control,  while 
TOP10 cells were employed as positive control.  The cells were then allowed to grow in 
the presence of different zinc ion concentrations (0-900 µM). The absorbance at 600 nm 
was measured after 12 hrs as an indicator of cell survival and plotted against the zinc ion 
concentration as described in details in materials and methods.  
Out  of  four  transporters  tested,  only  STM0758  could  markedly  enhance  the  zinc 
tolerances of the E. coli GG48 strain (Fig. 2.3B). The OD600 value of the negative control 
(GG48 transformed only with empty vector pTTQ18C3) rapidly decreased beyond 300 
µM ZnCl2 concentration and became almost zero at 450 µM concentration. Only the 
GG48  strain  transformed  with  the  STM0758  containing  plasmid  could  tolerate  zinc 
concentrations even above 800 µM.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Functional complementation of CDF transporters. (A) Western blot, developed 
using  anti-His  antibody,  showing  expression  of  4  transporters  in  GG48  cells.  (B) 
Complementation assay. Survival of zinc sensitive GG48 strain transformed with selected CDF 
transporters, as a function of zinc chloride concentration. 
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However, crystallization of membrane proteins requires sufficient amounts of pure and 
stable protein. When tried for large scale production, Aq_2073 out of the four selected 
targets of CDF transporters turned out to be the protein of choice in terms of yield and 
stability. 
 
2.1.4 Production, isolation and characterization of Aq_2073 
 
Aq_2073 showed a good expression level in whole cell lysate expression screening with 
all the constructs tested. In a pilot scale structural genomics studies, Surade et al. (2006) 
reported pBAD vector to heterologously overproduce the maximum number of targets. 
So, to work further with Aq_2073 in similar context, the pBAD constructs (A2 and C3) 
were chosen.  
 
2.1.4.1 Solubilization screening for choosing the right detergents  
After  fresh  transformation  into  E.  coli  TOP10  cells,  a  single  colony  of  Aq_2073  -
pBADC3 was inoculated in 400 ml LB for overnight culture. This was then used to 
inoculate  24  liter  LB  media  for  large  scale  production.  Cell  harvest  and  membrane 
preparation was done according to materials and methods. Membranes were stored in a -
80 °C freezer. For solubilization screening, aliquots of membranes were thawed on ice, 
and  subjected  to solubilization  screening.  Membranes  were solubilized  in  7 different 
detergents) with 1% final detergent concentration and at two different temperatures (4 °C 
and 50 °C. Detergents βLM, DM, LDAO and FOS12 turned out to be the most suitable 
ones. However, the temperature did not have any significant effect on solubilization (Fig. 
2.4).  
 
Figure 2.4: Solubilization screening 
of  Aq_2073.  Western  blot  was 
developed using an anti-His antibody. 
Alternate wells contain solubilizate of 
4 °C and 50 °C. 1,2 βLM; 3,4 DM; 
5,6  OG;  7,8  NG;  9,10  C12E9;  11,12 
LDAO; 13,14 FOS12. 
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 2.1.4.2 Affinity purification and homogeneity of Aq_2073  
In the presence of a His-tag, immobilized metal affinity chromatography (IMAC) using 
Ni-NTA matrix, is a simple and one step procedure to purify the target protein. After 
solubilization and ultracentrifugation, the solubilizate was allowed to bind to the Ni-NTA 
matrix either in batch method or using the HisTrap-HP columns in Aekta Prime system. 
The protein was eluted with either the 0-500 mM gradient of imidazole or with 350 mM 
of  imidazole  in  Aekta  Prime  or  batch  method  respectively.  There  was  no  notable 
difference in yield with both methods tested. The protein was more than 95% pure as 
judged  on  a  Coomassie  stained  gel.  Size  exclusion  chromatography  of  the  purified 
protein, using a Superdex 200 column in the SMART system, showed that the protein 
was homogeneous in the detergent βLM as indicated by the presence of a single peak 
(Fig. 2.5 A, B). 
 
Figure  2.5:  Purification  of 
Aq_2073.  (A)  Coomassie  stained 
SDS-PAGE  showing  a  single  band 
after  purification.  (B)  Gel  filtration 
profile of the purified protein using a 
superdex200  column  in  SMART 
system. 
 
 
 
 
2.1.4.3 Removal of His-tag using TEV digestion 
Removal  of  the  His-tag,  located  at  the  C-terminus  (A2  version)  or  N-terminus  (C3 
version) of Aq_2073, was necessary not only to characterize the protein’s binding and 
transport  properties  with  heavy  metals  (zinc,  cadmium,  nickel,  iron),  but  also  for 
crystallization attempts with the tag  free protein. TEV protease recognizes a specific 
sequence of amino acids and carries out a proteolytic cleavage of the substrate (Kapust et 
al. 2001). Both A2 and C3 versions have a TEV cleavage site before and after the His-
tag, respectively. The impurities in the sample after IMAC are supposed to have a high 
non-specific affinity for the IMAC-resin or metal. Hence, if the sample is treated with the 
TEV protease, it should cleave at the TEV site and separate the His-tag from the protein 
itself. When this reaction mixture is passed over an IMAC resin once again, all impurities 
with non-specific binding tendency and the His-tagged TEV protease should bind to the                                                                                                                              RESULTS 
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IMAC resin whereas the protein of interest can be recovered in the flow-through (Fig. 
2.6).  A  mutant  version  of  TEV  protease  S219V  (Kapust  et  al.  2001)  with  a  higher 
stability was used for these experiments. 
 
 
Figure  2.6. Tag removal 
with  TEV  digestion.  (A) 
Coomassie  stained  SDS- 
PAGE before [1] and after 
[2]  TEV  digestion.  (B) 
The  corresponding 
Western  blot  of  the  same 
gel.  (C)  Gel  filtration 
profile  of  the  tag  free 
protein. 
 
 
 
 
2.1.4.4 Stability and monodispersity of Aq_2073 
Stability  and monodispersity of  a  membrane  protein, prerequisites  for crystallization, 
depend  on  a  multitude  of  factors  like  pH,  salt  concentration,  detergents  etc..  Using 
analytical  size  exclusion  chromatography  (SEC),  a  large  set  of  these  factors  can  be 
screened  efficiently.  Conditions  that  are  beneficial  in  terms  of  stability  and 
monodispersity, can then be applied for purification and crystallization. 
Aq_2073  was  subjected  to  such  screenings  of  variables  like  detergents,  pHs  and 
temperatures and analyzed by superdex 200 column chromatography using a SMART 
system.  Aq_2073  was  stable  and  demonstrated  monodispersity  in  a  wide  range  of 
detergents and combination of detergents. Stability studies with the maltoside series of 
detergents demonstrated that monodispersity decreases with the decrease in carbon chain 
length of the detergent in the order LM>UM>DM>NM. The protein was less stable or 
not stable at all in the glucosidic detergents NG and OG, respectively. However, the 
protein was found to be stable and monodispersed in relatively  harsh detergents like 
FOS12  and  LDAO.  A  detailed  description  of  stability  in  different  detergents  with 
corresponding  gel  filtration  profiles  is  presented  in  Table  2.3.                                                                                                                                                                                                                       RESULTS 
  36
Table 2.3: Stability of Aq_2073 in different detergents analyzed by size exclusion chromatography (SEC) 
 
Detergent  Stability, SEC profile  Comments 
Maltosides and 
Glucosides  
 
 
 
 
βLM (+++)       UM (++)         DM (+)        NM (+)           NG (+)         OG (0)       OTG (0)     
βLM, UM and DM 
purified  proteins 
used  for 
crystallization trials 
Polyoxyethylene 
alkyl ether 
 
 
 
 
C12E9 (+)          C12E5 (0)           C10E5 (+) 
C10E5 purified 
protein used for 
crystallization trials 
Others 
 
 
 
 
 
FOS12 (++)      LDAO (++) 
Used for 
crystallization trials 
Mix 
 
 
 
 
 
βLM+OG (+)   βLM+NG (++)  βLM+FOS11 (+)     βLM+FOS12+LDAO (+)    DM+NG (+) 
FOS11  decreased 
stability;  others 
used  for 
crystallization trials 
+++ most stable; ++ intermediate stable; + less stable; 0 Visible aggregates 
All proteins were purified in 20 mm HEPES-NaOH, pH 8 
Visible 
aggregate                                                                                                                              RESULTS 
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For further characterization of the stability, the protein purified in βLM detergent was 
analyzed by SEC after storage at two different temperatures (4 ºC or room temperature) 
for different time intervals. After 15 days of storage, protein stored at 4 ºC showed better 
homogeneity compared to protein stored at RT which eluted with a small hump before 
the actual peak (Fig. 2.7). Aq_2073 showed stability in pH values ranging from 4 to 9. 
However, pH7  and pH 8 demonstrated  maximum monodispersity with  a  single peak 
without any hump or shoulder (Appendix 3). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Stability of Aq_2073 with respect to time and temperature. Protein was purified 
in 0.03% βLM, stored either at 4 ºC or at room temperature and homogeneity (elution profiles) 
was checked at different time points by SEC using superdex 200 column in SMART system. 
 
2.1.4.5 Thermal unfolding studies using DSC 
Differential scanning calorimetry is a useful method to study protein stability besides the 
phenomenon associated with protein unfolding. The melting point or Tm determined by a 
DSC experiment is the direct reflection of the tested protein’s stability. Aq_2073 was 
subjected to DSC scans at 5 different pH values. All measurement buffers of respective 
pH values (Acetate buffer pH 4 and 5; MES pH 6; HEPES pH 7 and 8: all at 50 mM 
concentration)  additionally  contained  150  mM  NaCl  and  0.02%  βLM.  After  affinity 
purification,  the  protein  samples  were  dialyzed  overnight  with  a  change  against 
respective buffers, the concentration was adjusted to 0.5-1 mg/ml and the sample was 
filtered before injection into the sample cell. The corresponding buffers were used in the 
reference cell.  
 
Stored @ 4 °C  
Immediately after 
purification 
Stored @ 4 °C 
 
Stored @ Room 
temperature 
 
5 days  15 days 
Stored @ Room 
temperature 
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Figure 2.8: DSC scan of Aq_2073 at different pH values. All measurements were done at a 
scan rate of 90 °C/ hr scan rate with 59-60 psi pressure. Differences of heat capacity between 
reference and sample cell (Cp) are plotted against temperature. 
 
All measurements were done at a scan rate of 90 °C/ hr scan rate with 59-60 psi pressure. 
As observed from the combined thermogram in Fig. 2.8, the melting temperature (Tm) 
started to increase from pH 4 to pH 8. Moreover, the scans at pH 4, 5 and 6 yielded an 
additional peak at a higher temperature. This could be due to the presence of a small 
fraction of higher oligomeric or aggregated protein present in the sample at these pH 
values which unfold separately. The gel filtration profiles of the same sample at pH 4, 5 
and 6 showed a small hump before the main peak corresponding to higher oligomeric 
states (Appendix 3). On the other hand, scans at pH 7 and 8 yielded a single peak with a 
Tm of approximately 96 °C.  
 
2.1.4.6 Oligomerization studies  
The oligomerization state of Aq_2073 was tested by three different methods, namely, 
blue  native  PAGE  (BN-PAGE),  crosslinking  studies  and  analytical  gel  filtration 
chromatography. In BN-PAGE, Aq_2073 migrated as two distinct bands, one just above 
146 kD and the other between 242 kD and 480 kD (Fig. 2.9A). As reported by Heuberger 
et al. (2002), using the conversion factor of 1.8 for bound CBB dye, these two bands 
correspond  to  a  dimer  and  a  pentamer,  respectively.  The  presence  of  further  higher 
oligomers could also be observed as a faint band above 480 kD. 
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Glutaraldehyde crosslinking experiments were performed with 20, 50 and 100 mM of 
glutaraldehyde with protein at a concentration of 0.1 mg/ml for 1hr at room temperature. 
A control experiment was also set up with 1% final SDS and 50 mM glutaraldehyde. At 
all concentrations, the monomeric band faded away and a prominent band above 62 kD 
started appearing when analyzed by SDS-PAGE. This band corresponds to a possible 
dimer. Moreover, one could also see bands corresponding to higher oligomers. Even the 
sample without glutaraldehyde and the control sample with glutaraldehyde and SDS also 
showed additional bands which possibly are SDS resistant higher oligomers (Fig. 2.9B). 
SEC analysis using a superdex 200 PC 3.2/30 column, calibrated with a range of standard 
soluble proteins in sample buffer (20 mM HEPES, pH8, 150 mM NaCl, 0.02% βLM), 
was used to calculate the mass of Aq_2073 in detergent solution. Aq_2073 solubilized 
and purified in βLM elutes at 1.33 ml which corresponds to roughly 283 kD (Fig. 2.9C). 
Thus,  the  eluted  mass  of  the  protein  detergent  complex  is  as  big  as  280  kD.  This 
definitely indicates a higher oligomeric state. However, the determination of the exact 
oligomeric state from gel filtration profile is rendered difficult as the amount of bound 
detergent is unknown.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9:  Oligomerization  studies  of  Aq_2073. (A) Blue  Native  gel  electrophoresis.  [M] 
Standard  marker  (B)  SDS-PAGE  analysis  of  glutaraldehyde  crosslinking  samples. 
Glutaraldehyde concentrations (mM) are  mentioned  at the top  of the  gel (C) Analysis of  gel 
filtration elution volume with standard calibration. Black dots indicate elution volume of standard 
proteins while green dot is of Aq_2073. 
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2.1.4.7 Substrate binding assay with DSC      
Though  primarily used for studying  stability  and  folding, DSC can  also be used for 
binding studies. When a small molecule ligand or substrate preferentially binds to the 
native form of a protein, the ligand stabilizes the protein and the Tm of the protein-ligand 
complex is higher than that of the protein in the absence of the ligand. If the ligand 
preferentially binds to the denatured protein, the Tm decreases in the presence of the 
ligand.  
Aq_2073 was purified as mentioned before. The polyhistidine tag was removed by TEV 
digestion as the tag might interfere with the binding of putative heavy metal substrates 
(Zn, Ni, Fe(II), Cd etc.). The polyhistidine tag free protein was incubated on ice with 10 
mM EDTA for 30 minutes to remove traces of divalent metal ions. Before subjecting to 
the DSC scan, the sample was dialyzed against the measurement buffer (HEPES-KOH, 
pH 6.8, KCl 150 mM, βLM 0.02%) with one change after 6 hrs. The chloride salts of 
zinc, cadmium, nickel, magnesium (as negative control) and the sulfate salt of iron (Fe II) 
were dissolved in the same buffer at 10 mM stock concentration. Ferrous sulfate (II) 
solution was stabilized by 1% (W/V) ascorbic acid. Protein samples without substrates 
and with substrates (each at 500 µM final concentration) were scanned separately. A 
reference scan with buffer in both the cells (sample and reference) was performed and 
subtracted from the protein scan. All scans were done at 90 °C/hr scan rate. Fig. 2.9 
shows  the  combined  thermogram  after  baseline  normalization.  Aq_2073  at  pH  6.8 
showed a Tm around 97 °C. When Ni
+2, Zn
+2 or Mg
+2 were added to the sample no 
significant change in Tm could be observed. In case of Fe(II), two overlapping peaks 
were evident, one with Tm 90.82 °C  and the other around 97.6 °C. This might indicate 
towards interaction of Fe (II) with a fraction of the protein or to a certain domain of the 
protein. In case of Cd
+2, a significant increase of Tm to 106.9 °C was observed (Fig. 
2.10). 
The binding studies showed that only cadmium ions can significantly stabilize the protein 
structure as evident from the increased Tm. However, further experiments like isothermal 
titration calorimetry are necessary to precisely determine the parameters associated with 
protein-substrate binding. 
                                                                                                                              RESULTS 
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Figure 2.10: Heavy metal substrate binding with Aq_2073 using DSC. All measurements 
were done at a scan rate of 90 °C/ hr scan rate with 59-60 psi pressure. Differences of heat 
capacity between reference and sample cell (Cp) is plotted against temperature. 
 
 
2.1.4.8 Generation of Aq_2073 constructs for crystallization 
One general aspect of protein crystallization that is universally recognized is that rigid, 
stable proteins are much more likely to crystallize than proteins that are flexible or have 
dynamic surfaces. If we analyze Aq_2073 using secondary structure prediction software 
(PredictProtein), many unstructured regions in the C- terminal domains can be observed 
(Fig. 2.11). To minimize the flexibility rendered by these unstructured regions at the C-
terminus and hence to facilitate crystallization, different constructs with varying length of 
C-terminal domains were made based on homology allignment. Moreover, two different 
constructs of the C-terminal domain only were generated in order to check whether it 
could fold and function independently (Table 2.4). All constructs were cloned into the C3 
version of the pBAD vector. Out of the 5 constructs checked for expression, 4 constructs 
were found to be expressed by whole cell lysate screening (Table 2.4).  
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Figure 2.11: Secondary structure prediction of Aq_2073 using the server  PredictProtein (www.predictprotein.org). The C terminal region is marked 
with a box. H denotes predicted helix region, L denotes predicted loop region, E denotes predicted extended sheet region while only dot (.) denotes regions 
with no possible prediction because of low reliability.  These dot regions represent possible unstructured regions. 
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Table 2.4: Different constructs of Aq_2073 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
X denotes expression, purification and crystallization trials at corresponding stages; 0 denotes no 
expression; - denotes not tried 
Constructs  were  generated  based  on  homology  alignment  using  NCBI  BLAST  tool.  The 
transmembrane and cytoplasmic region boundary was determined using TMHMM prediction 
 
 
2.1.4.9 Isolation, purification and characterization Aq_2073 constructs  
2.1.4.9.1 Aq_2073 C1 
After large scale membrane preparation and solubilization with 1% βLM, the Aq_2073 
C1 construct can be purified in 0.02% βLM using one step Ni-NTA affinity purification 
(Fig.  2.12A).  Aq_2073  C1  was  further  characterized  for  its  stability  in  different 
detergents as described in Fig. 2.12B. It was found that like the full length construct, C1 
was  also  stable  in  a  range  of  detergents  (βLM,  UM,  LDAO,  FOS12).  The  thermal 
stability of the construct was determined by DSC as described in materials and methods. 
The DSC scan at pH 8 revealed its Tm to be 93.88 (Fig. 2.12C).  
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-32.5 kda 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.12: Purification and characterization of the Aq_2073 C1 construct. (A) Coomassie 
stained SDS-PAGE  after  affinity purification (B) Gel filtration profile in  different  detergents 
performed using superdex 200 column in SMART system (C) DSC profile of Aq_2073 C1 at pH 
8 with 90 °C/hr scan rate, showing a Tm of 93.88 °C. 
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2.1.4.9.2 Aq_2073 CTD1 and Aq_2073 CTD2 
Aq_2073  has  197  out  of  385  (51%)  amino  acids  as  a  C-terminal  soluble  domain 
(predicted by TMHMM server). As reported in literature, the C-terminal domain can fold 
independently and bind substrate (Cherezov et al. 2008). To check if this holds true for 
Aq_2073, two different constructs of the C-terminal domain, CTD1 (189-385) and CTD2 
(203-385) were generated based on TMHMM prediction.  
The purification was carried out as described in materials and methods. Both constructs 
could  be  purified  to  an  acceptable  level  of  purity.  After  one  step  Ni-NTA  affinity 
purification, the protein was further polished by size exclusion chromatography using 
superdex  200  column.  CTD1  was  found  to  be  more  stable  compared  to  CTD2  as 
determined by SEC (Fig. 2.13). Both constructs were subjected to crystallization after 
preparative gel filtration. 
 
 
   
   
 
 
 
 
 
 
Figure 2.13: Purification of Aq_2073 CTD1 and CTD2. (A) Coomassie stained SDS-PAGE of 
CTD1 and CTD2 after affinity purification. Gel filtration profile of CTD1 (B) and CTD2 (C), 
performed  using superdex 200  column. The  coloured  fractions  were pooled and subjected to 
crystallization trials. 
 
 
2.1.5 Two-dimensional (2D) crystallization  
 
The 2D crystallization experiments were carried out using dialysis bags (Roth). Lipid, 
detergent, LPR, pH and salt concentrations were varied as described in Table 2.5. E. coli 
lipids were tried (total extract and polar lipid) as the protein was expressed well in E. coli 
host cells. Aq_2073 and Aq_2073 C1, both were subjected to 2D crystallization trials. 
Protein incorporation into vesicle was only observed with E. coli total extract lipids. 
 
28 kD - 
17 kD - 
14 kD - 
38 kD - 
49 kD - 
A         B              C 
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Table 2.5. Details of 2D crystallization conditions tested 
 
 
Figure 2.14: Gallery of 2D crystallization vesicles. 
ETL: E. coli total lipid; EPL: E. coli polar lipid;  
LPR: Lipid protein ratio.
Parameter  Variation  Comment 
Construct  Aq_2073 and Aq_2073 C1  Both yielded vesicles with 
protein incorporation. 
Lipid  E. coli total extract and E. coli polar lipid  Only E. coli total extract 
incorporates protein. 
Lipid in 
detergent 
OG, βLM, DM  OG is best, LM needs more 
dialysis time. 
Protein in 
detergent 
βLM  Protein is most stable in 
βLM. 
LPR  0.2, 0.5, 0.8, 1.1, 1.4 (Initial screening) 
0.2, 0.3, 0.4, 0.5, 0.6 (Fine screening) 
LPR 0,5 produce optimally 
sized vesicle. 
pH  4, 5, 6, 7, 8  pH 7 is most suitable. 
Salt (mM)  50, 200, 350, 500, 750 (Initial screening) 
0, 10, 20, 40, 60, 80, 100, 150 (Fine screening) 
20 to 50 mM salt yielded  
optimally  sized vesicle with 
protein incorporation. 
Temperature  21°C, 30 °C, 37 °C  30 °C turned out to be 
optimal. 
Additives  MPD (5%), Glycerol (5%). All in 5 mM 
concentration- ZnCl2, CaCl2, MgCl2, CdCl2, 
Cs2SO4 
No significant effect of any 
additives. 
Time  7 days to 1 month  10 days are optimal when 
using OG. For βLM, longer 
period is necessary for 
complete detergent removal. 
EPL, pH 7.5, LPR 0.5 
ETL, MPD (5%), LPR 0.5 
ETL, 0 salt, pH 7, LPR 0.5 
ETL, 20 mM salt, LPR 0.5 
ETL, pH 7, LPR 0.5  ETL in DM, LPR 0.8                                                                                                                              RESULTS 
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Crystallization with a LPR of 0.5 at pH 7 with minimum salt (29-50 mM NaCl) yielded 
optimally  sized  vesicles  with  maximum  protein  incorporation.  Though  vesicles  with 
several  crystallization  patches  were  obtained,  there  was  no  sign  of  well  formed  2D 
crystals in any of the conditions tested (Fig. 2.14).  
 
2.1.6 Three-dimensional (3D) Crystallization  
Aq_2073  and its  modifications (Aq_2073  C1, Aq_2073 CTD1  and  Aq_2073 CTD2) 
were extensively tried for crystallization. All the constructs were tried with polyhistidine 
tags and also after removal of the tag by TEV protease digestion. Commercially available 
crystallization  screens,  namely,  Hampton,  Jena  bioscience,  Sigma  and  Qiagen 
crystallization screens were used in 96 well format using a robot. Drop volumes were 
100nL to 1uL with a protein to reservoir buffer ratio of typically 1:1. Initially, Aq_2073 
produced small needle like crystals (Fig. 2.15), which did not diffract properly. Extensive 
optimization of the initial condition did not improve the shape or size of the crystal. 
Different detergents and combination of detergents  were tried for both Aq_2073 and 
Aq_2073 C1, but without yielding promising crystals. A gallery of crystallization drops 
is depicted in Fig. 2.15. 
 
 
 
 
 
 
 
 
 
 
Figure  2.15:  Gallery  of  crystallization  drops.  Images  were  taken  using  Leica  M165C 
stereomicroscope. 
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2.2 Potassium uptake permease (KUP) family 
   
2.2.1 Expresion screening of different constructs 
 
STM3880  of  Salmonella  typhimurium  is  a  69  kD  protein  with  12  predicted 
transmembrane segments. The gene was amplified from S. typhimurium genomic DNA 
by PCR and subsequently cloned into pBAD, pTTQ18 and pQE vectors with each having 
2 different constructs, A2 and C3. Next, all the six constructs were screened for whole 
cell  lysate  expression  as  described  in  materials  and  methods.  Only  the  pBADA2 
construct having a C-terminal deca His-tag allowed expression of the protein. 
 
2.2.2 Solubilization screening and large scale purification 
 
After a large scale membrane preparation (24 L culture), solubilization screening was 
carried out with 8 selected detergents. The SDS-PAGE and Western blot analysis of the 
supernatant  after  solubilization  revealed  that  maltosides  and  FOS12  can  efficiently 
extract the protein from the membrane (Fig. 2.16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  2.16.  Solubilization  trials  of  STM3880  in  different  detergents.  Solubilization  was 
carried out at 4 °C for 1 hr. After centrifugation for 1 hr at 50000 RPM (TLA 55 rotor, Beckman 
Coulter), the  supernatant  was used  to  run  SDS-PAGE and  subsequently  a  Western  blot  was 
developed using anti-His antibody. 
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-62 kD 
-49 kD                                                                                                                              RESULTS 
  49
M     FT     W      E 
Large scale production and affinity purification using IMAC resulted in pure STM3880 
as determined by using Coomassie stained gels. The yield was roughly 1mg of purified 
protein from 1 L culture volume as judged by BCA protein assay. STM3880 migrated 
between  46  and  58  kD  which  is  normal  for  a  59  kD  membrane  protein.  STM3880 
purified  in  0.03%  βLM  lacked  stability  and  tended  to  aggregate  when  kept  at  4  ºC 
overnight. Even in SDS-PAGE, higher molecular weight bands close to 175 kD could be 
observed. These are probably SDS resistant aggregates (Fig. 2.17). 
 
 
Figure  2.17:  STM3880,  IMAC 
purification via batch method (A) and 
Akta Prime method (B). 
M: marker; E: eluted fraction; FT: flow 
through; W wash fraction. 
 
 
 
 
 
 
 
2.2.3 Characterizing stability in different conditions 
 
STM3880 showed severe stability problems as mentioned before. The protein tends to 
form visible aggregates when stored at 4 ºC overnight. To improve the stability and 
homogeneity, different detergents, pHs, salt concentrations and additives were screened 
and corresponding size exclusion chromatography profiles of STM3880 were recorded as 
a measure of stability. The results are presented in Table 2.6. 
The protein showed a relatively higher stability at pH 6 than at the other pH values and 
with detergent FOS12. 
 
 
M    E     
 A               B 
46- 
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Table 2.6: Variables tested to improve purification and stability of STM3880 
 
Parameter  Variation  Comment  Gel filtration profile 
pH   4, 5, 6, 7, 8, 9  Protein eluted at 
pH 6 is relatively 
more stable. 
Salt 
concentration 
50 mM to 1 M  No effect of salt. 
Additives  •  KCl  up to 100 mM 
•  Glycerol up to 20% 
•  Sucrose up to 20% 
•  β ME up to 10 mM 
•  Arginine, proline, aspartate  
(upto 20 mM) 
 
No effect of 
additives. 
Detergents  LDAO, FOS12, OG, NG 
CYMAL6, C12E9 
βLM, βLM +ETL* 
Relatively stable in 
FOS12 and βLM. 
No effect of lipids. 
 
Method  Aekta prime (GE health care), 
Batch method (manual) 
No effect.   
Others  Low temperature induction  No effect.   
* E. coli total lipid extracts with a final lipid concentration of 0.25 mg/ml 
   Red arrows indicate the void volume of the column used (Superdex 200)
pH 5
pH 6
FOS12 CYMAL6
βLM +ETL  Tris-Phosphate  
pH 6                                                                                                                              RESULTS 
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2.2.4 Reconstitution and freeze fracture 
 
Reconstitution of STM3880 was performed immediately after purifying the protein in 
either 0.02% βLM or 0.14% FOS12. E. coli total lipid extract was dried under nitrogen 
gas, dissolved in reconstitution buffer (50 mM HEPES-Tris, pH 7.5, 100 mM NaCl) at a 
concentration of 10 mg/ml and extruded through the liposoFast extruder (Avestin) as 
mentioned in materials and methods. Reconstitution was performed by the rapid dilution 
method with a lipid to protein ratio of 1:20. 
In order to check the incorporation of STM3880 into the liposomes, freeze fracturing of 
proteoliposome vesicles was carried out. The analysis revealed that the protein purified 
with βLM was reconstituted into the liposomes but not protein purified with FOS12 (Fig. 
2.18).  
 
 
 
Figure  2.18:  Freeze  fracture  images  of 
STM3880 reconstitution in liposomes.  
The  protein  was  reconstituted  in  liposomes 
prepared  from  E.  coli  total  lipid  extract. 
Freeze  fracture  was  performed  by  Dr.  W. 
Haase,  Department  of  Structural  Biology, 
MPIBP. 
 
 
 
 
 
 
 
 
 
2.2.5 Solid supported membrane experiment to check functionality 
 
Electrophysiological measurements based on solid supported membranes (SSM) were 
used  to  functionally  characterize  STM3880.  In  this  method,  proteoliposomes  are 
adsorbed to a SSM and are activated using a rapid substrate concentration jump. The 
charge translocation is measured via capacitive coupling of the supporting membrane                                                                                                                              RESULTS 
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(Schulz et al. 2008). Two sets of activating (A) and non activating (NA) buffer solutions 
were used as described in table 2.7. 
 
Table 2.7: Buffers used for SSM experiment 
Non-activating 
(NA) 
 
50 mM HEPES-Tris, pH 7.5, 1 mM NaCl, 1 mM DTT  
 
Buffer set I 
Activating (A)  50 mM HEPES-Tris, pH 7.5, 1 mM KCl, 1 mM DTT  
 
Non-activating 
(NA) 
 
50 mM HEPES-Tris, pH 6, 1 mM NaCl, 1 mM DTT  
 
Buffer set II 
Activating (A)  50 mM HEPES-Tris, pH 6, 1 mM KCl, 1 mM DTT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  2.19:  SSM  with  STM3880.  (A)  Adsorption  geometry  of  proteoliposome.  The  SSM 
consists  of  the  gold  layer,  the  octadecane  monolayer  and  the  lipid  monolayer  on  top.  The 
equivalent circuit describing the electrical properties of the compound membrane is included 
(B) Electrical signal generated by STM3880 after solution exchange with buffer set I. 
 
Fig. 2.19B shows the current induced by a 1 mM concentration jump of the substrate 
potassium ion at pH 6. In artifact, a current in opposite direction measured with non 
activating solution in both chambers, was observed. No significant current compared to 
the artifact was observed when the experiment was repeated with buffer set II (pH 7.5). 
This observation indicates that the protein is probably active only at low pH (6). 
       A                                                                   B                                                                                                                              RESULTS 
  53
2.3 Cell-free production of selected transporters 
 
In  recent  years, cell-free  expression  has  emerged  as  a viable  alternative to  the  most 
limiting  step  of  membrane  protein  structural  endeavor,  namely  overexpressing  the 
membrane protein targets. My objectives were not only to produce difficult targets but 
also to compare the stability and folding with that of in vivo produced protein. I selected 
several secondary active transporters from four different families for cell-free expression 
based on E. coli S30 extracts. All reactions were performed in continuous exchange cell-
free (CECF) mode with either detergent in the reaction mix (DCF) or without (PCF) at 30 
°C, if not stated otherwise.   
 
2.3.1 PF0708 of the MOP family 
 
PF0708  of  the  multidrug/oligosaccharidyl-lipid/polysaccharide  flippase  superfamily 
(MOP) was cloned into a modified pET21a vector encoding for a N-terminal T7 tag and 
a C-terminal deca His-tag. After initial small scale (70 µl) expression check using the 
continuous exchange (CECF) method, screening for optimal K
+ and Mg
+2 concentrations 
was  performed.  It  is  worth  mentioning  that,  this  K
+/Mg
+2  screening  for  optimal 
concentrations was performed with every new batch of an S30 extract. A typical K
+/Mg
+2 
screening  result  is  shown  in  Fig.  2.20A,  which  demonstrates  that  the  expression  is 
maximum at a Mg
+2 concentration of 18-20 mM with K
+ in the range of 270-310 mM. 
 
2.3.1.1 PCF mode production of PF0708 
In the PCF mode, the protein is produced without any detergent in the reaction mixture as 
a  precipitate.  This  precipitated  protein  or  pellet  is  then  solubilized  with  a  suitable 
detergent, typically at 30 °C for 2 hrs. Fig. 2.20B shows the result of detergent screening 
for  solubilization.  The  Western  blot  revealed  that  beside  SDS,  which  worked  as  a 
positive control, FOS12, LMPG and LMPC could solubilize the protein effectively. On 
the  other  hand,  mild  detergents  like  βLM  or  C10E5  failed  to  do  so.  Overnight 
solubilization with βLM at 4 °C yielded less solubilized product than at 30 °C. LMPG 
was chosen for further large scale production. 
 
                                                                                                                              RESULTS 
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Figure 2.20: PF0708, expression screening and purification. (A) Western blot of Mg
+2/K
+ 
screening. Lanes 1-4 (Mg:14, K:250, 270, 290, 310); Lanes 5-8 (Mg: 16, K: 250, 270, 290, 310); 
Lanes 9-12 (Mg: 18, K: 250, 270, 290, 310); Lanes 13-16 (Mg: 20, K: 250, 270, 290, 310). (B) 
Western  blot  of  detergent  screening  after  resolubilization.  Odd  and  even  number  lanes  are 
supernatant and pellet fractions respectively. Lanes 1-2: SDS, 3-4: βLM at 30 °C, 5-6: βLM at 4 
°C, 7-8: FOS12, 9-10: LMPG, 11-12: C10E5 at 4 °C, 13: Supernatant of LMPC. (C) Coomassie 
stained  SDS-PAGE  of  PF0708  after  affinity  purification  and  (D)  corresponding  Blue  Native 
PAGE. (E) Gel filtration profile, after storage for one week at 4 °C. 
 
Large scale production, typically in 2 ml or its multiple, was carried out at 30 °C as 
described in materials and methods. The pellet was solubilized in a final concentration of 
1% LMPG and after centrifugation the supernatant was applied to a 1 ml HisTrap-HP 
column (GE healthcare). The detergent was exchanged from LMPG to C10E5 during the 
purification. The protein was eluted with an imidazole gradient of 0-500 mM. Coomassie 
stained SDS-PAGE revealed the protein to be more than 95% pure and migrating just 
below 38 kD. Two bands close to each other were observed in SDS-PAGE which could 
be caused by two differently folded states of the protein. The same sample was subjected 
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to blue native gel eletrophoresis, which revealed two bands migrating at 242 kD and 480 
kD (Fig. 2.20 C and D). The gel filtration profile after superdex 200 column showed 
homogeneity of the protein, even after a week of storage at 4 °C (Fig. 2.20E). The peak 
fractions of a gel filtration run of another batch of purification from a 10 ml reaction mix 
were pooled and concentrated to 2 mg/ml and crystallization trials were set.  
 
2.3.1.2 DCF production of PF0708 
In DCF mode, the protein is produced in the presence of detergents and recovered from 
the  reaction  mix  as  a  detergent  soluble  product.  Prior  to  the  large  scale  production, 
PF0708 was screened for the most suitable detergent. Brij35 and Digitonin were the best 
among 5 detergents tried. The large scale production of 2 ml reaction mix was carried out 
in the presence of Brij35 as described in materials and methods. The reaction mix was 
centrifuged and the protein was purified from the supernatant using IMAC as described 
in PCF production. The protein was less pure than protein produced using the PCF mode 
production. The yield was also lower by at least 20-30%. However, gel filtration resulted 
in a single peak (Fig. 2.21). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.21: DCF  production of  PF0708.  (A)  Coomassie  stained  SDS-PAGE  after  affinity 
purification. M: Invitrogen seeBlue plus 2 prestained protein marker, 1: Purified protein, 2: In 
vivo purified protein as control. (B) Gel filtration profile of purified protein in superdex 200 
column. 
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2.3.2 STM3476 of the FNT family 
 
2.3.2.1 Detergent screening in the PCF and DCF mode 
STM3476 was cloned into the pET21a vector encoding for a N-terminal T7 tag and a C-
terminal deca His-tag. Expression screening was carried out both in PCF and DCF mode 
at 30 ºC. Out of 7 detergents screened in the PCF mode, LMPC, LMPG and FOS12 
emerged as the preferred detergents for solubilizing STM3476 (Fig. 2.22A).  
For  DCF  screening,  the  protein  production  was  best  in  Brij  35,  Brij58  and  Brij78. 
Addition of E. coli total lipid extract (0.1 mg/ml  final concentration) to βLM in the 
reaction mix could not increase the expression level as evident from the Western blot 
(Fig. 2.22B). 
 
 
 
 
 
 
 
Figure 2.22: Detergent screening for STM3476. (A) PCF mode production and Western blot of 
solubilization screening with supernatant and pellet fraction loaded into alternative lanes. (B) 
DCF mode production in the presence of indicated detergents with alternate lanes loaded with 
pellet and supernatant fractions. M: Seeblue plus 2 prestained marker; ETL: E. coli total lipid 
extract with 0.1 mg/ml final concentration. All reactions were performed at 30 ºC with continious 
exchange (CECF) mode. The desired location of the protein in the blot is marked with a red 
arrow. 
 
2.3.2.2 Effect of temperature on expression and solubilization 
As temperature is known to influence not only protein production but also its folding, 
both PCF and DCF mode production was carried out at different temperatures. Typically 
the production level goes down with decreasing temperature but this lowering of the 
temperature is often reported to enhance native folding. On the other hand in the PCF 
mode production, the resolubilization temperature is more important when actually the 
protein  refolding  takes  place  from  insoluble  aggregates.  My  trials  with  STM3476 
revealed that the production levels go down when the temperature is lowered in both the 
DCF and PCF mode. In PCF mode, the difference was significant between 30 ºC and 20 
A                  B                                                                                                                              RESULTS 
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ºC but not between 30 ºC and 25 ºC (Fig. 2.23A). However, considering the overall low 
protein  yield  in  the  cell-free  expression  system,  30  ºC  was  chosen  as  the  preferred 
temperature for further large scale production of STM3476 using the PCF mode. When 
the resolubilization of PCF produced protein was carried out at 4 ºC, 20 ºC and 30 ºC 
with two different detergents, a prominent effect of detergent rather than of temperature 
was observed. FOS12 was equally good for resolubilization at all temperatures compared 
to βLM (Fig. 2.23B). In the DCF mode, the difference was significant at a 10 ºC interval 
with the maximal production observed at 37 ºC (Fig. 2.23C). 
 
 
 
 
 
 
 
 
 
Figure 2.23 Production of STM3476 at different temperatures. (A) Western blot of protein 
produced  at  different  temperatures  in  PCF  mode.  Only  the  pellet  fraction  was  loaded.  (B) 
Solubilization screening of PCF produced protein with indicated detergent and temperature (in 
bracket).  (C)  Western  blot  of  produced  protein  in  DCF  mode  (with  Brij  58)  at  different 
temperatures. S: supernatant fraction, P: pellet fraction. 
 
 
2.3.2.3 Large scale production and purification 
Large scale production of the STM3476 protein, in 2 ml reaction mix, was carried out in 
the PCF mode. The pellet was washed once with washing buffer (20 mM HEPES, pH8, 
150 mM NaCl, 2 mM βME) and solubilized with final concentration of FOS12 at 1% in 
the same buffer for 1.5-2 hrs at 30 ºC. After centrifugation at 15000 RPM (Eppendorf 
centrifuge 5417R) for 15 minutes, the supernatant was diluted 5-8 times with the same 
buffer but without βME and with 300 mM NaCl. The supernatant was then allowed to 
bind  to  the  Ni-NTA  matrix  for  2  hrs  and  the  protein  was  eluted  with  350  mM  of 
imidazole. As depicted in Fig. 2.24, the protein migrated between 28 and 17 kD which 
was  confirmed  to  be  STM3476  by  peptide  mass  fingerprinting  (PMF)  using  mass 
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spectrometry (MS). The other higher bands visible in the Coomassie stained gel could be 
caused by different oligomeric states. MS confirmed the presence of STM3476 in the 
bands migrating around 38 kD and 49 kD. The purified protein showed aggregation, 
when  concentrated.  This  was  evident  from  the  aggregation  peak  observed  in  the 
analytical gel filtration chromatography using superdex 200.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.24: PCF production and purification of STM3476. The Coomassie stained gel shows 
the  purified  protein  after  affinity  chromatography  and  gel  filtration.  1  and  2  shows  the 
corresponding fractions of the gel filtration profile indicated next to it. The blue arrow in the gel 
shows the desired location of the band while the red arrow in the gel filtration profile indicates 
the void volume of the column. 
 
 
2.3.3 STM1781 of the SulP family 
 
STM1781, belonging to the Sulphate permease (SulP) family, was expressed in PCF 
mode.  After  initial  detergent  screening  for  solubilization  (Fig.  2.25A),  FOS12  was 
chosen to resolubilize the protein in large scale PCF production. The protein was purified 
by Ni- NTA affinity chromatography as described earlier. The Coomassie stained SDS-
PAGE showed a pure protein band (Fig. 2.25B). The final yield was below 100 µg of 
purified protein from 1 ml of reaction mix as judged by Western blot. However, in SDS-
PAGE  the  purified protein  did  not  show  any  sign  of  degradation  unlike  the  in  vivo 
produced STM1781. The analytical gel filtration chromatography profile, which is the 
benchmark  standard for protein  homogeneity,  was  improved  when  the  detergent  was 
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exchanged from FOS12 to βLM in the course of purification along with the addition of  1 
mM sodium sulfate in the elution buffer (Fig. 2.25C ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.25: Expression and purification of STM1781. (A) Western blot of detergent extracted 
proteins to test the solubilization efficiency after PCF production. S and P denote supernatant and 
pellet fraction after solubilization. (B) Coomassie stained SDS gel after IMAC purification. (C) 
Gel filtration profile of STM1781 purified either with FOS12 or βLM. 
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2.3.4 STM3959 of the RhtB family 
 
Resistance  to  homoserin/threonin  (RhtB)  family  proteins  are  small  with  6  predicted 
trnasmembrane helixes and molecular weights ranging between 22 and 23 kD. When 
checked for expression screening in vivo, they failed to express within the detection limit 
in our set of conditions (see appendices). I selected three members, namely, STM1270, 
STM3959  and  STM3960  for  cell-free  expression.  After  initial  screening  in  the 
continuous exchange mode, STM3959 was selected for further trials in PCF mode. 
After detergent screening for solubilization (Fig. 2.26A), large scale PCF production in 2 
ml reaction mix was carried out. The pellet was solubilized with LMPG and purified with 
βLM using a Ni-NTA affinity matrix. The purified protein could be observed in the 
Coomassie stained SDS gel migrating between 28 and 17 kD (Fig. 2.26B). In analytical 
gel filtration runs, the protein showed a broad peak (Fig. 2.26C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.26: PCF production and purification of STM3959. (A) Western blot of detergent 
extracted proteins; P and S denote supernatant and pellet fraction of solubilization experiment 
respectively (B) Coomassie stained SDS gel of the IMAC purified protein. (C) Gel filtration 
profile of the purified protein using a superdex 200 column. 
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2.4 MBP fusion and effect on production 
 
To evaluate the effect of full length MBP on the heterologous production of secondary 
active  transporters,  I  fused  MBP  to  the  N-terminus  of  three  prokaryotic  membrane 
transporters belonging to 2 different families. In parallel, to distinguish the effect of MBP 
from His-tag on the production level of the target protein, both N- and C- terminal His-
tag fusions were tested.  
Table  2.8  provides  information  about  the  selected  targets  of  respective  families,  the 
number of  predicted transmembrane  helixes  and  the  topology  evaluated  with  several 
prediction programmes. The reason behind choosing the CDF family target was to check 
how  MBP  fusion  affects  the  overall  yield.  On  the  other  hand,  the  RhtB  family 
transporters failed to express with the conventional strategy. So, the aim was to check if 
the MBP fused protein could be expressed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  2.27:  Effect  of  MBP  fusion  on  expression.  (A)  Western  blot  of  whole-cell  lysate 
expression developed using anti-His antibody. Black arrows indicate signals of His-tag fusions, 
white arrows indicate MBP fusions and grey arrows indicate degraded targets. (B) Western blot 
of whole cell lysate expression developed using anti-MBP antibody. Filled arrows indicate the 
expected band position. (C) Purified STM0758 without and with MBP fusion. Coomassie stained 
gel (left) and corresponding Western blot (right), developed using anti-His antibody. 
(-) and (+) denotes the absence or presence of MBP tag, C and N denote the presence of His-tag 
on either C terminus or N terminus. 
 
 
The overall result of the whole cell lysate expression screening is summarized in Table 
2.9 and the corresponding Western blots, developed using either anti-His antibody or 
anti-MBP antibody are depicted in Fig. 2.27 A and B.   
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Table 2.8: Selected transporter for MBP fusion, their predicted topology and experimental evidence 
 
 
 
 
 
 
 
 
 
SN: Serial number; ST: S. typhimurium; TMH: transmembrane helix 
 
Table 2.9:Expression screening of whole cell lysate, determined by both anti-His and anti-MBP antibody 
 
 
 
 
 
 
 
 
(0) represents signal below detection limit, (+) represents 0.05 to 0.2 µg of protein, (++) represents 0.3 to 0.6 µg of protein. Protein  
concentrations were estimated with known amount of His-tagged protein (Positope: Invitrogen) 
(a) protein mobility in SDS-PAGE was different from that of predicted molecular mass, (b) degradation of the recombinant protein was observed 
 
Table 2.10: Summary of purification and yield of STM3959 with and without MBP fusion 
 
Protein yield was measured by the Bradford assay; estimated 
purity  (%)  was judged according to the Coomassie  stained 
SDS-PAGE gels; ratio of the increase (+) or decrease (-) of 
the  yield  has  been  calculated  comparing  the  intensities  of 
protein  bands  on  Coomassie  stained  gels  (in  brackets: 
comparing Western blot signals) 
S
N  Gene  Origin  Family 
HMMTOP 
(TMH/N 
terminus) 
TMHMM 
TMH/N 
terminus 
TopPred 
(TMH/N 
terminus) 
TMpred 
(TMH/N 
terminus) 
SOSUI 
(TMH/N 
terminus) 
Experimental 
topology 
(TMH/N terminus) 
Reference 
1  STM0758  ST  CDF  5/ in  5/ in  5/ in  5/ in  6/ -  YiiP (E. coli) 
6/ In 
Lu and Fu 
(2007) 
2  STM0365  ST  RhtB  6/ out  6/ out  6/ out  6/ in  5/ -  -  - 
3  STM3959  ST  RhtB  6/ out  6/ out  5/ out  5/ out  6/ -  -  - 
Gene  Family  Length 
(AAs)  Vector 
N-term  
His10 
(anti-His) 
MBP 
N-term His10 
 
(anti-His)     (anti-MBP) 
C-term 
His10 
(anti-His) 
MBP 
C-term His10 
 
(anti-His)     (anti-MBP) 
STM0758  CDF  312  pTTQ18  +  ++  +b  ++  +  ++b 
STM0365  RhtB  210  pTTQ18  0  0  0  0  0  ±b 
STM3959  RhtB  206  pTTQ18  0  + a    ++ a b    0  0  0 
Gene 
Construct 
 
N- Term tag       C- Term tag 
Yield  
(mg/ 1 Lit 
culture) 
% of purity  Ratio of 
decrease 
His10  Strep tag II  0.057 mg  80   
His10 - MBP  Strep tag II  0.033 mg  95  2 ( 3.4) 
-  His10  0.087 mg  70   
STM0758 
MBP  His10  0.045 mg  95  1.5 (5.9)                                                                                                                              RESULTS 
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The anti-His antibody developed Western blot showed that STM0758 is slightly better 
produced with MBP when the His-tag was present at the N-terminus, but the effect was 
opposite when His-tag was present at the C-terminus. However, the production levels 
seem to be equal when the Western blot was developed using anti-MBP antibody. No 
production of STM0365 was detected when developed with an anti-His antibody, but the 
MBP fused STM0365 with the His-tag at the C-terminus showed signals of degradation 
when developed with an anti-MBP antibody. MBP fused STM3959 with N-terminal His-
tag showed a signal, migrating at an altered position in anti-His developed Western blot. 
However, the anti-MBP developed blot showed several degraded bands with no clear 
signal at the desired position. 
Only STM0758 was subjected to membrane preparation and protein purification from 1 
liter culture volume (Fig. 2.27C). The comparative yield and purity, judged by Bradford 
assay and Coomassie stained gels are summarized in Table 2.10. This revealed that the 
actual production or integration of the protein into the membrane upon MBP fusion is 
lowered by 3.4 times and 5.9 times when a His-tag is present at the N-terminus and at the 
C-terminus, respectively. 
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3.1 Cation diffusion facilitator (CDF) family 
 
3.1.1 The proteins 
 
The CDF proteins form a phylogenetically ubiquitous family of membrane transporters 
generally believed to play a role in the homeostasis of a wide range of divalent metal 
cations. CDFs are found in varities membranes, including the bacterial cell membrane, 
the vacuolar membrane of both plant and yeast, and the Golgi apparatus of animals. All 
CDF proteins characterized in bacteria so far are involved in resistance to zinc and other 
heavy metal cations. They function typically as homodimers and use proton antiport to 
drive substrate translocation. The best characterized CDF proteins  are YiiP and ZitB 
from E. coli; CzcD from R. metallidurans and ZnT3 and ZnT8 from human. Among my 
selected  transporters,  STM0758  and  STM4061  are  closely  related  to  the  E.  coli 
homologues ZitB and YiiP respectively. STM0758 also shares significant identity (30-
31%) with the human homologues. On the other hand, CDF proteins from A. aeolicus 
share significant  identity with CzcD  from R. metallidurans (Table 2.1). Phylogenetic 
analysis  of  the  selected  CDF  proteins  for  this  work  and  their  well  characterized 
homologues revealed three distinct clusters. STM0758 and Aq_1073 are more closely 
related to ZitB of E. coli, while STM4061 and Aq_2073 are closely related with YiiP of 
E. coli. Znt3, ZnT8 and CzcD have their own distinct locations in the tree (Fig. 2.1). 
 
3.1.2 Expression screening  
 
There are several groups who have attempted to compare the use of different vectors, 
tags and expression strains in the production of integral membrane proteins. Eshaghi et 
al. (2005) analyzed the production of 49 E. coli proteins in E. coli using different vectors 
and strains and reported a success rate of 71%. However, for any single vector tested the 
number of targets produced was approximately 50%. Psakis et al. (2007) carried out a 
medium-throughput  cloning  and  expression  screening  of  integral  membrane  proteins 
from Helicobacter  pylori  using E. coli as the expression host. One-hundred sixteen H. 
pylori targets were cloned into two different vector systems and heterologously expressed 
in E. coli. Eighty-four percent of these proteins displayed medium to high expression. 
They could not observe any clear-cut correlation between expression levels and number                                                                                                                        DISCUSSION 
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of putative transmembrane spans, predicted functionality, and molecular mass. However, 
transporters of  40 kD and with an average of four to six transmembrane helices showed 
overall adequate expression, irrespective of the tag position. They also advocated that 
neither  the  location  nor  the  length  of  the  His-tag  could  solely  define  expression 
efficiency. However, targets with an N terminal His-tag displayed overall higher levels of 
expression. In another study, Lewinson et al. (2008) cloned 36 P-type ATPases from 11 
different  genomes  into  four  different  expression  vectors  (with  T7  and  arabinose 
promoter)  having  varying  tag  positions  and  analyzed  the  expression  screening  in  5 
different E. coli expression hosts. They observed a significant influence of the affinity tag 
location. Some proteins expressed better with an N-terminal His-tag while others with C- 
terminal  His-tag  though  at  lower  frequency.  They  also  observed  a  better  correlation 
between  the  expression  level  in  whole-cell  lysates  and  the  expression  level  in  the 
membrane  fraction  for  proteins  expressed  under  the  control  of  arabinose  promoter 
compared to proteins expressed under the control of the T7 promoter. 
A similar study was also carried out in our lab by Surade et al. (2006). They presented 
comparative expression data for 37 secondary active transporters from S. typhimurium, A. 
aeolicus and P. furiosus in E. coli and L. lactis host cells. Four different vectors with two 
different tag positions were used for this study. An expression rate of approximately 50-
60% was observed for any individual vector while 76% total expression was observed for 
all the vectors combined. The overall observations were: (i) E. coli is a robust production 
host  for  heterologous  prokaryotic  membrane  proteins,  (ii)  there  is  no  single  E.  coli 
expression host / vector system that shows overwhelming advantages over others, (iii) a 
combination of two or more different vectors and host strains should be preferred when 
feasible,  (iv)  screening  of  additional  vectors  is  more  advantageous  than  screening 
additional tag positions, (v) screening of orthologues,  ie.,  same  target  from  different 
organisms, increases the expression space significantly (20% in this study). 
Therefore, in order to express my selected CDF transporters from A. aeolicus and S. 
typhimurium,  I  cloned  them  into  pBAD,  pTTQ18  and  pQE  vectors.  In  structural 
genomics  projects,  working  in  a  highthroughput  mode  is  a  vital  part  of  the  overall 
strategy. In order to make the cloning step highthroughput, each of the three selected 
vectors (pBAD, pTTQ8 and pQE) were modified at multiple cloning sites (MCS) to have 
the same pair of restriction enzyme sites. Moreover, each vector has two different version 
based on the tag positions, A2 and C3. The A2 version has a deca His-tag at the C-                                                                                                                       DISCUSSION 
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terminus whereas the C3 version has a deca His-tag at the N-terminus and a Strep tag II 
at the C-terminus. All 24 constructs were expressed quite well as judged by whole cell 
lysate screening. Aq_2073 and STM0758 showed a slightly better expression with the 
His-tag at the N-terminus (Table 2.2). This is in agreement with other reports (Lewinson 
et al. 2008). A well expressing tag, such as a His-tag at the beginning of the ORF (N-
terminus) often enhances the expression.  
 
3.1.3 Functional complementation  
 
The  functional production of CDF transporters was primarily  investigated in vivo by 
means of complementation. In the E. coli strain GG48, the zinc exporting primary pump 
ZntA and the CDF transporter ZitB were deleted. This manipulation renders the strain 
highly zinc sensitive. Grass and colleagues have used this system to demonstrate that the 
ZitB protein functions as a zinc ion transporter (Grass et al. 2001). 
The complementation system of GG48 by additional transporters offers a great system to 
determine the functional production of the protein. Our results, the functional production 
of the STM0758 protein, demonstrate that this was properly targeted to the membrane 
and correctly folded. However, other proteins like Aq_1073, Aq_2073 and STM4061 
could not complement the stressed cells. Upon multiple alignments of these four proteins 
(Fig. 1.4), and by drawing their phylogenetic tree (Fig. 2.1), one can see that proteins 
STM4061 and Aq_2073 are closely related, which in turn are closely placed to YiiP of E. 
coli. Protein Aq_1073 and STM0758 are closely placed to ZitB of E. coli. It is worth 
mentioning here that YiiP has been reported to transport ferrous ion in vivo (Grass et al. 
2005). This relation indicates that the primary function of the STM4061 and Aq_2073 
proteins could be to relieve iron stress in vivo and not zinc stress. Such a function could 
explain the observed pattern. The inability of the A. aeolicus transporter Aq_1073 to 
complement zinc transport function in E. coli strain GG48, could be attributed mainly to 
its hyperthermophilic origin or a need of specific lipid. A. aeolicus is known to grow at 
temperatures between 70 °C to 90 °C and proteins from this organism are reported to 
function  optimally  at  or  above  60  °C  (Chintalapati  et  al.  2008).  The  different  lipid 
environment  in the E coli membrane could be the other possible reason for its non-
functionality (Opekarova and Tanner 2003, Hunte and Richers 2008). 
                                                                                                                        DISCUSSION 
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3.1.4 Purification and stability of Aq_2073 
 
The  pBADC3  construct of Aq_2073  was  preferred for  large scale  production of the 
protein for crystallization purpose. The C3 version of the construct offers an optional 
second step of affinity purification using the strep tag, if necessary. Moreover, with dual 
tags the integrity of the purified protein can also be checked by Western blot. 
An important step in purifying the membrane protein is the efficient extraction of the 
protein from the host membrane. This is achieved by solubilizing the membrane with a 
suitable detergent. Solubilization involves a number of intermediary states. It usually 
starts  by  destabilization  of  the  lipid  component  of  the  membranes,  a  process  that  is 
accompanied  by  a  transition  of  detergent  binding  by  the  membrane  from  a 
noncooperative  to  a  cooperative  interaction  already  below  the  critical  micellar 
concentration (CMC). This leads to the formation of membrane fragments of proteins and 
lipids  with  detergent-shielded  edges.  In  the  final  stage  of  solubilization  membrane 
proteins  are  present  as  protomers,  with  the  membrane  inserted  sectors  covered  by 
detergent. le Maire et al. (2000) have concluded that in general detergent binding as a 
monolayer ring, rather than a micelle, is the most probable mechanism. 
Since,  Aq_2073  is  from  a  hyperthermophilic  source  organism,  the  solubilization 
experiment was carried out both at 4 °C and 50 °C with a range of detergents reported to 
be useful for membrane protein crystallization. Detergents of the maltoside group (βLM 
and DM), LDAO and FOS12 could solubilize the protein efficiently with no significant 
effect of temperature (Fig. 2.4).  
For  purification  of  recombinant  proteins,  immobilized  metal  affinity  chromatography 
(IMAC) is probably the method of choice for all structural genomics style of projects. A 
comparative analysis of different tags used for this purpose is documented by Lichty et 
al. (2005) and Waugh (2005). A single step IMAC using Ni-NTA matrix resulted into 
more  than  90%  purity  of  Aq_2073.  The  protein  showed  a  homogeneous  peak  in 
analytical gel filtration which is a reflection of its monodispersity (Fig. 2.5).  
Due to their amphiphilic nature, membrane proteins tend to aggregate fast in unfavorable 
conditions,  precluding  crystallization.  This  is  especially  critical  for  membrane 
transporters  because  of  their  multiple  membrane  spans  and  large  hydrophobic  areas. 
Individual  membrane  transporter  proteins  demonstrate  unique  sensitivities  for  their 
environment, like, detergent, pH and temperature. Crystallization requires the protein to                                                                                                                        DISCUSSION 
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be stable and monodisperse in solution. Previous work on membrane transporters has 
shown  that  the  types  of  detergent  and  pH  used  are  the  most  important  parameters 
influencing the monodispersity of the protein (Boulter and Wang 2001; Li et al. 2001; 
Engel et al. 2002). 
In a relevant study, Lemieux et al. (2003) observed a clear relationship between the 
ability of a detergent to preserve the monodispersity of glycerol-3-phophate transporter 
(GlpT) and the possibility of yielding protein crystals. In this report, nine detergents that 
retained GlpT monodispersity produced protein crystals of various qualities. However, 
three detergents that were unable to preserve the monodispersity of the protein failed to 
yield any crystal. This clearly showed a strong correlation between the monodispersity 
and the crystallizability of a membrane protein in a particular detergent. Additionally, 
specific  lattice  contacts  in  any  membrane  protein  crystal  are  made  exclusively  via 
protein–protein  interactions, and a too large detergent micelle can be an obstacle for 
protein crystallization. Therefore, optimizing the detergent micelle  size  and shape by 
carefully choosing the right detergent or a mixture of detergents, the area available for 
the  formation  of  lattice  contacts  can  be  essentially  increased,  thereby  improving  the 
protein crystallizability.  
Aq_2073  showed  stability  and  monodispersity  in  pH  4  to  pH  9.  The  βLM  purified 
protein remained monodispersed for 15 days when kept at 4 °C at pH 8 and showed little 
sign  of  heterogeneity  when  kept  at  room  temperature  (Fig.  2.7).  When  subjected  to 
detergent screening, Aq_2073 exhibited monodispersity in a wide range of detergents 
and  detergent mixtures (Table 2.3). One  important  observation was that  the stability 
decreased in the order LM>UM>DM>NM and the protein completely aggregated in OG. 
This could be explained when we consider the detergent micelle size. Detergents with 
small carbon chain length have a smaller micelle size which probably is not sufficient to 
cover the hydrophobic surface area of the protein to keep it soluble or monodispersed. 
However, the protein was substantially stable in relatively harsh detergents like LDAO 
and  FOS12.  So,  apart  from  the  head  group  specificity,  carbon  chain  lengths  of  the 
detergents also play an important role in membrane protein stability. 
When the stability of Aq_2073 was checked by DSC, it showed a Tm around 96 °C at 
physiological  pH  range.  DSC  profile  also  revealed  that  the  Tm  decreased  with  the 
decrease in pH (Fig. 2.8).                                                                                                                        DISCUSSION 
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The stability of Aq_2073 in such a wide range of conditions and an apparently higher Tm 
value in DSC could be attributed to its hyperthermophilic origin and this observation is in 
agreement with other reports in literature (Pfeil et al. 1997; Wassenberg et al. 1999; 
Razvi and Scholtz 2006). 
 
3.1.5 Oligomeric state of Aq_2073 
 
Their existence as oligomer is a general feature of secondary transport proteins. The 
experimental determination of the physiologically relevant oligomeric state of a protein is 
technically  demanding.  However,  several  complementary  techniques  can  be  used  to 
determine the oligomeric structure of proteins either in detergent solution or embedded in 
membranes. An overview of the different techniques, with their prerequisites, advantages 
and shortcomings are discussed in details by Veenhoff et al. 2002. Table 3.1 briefly 
describes the techniques I employed to determine the oligomeric states of Aq_2073. 
The retention volume of Aq_2073 in calibrated gel filtration column was 1.33 ml which 
corresponds  to  an  approximate  mass  of  280  kD.  The  molecular  weight  of  Aq_2073 
calculated from the amino acid sequence corresponds to 43 kD and a Aq_2073 dimer 
would  have  a  molecular  weight  of  86  kD.  However,  this  technique  is  applied  to 
membrane protein in detergent solution. So, the contribution of bound detergent needs to 
be accounted for. According to Heuberger et al. (2002), for secondary transporters with 
multiple membrane spanning helices, the amount of detergent (βLM) bound is in the 
range of 150-180 molecules per monomer, corresponding to 70-90 kD. The amount of 
bound detergent is thus critical to interpret the gel filtration profile. Therefore, taking this 
fact into account, the observed elution volume of Aq_2073 (Fig. 2.5B and Fig. 2.9C) 
would correspond to a dimer (~266 kD), rather a monomer (~133 kD) or a trimer (~400 
kD).  This  is  in  agreement  with  the  reported  oligomerization  state  of  YiiP,  the  CDF 
protein from E. coli (Lu and Fu 2007). In order to determine accurately the oligomeric 
state of a membrane protein by gel filtration chromatography, one has to run the protein 
in a series of detergents differing in the length of the alkyl chain (eg. 14M, 13M, LM, 
UM, DM, NM, OM) and eventually extrapolate the exact hydrodynamic radius of the 
protein molecule (Bamber et al. 2006). However, this is only possible when the protein is 
stable, eluting as a single narrow peak and assuming the same oligomeric state in the 
whole series of detergents.                                                                                                                        DISCUSSION 
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Table: 3.1 Overview of different oligomerization techniques 
Techniques  Principles and unique features  Prerequisites and drawbacks 
Size-exclusion 
chromatography 
♦  In combination with a sedimentation 
coefficient, a reasonable estimate of 
the molecular mass can be obtained 
♦  Amount  of  bound 
detergent/lipids  needs  to  be 
determined 
♦  Dependent on protein shape 
♦  Calibration  is  problematic  for 
membrane proteins 
♦  kD  of the complex needs to be 
relatively low 
Blue native gel 
electrophoresis 
♦  Protein stops migrating when trapped 
at region of appropriate pore size 
♦  Many  different  samples  can  be 
analyzed simultaneously 
♦  Calibration  on  soluble  proteins  is 
possible when the additional mass of 
bound CBB is accounted for 
♦  Protein solubility and stability in 
the presence of CBB 
♦  Non-equilibrium method 
♦  kD  of the complex needs to be 
relatively low 
 
Chemical cross-
linking 
♦  Simple method to demonstrate close 
proximity of proteins in their native 
state 
♦  Accessibility of target sites 
♦  Modification  of  the  protein  is 
needed 
♦  Difficult to  exclude nonspecific 
cross-links 
Freeze-fracture 
EM 
♦  Determination of the oligomeric state 
in the membrane 
♦  Empirically  determined  1.4  nm
2/α 
helix  in  combination  with  the 
predicted number of TM α helices is 
used to estimate the oligomeric state 
♦  Large  excess  of  the  protein  of 
interest in the native membrane 
or  incorporation  of  purified 
protein into liposomes 
♦  Secondary structure information 
is needed  
♦  Thickness  of  the  metal  film 
needs to be determined 
 
In BN-PAGE, Aq_2073 migrated as two distinct bands, one just above 146 kD and the 
other between 242 kD and 480 kD (Fig. 2.9A). During blue native electrophoresis, the 
detergent bound to the proteins is replaced by the amphipathic Coomassie Brilliant Blue 
(CBB) dye. The mass of the bound CBB dye needs to be quantified as it influences the 
migration of the protein band. Heuberger et al. (2002) carried out a systematic study and 
concluded that bound CBB dye increases the molecular mass by 1.8 times for a protein 
with  12  transmembrane  helices.  Taking  this  conversion  factor  of  ~  1.8,  the  band 
migrating around 146 kD of Aq_2073 corresponds to a dimer (154.8 kD). However there 
is another prominent band between 242 kD and 480 kD and a very faint band above that. 
These are probably higher oligomers (tetramer and above) of Aq_2073. In glutaraldehyde 
crosslinking experiment, one could also observe bands corresponding to higher oligomers 
in addition to a clear band corresponding to a dimer (Fig. 2.9B). Whether these higher 
oligomeric states are a property of Aq_2073 or due to aggregation, needs to be verified. 
Many different membrane proteins have been observed to exist in multiple oligomeric 
states.  The  MFS  family  sugar  transporter  LacS  from  Streptococcus  lactis  has  been                                                                                                                        DISCUSSION 
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reported to be in equilibrium between monomer and dimer (Heuberger et al. 2002), while 
GLUT1 and Band 3 anion exchanger have reported to exist both as dimers and tetramers 
(Veenhof et al. 2002).  
Incorporation of Aq_2073 into artificial liposome failed to generate prominent crystalline 
arrangements. Thus, the possibility of determining the oligomeric state in a more native 
like condition is excluded. 
 
3.1.6 Substrate(s) of Aq_2073 
 
Members  of  CDF  family  proteins  are  reported  to  transport  a  range  of  heavy  metal 
substrates. The E. coli CDF protein YiiP appears to be responsible for iron detoxification 
in vivo (Grass et al. 2005) but is capable of zinc and cadmium transport in vitro (Wei and 
Fu 2006). ZitB, the other CDF protein of E. coli has been reported to transport zinc and 
cadmium (Chao and Fu, 2004). Recently, Rahman et al. (2008) showed both by solid 
state NMR and metal ion uptake studies that ZitB is potentially capable of transporting 
not  only  zinc  and  cadmium  but  also  nickel  and  copper.  Various  methods,  like, 
calorimetry, equilibrium dialysis, fluorescence and NMR have all previously been used 
to examine substrate binding to transporters. I tried differential scanning calorimetry to 
check if any of the putative substrates could actually bind to Aq_2073. If a substrate 
binds to the protein in question and stabilizes the native structure, it will increase the 
melting temperature (Tm). On the other hand, if substrate binding destabilizes the native 
structure, the Tm will be lowered. Previously, Epand et al. (1999 and 2001) found that the 
Tm of the glucose transporter GLUT 1 from human erythrocytes increased in the presence 
of  glucose  while  it  decreased  in the  presence of ATP. I  used a His-tag  free protein 
(removed by TEV digestion) for binding studies. The result showed that out of six metal 
ions (zinc, cadmium, ferrous, nickel and magnesium as  negative control) tested only 
cadmium can significantly increase the melting temperature (by ~ 10 °C). Among the 
characterized  CDF  transporters  so  far,  none  has  been  reported  to  solely  transport 
cadmium. For all the CDF transporters of prokaryotic origin, zinc remains the major 
transporting  substrate.  In  complementation  assay,  Aq_2073  failed to  complement the 
zinc deficiency of E. coli strain GG48 (Fig.2.3). However, Aq_2073, being a protein 
from the hyperthermophilic bacteria A. aeolicus, may not function optimally at 37 °C. 
For a similar reason, the substrate uptake assay in reconstituted liposomes with Aq_2073                                                                                                                        DISCUSSION 
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and a trapped fluorescent dye at room temperature, showed no significant transportation. 
So,  further  experiments,  like  isothermal  titration  calorimetry  or  reconstitution  for 
substrate uptake assays in different lipids are needed to determine the exact substrates of 
Aq_2073. 
 
3.1.7 Construct design and crystallization of Aq_2073 
 
The protein itself is the most vital factor in protein crystallization. Flexible termini and 
loops in a protein often hinder the formation of high-quality crystals. After the removal 
of such flexible termini, the protein core tends to crystallize more readily. As a result, it 
is now a standard procedure for improving crystal quality to identify the protein core and 
redesign the protein construct accordingly. Doyle et al. (1998) had solved the structure of 
a  truncated  version  of  KcsA  K
+  channel  (amino  acid  residue  23  to  119)  at  3.2  Ǻ. 
Lemieux et al. (2003) reported that the crystallization of full length Glycerol-3-Phosphate 
transporter (GlpT) from Escherichia coli resulted into a shower of microcrystals. They 
subsequently generated several constructs and finally solved the structure of GlpT448 
(amino  acid  residues  2-448)  at  3.2Ǻ  resolution  (Huang  et  al.  2003).  N-terminally 
truncated versions of FocA from E. coli and BetP from Corynebacterium glutamicum 
have been solved in recent years (Ressl et al. 2009; Wang et al. 2009). 
Initial  crystallization  trials with Aq_2073  resulted  in  small  needle  like crystals  (Fig. 
2.15).  When  the  secondary  structure  of  Aq_2073  was  analyzed  using  PredictProtein 
server  (Fig.  2.11),  the  results  indicated  that  C-terminal  domain  possesses  several 
unstructured regions. Moreover, the C terminal domain has several lysine amino acid 
residues, which are least abundant in crystal contacts (Dasgupta et al. 1997). So, I made 
several  constructs  of Aq_2073 based on homology  alignment.  In  addition  to  making 
several C-terminally truncated versions, I also made two constructs only of the soluble C-
terminal domain, CTD1 and CTD2 (Table 2.4). The atomic structure of the cytoplasmic 
domain of CDF proteins from Thermus thermophilus and Thermotoga maritima were 
solved (Cherezov et al. 2008; Higuchi et al. 2009). 
Out of the 6 constructs generated, 4 were tried for purification and 3 out of them could be 
purified to homogeneity. The construct Aq_2073 C1 was extensively characterized for 
detergent compatibility and stability.                                                                                                                         DISCUSSION 
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Both Aq_2073 and Aq_2073 C1 were tried for 2D crystallization. 2D crystals are formed 
by  reconstitution  of  purified  protein  into  lipid  bilayers  and  subsequent  removal  of 
detergents. So choosing the right lipid and a LPR (Lipid Protein Ratio) screen are the 
first step towards 2D crystallization. I tried two different lipids, E. coli polar extract and 
E. coli total extract. The incorporation of Aq_2073 into liposome was only achieved with 
E. coli total lipid extract (Fig. 2.14). Other important parameters, like, ionic strength 
(pH), salt concentration, additives, temperature and detergents were screened. Most of 
the conditions resulted into protein incorporation in the liposome. Reconstitution at pH 7, 
LPR 0.5, 30 °C incubation for 10 days, minimal salt concentration (10-20 mM NaCl) 
with protein solubilized in βLM and lipid in OG resulted into optimum sized vesicles 
with  crystalline  patches.  However,  none  of  the  condition  tested  resulted  into  a  well 
ordered 2D crystal. 
3D trials with full length and truncated Aq_2073 resulted into some initial crystal forms 
(Fig. 2.15).  However,  extensive optimization  of  these conditions  and  trials  with  new 
conditions did not generate any optimistic results. Constructs of the C-terminal domain, 
CTD1 and CTD2 were also tried for 3D crystallization. But both constructs lack long 
term stability  and in crystallization trials, 70%-80% of the drops showed amorphous 
precipitate. This observation indicates an inherent instability of the C-terminal domain 
itself. 
Probably this large soluble C-terminal domain (more than 50% of the amino acids belong 
to the C-terminal domain according to TMHMM prediction) with inherent flexibility and 
abundance  of  lysine  amino  acid  residues  (least  present  in  crystal  contacts)  made 
Aq_2073  a  challenging  target  for  crystallization.  Making  more  constructs  and 
crystallization  trials  with  additives  that  somehow  make  the  C-terminal  domain  less 
flexible are the option one could try to obtain a well diffracting crystal of Aq_2073. 
 
3.2 Potassium uptake permease (KUP) family 
 
3.2.1 STM3880: expression, purification and stability 
 
In  prokaryotes,  accumulation  of  potassium  takes  place  by  multiple  uptake  systems. 
Among these, TrkA and KUP are constitutive low affinity systems while Kdp is known 
to be a high affinity system.                                                                                                                         DISCUSSION 
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STM3880  is  the  only  KUP  protein  present  in  S.  typhimurim.  It  has  12  predicted 
transmembrane  helices  and  a  calculated  mass  of  69.3  kD.  The  C-terminal  domain, 
predicted to be 182 amino acid long (TMHMM), forms a hydrophilic domain in the 
cytoplasm.  The  closest  homologue  of  STM3880,  the  E.  coli  KUP  protein  was 
characterized in vivo by Zakharyan and Trchounian (2001). They reported that KUP is 
the major potassium uptake system in hyperosmotic stress at low pH (5.5). They also 
advocated that KUP is a proton-potassium symporter. So far, there is no report on the 
isolation of the protein from the membrane and subsequent characterization. 
I cloned STM3880 into 3 different vectors with 2 different versions (A2 and C3) and 
found only  pBADA2  version  to  express  the  protein  (Section  2.2.1).  The  large  scale 
production and IMAC purification resulted in pure protein in miligram amount from 1 L 
cell culture (Fig. 2.17). However, STM3880 lacked long term stability. As described in 
Table  2.6,  several  parameters  were  varied  extensively  to  make  the  protein  stable. 
However, only a low pH elution (Tris-phosphate, pH 6) could make the protein relatively 
stable. This  suggests  that the protein  is  extremely unstable  when extracted  from the 
native  membrane  and  in  vitro  functional  characterization  and  structural  studies  with 
STM3880 are a challenging task.  
 
3.2.2 Solid supported membrane based electrophysiological studies 
 
Recently  there  are  several  reports  of  membrane  transporters  characterized  by  solid 
supported  membrane  (SSM)  based  electrophysiology  (Garcia-Celma  et  al.  2008  and 
2009). Interestingly, the method is well established in our institute. I tried to functionally 
characterize STM3880 protein by SSM. Purified STM3880 was reconstituted into E. coli 
total lipid extract by the rapid dilution method. The freeze fracture images showed the 
reconstituted proteoliposome in Fig. 2.18. The SSM experiment was carried out at two 
pHs, pH 7.5 and pH 6. The activating solution contained KCl while the non-activating 
solution contained NaCl. Only at pH 6, a substrate concentration jump of 1 mM produced 
a detectable current. This indicates that the protein is probably active only at low pH in 
agreement  with  an  earlier  report  (Zakharyan  and  Trchounian  2001).  However,  the 
amount of current generated was low compared to the extent of protein incorporation into 
the liposome. This observation could be explained by the poor stability of the purified 
protein. Probably, only a small fraction of the protein reconstituted into the liposome was                                                                                                                        DISCUSSION 
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stably  folded.  Either  improving  the  stability  of  the  purified  protein  or  an  in  vivo 
functional characterization could be alternative means to characterize STM3880.   
 
3.3 Cell-free production 
 
Initially, cell-free (CF) reactions were carried out in batch mode where all necessary 
components are present in a single compartment. This mode was accompanied by short 
lifespan (0.5-2 hrs) and consequently low yield. The main reason was rapid depletion of 
phosphate pool which took place even in the absence of protein synthesis. In turn, this 
leads  to  the  accumulation  of  free  phosphates,  which  can  apparently  complex  with 
magnesium, and further inhibit protein synthesis. Later, this problem was overcome by 
Sprin and coworkers (1988) with the introduction of the continuous exchange cell-free 
reaction (CECF) system. In CECF, a compartment (RM) with high molecular weight 
compounds such as protein and nucleic acids is separated from the other compartment 
(FM) with low molecular weight precursors such as nucleotides and amino acids, by a 
semipermeable membrane. Thus, ensuring efficient exchange of low molecular weight 
products and precursors extends the reaction time to 14-16 hrs. Miligram amounts of 
protein production from a 1 ml reaction mixture are reported through the CECF reaction 
set up (Spirin et al. 1988; Shirokov et al. 2007). I used the CECF mode for all my cell-
free reactions.  
 
3.3.1 Cell-free production and characterization of PF0780 
 
PF0780 is a MATE family transporter from P. furiosus with 12 transmembrane helices 
and a calculated mass of 49.2 kD. In vivo produced PF0780 generated well diffracting 
crystals in our lab. My objective was to establish a purification protocol for cell-free 
produced  PF0780  and  if  found  stable,  homogeneous  and  pure,  then  crystallizing  the 
protein. By doing so, one can check the crystallizibility of cell-free produced protein in 
addition to compare the folding and oligomerization behavior of in vitro and in vivo 
produced proteins. For production of PF0780, I followed two approaches: (i) producing 
the protein in absence of detergents as precipitates (PCF), (ii) in the presence of detergent 
micelles in soluble form (DCF).                                                                                                                         DISCUSSION 
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3.3.1.1 PCF mode production and characterization 
The precipitated protein obtained in the PCF mode is different from the protein isolated 
from inclusion bodies of cell based protein production. PCF produced proteins are readily 
soluble  in  relatively  mild  detergents  yielding  functional  proteins  unlike  proteins  in 
inclusion  bodies  which  need  strong  denaturing  detergents  or  chaotropic  agents  for 
solubilization.  There  are  several  reports  in  the  literature  which  show  functional 
solubilization of PCF produced proteins (Klammt et al. 2005 and 2007). PF0780 could be 
efficiently  solubilized by  LMPG, LMPC  and FOS12.  Relatively  mild  detergents like 
βLM and C10E5 were less efficient in solubilizing the protein (Fig.2.20B). The LMPG 
solubilized protein was purified by IMAC and the detergent was exchanged to C10E5 
during the purification. SDS-PAGE revealed the protein to be more than 90% pure and 
migrated just below 38 kD which is normal for a membrane protein with a calculated 
mass of 49.2 kD.  
Structural genomics projects deal with many IMPs which have either unknown function 
or  putative  substrates.  So,  establishing  a  functional  assay  is  often  difficult.  In  this 
situation  one must  employ other  methods to benchmark  the  quality  of  CF  produced 
proteins. I employed analytical gel filtration as an indicator for homogeneity, purity and 
stability for most of my target proteins. Typically a monodisperse protein which elutes as 
a single peak and stable over time is mostly correctly folded and functional.  
PF0780 eluted as a single monodisperse peak and the gel filtration profile remained the 
same for at least 10 days when stored at 4 °C. I carried out several crystallization trials 
with  PF0780  after  gel  filtration.  When  the  protein  was  subjected  to  BN-PAGE,  it 
migrated as two distinct bands, one at around 240 kD and the other around 480 kD (Fig. 
2.2D). This indicates that the PF0780 is definitely oligomeric in nature and may exists as 
two different oligomeric forms. But whether this observed higher oliogomeric form is a 
feature of PF0780 or originated due to concentration and storage, needs to be verified by 
other  complementary  experiments,  like  crosslinking  studies  or  analytical 
ultracentrifugation. The yield of the PCF produced protein was ~ 200 µg per ml of cell-
free reaction. However, the final yield went down with every added step of purification 
like gel filtration and protein concentration by centrifugation.  
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3.3.1.2 Soluble production in DCF mode 
Production of PF0708 as soluble form in the presence of detergent was carried out with a 
set of six detergents (Brij-35, Brij-58, Brij-78, Brij-98, βLM and digitonin) as described 
by Klammt et al. (2005). After choosing the suitable detergent, large scale production 
and purification was performed with Brij-35. The SDS-PAGE showed that the protein is 
less pure compared to the PCF produced protein and the final yield also went down by at 
least 20%-30% (Fig. 2.21).  
So, I found that PCF mode production is a better option for structural and functional 
characterization of PF0780 considering its purity, homogeneity and stability. The final 
protein  yield  remains  low  for  regular  crystallization  trials  as  this  is  still  a  major 
bottleneck for cell-free production of large membrane proteins. 
  
3.3.2 Cell-free production and characterization of STM3476 
 
STM3476 is a FNT family protein from S. typhimurium with 6 predicted transmembrane 
helices.  Recent  structures  of  FocA,  a  FNT  family  protein,  showed  that  they  are 
pentameric  in  nature  and  function  as  a  channel  rather  than  as  a  transporter.  In  vivo 
produced STM3476 initially showed functional transport of nitrite by SSM experiment in 
our lab (unpublished result). I established a cell-free production protocol for STM3476. 
Upon successful purification, I planned to carry out functional studies with reconstituted 
protein and crystallization if the yield is sufficient. 
 
3.3.2.1 Detergent screening in PCF and DCF mode 
The precipitate mode production was followed by detergent screening to choose the right 
detergent for solubilization. The most efficient detergents turned out to be LMPC, LMPG 
and  FOS12.  These  detergents  are  relatively  harsh  compared  to  mild  detergents  like 
maltosides  and  are  known  to  efficiently  solubilize  the  protein  precipitates  of  PCF 
production (Klammt et al. 2005; Keller et al. 2008).  
The DCF mode of production was carried out with a set of detergents (Brij-35, Brij-58, 
Brij-78, Brij-98, βLM) reported earlier to efficiently produce soluble membrane proteins. 
Additionally, one reaction was performed with 0.1 mg/ml (final concentration) of E. coli 
total  lipid  extracts  solubilized  in  βLM.  Specific  lipid  molecules  are  often  tightly 
associated with membrane proteins and are known to play a significant role in functional                                                                                                                        DISCUSSION 
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folding (Lee 2003). My screening results showed that Brij detergents (Brij 35, Brij58 and 
Brij78) were equally good in producing the detergent solubilized protein. Addition of 
lipids to βLM did not have a positive effect on yield compared to a reaction with only 
βLM. However, addition of lipids might increase the functional folding which remains to 
be proved once a functional assay has been established for cell-free produced STM3476. 
 
3.3.2.2 Effect of temperature 
Temperature  is another  important  factor  not only  for  protein  production  but also for 
functional folding in a coupled transcription translational cell-free system. In a relavant 
study, Iskakova et al. (2006) were able to increase the functional production of Green 
fluorescent protein (GFP) by either using a slower T7 transcriptase (mutant version) or 
reducing  the  reaction  incubation  temperature  to  20  °C.  I  checked  the  effect  of 
temperature  on  PCF  and  DCF  mode production  of  STM3476  and  also  its  effect  on 
solubilizing the PCF precipitated protein. Both in PCF and DCF mode production, the 
yield went down linearly with the decreasing temperature (Fig. 2.23 A and C). On the 
other hand, solubilization of precipitates (PCF mode) at different temperatures (4 °C, 20 
°C  and 30 °C) with two different detergents revealed that the detergent  head groups 
played a significant role rather than the temperature. FOS12 could solubilize the protein 
equally well at both the temperatures while βLM failed to do so. However, I could not 
comment about the amount of functionally produced protein at different temperatures 
because of a lack of established functional assay for STM3476. 
 
3.3.2.3 Large scale PCF production, purification and characterization 
Large scale production was carried out in PCF mode only. After solubilizing the protein 
precipitate  by  FOS12,  the  detergent  was  exchanged  to  βLM  over  the  course  of  the 
purification. Coomassie stained SDS-PAGE showed the protein to be pure (Fig. 2.24A). 
The yield was between 400-500 µg of protein from 1 ml reaction mix in different batches 
of purification. The cell-free produced and IMAC purified protein migrated as a major 
band between 17 kD and 28 kD. The calculated mass of the protein is 28 kD. However, 
careful observation revealed several other bands migrating just above 38 kD and 49 kD. 
These bands were also identified as STM3476 by peptide mass fingerprinting carried out 
in our in-house facility. As we know that FNT proteins assume higher oligomeric states,                                                                                                                        DISCUSSION 
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these extra bands could be incompletely denatured or SDS resistant oligomeric states of 
STM3476.  
The  analytical  gel  filtration  using  superdex 200  showed that the protein  is relatively 
unstable at pH 8 in βLM detergent (Fig. 2.24B). It eluted as a sharp peak near the void 
volume and another peak at around 1.32 ml. Both the peak fractions showed identical 
band pattern on a Coomassie stained SDS gel. Changing the pH to either higher (9) or 
lower (5, 6, 7) and the detergent from βLM to OG did not improve the elution profile 
markedly.  A  further  characterization  with  different  detergents,  additives  and  pHs  is 
necessary to improve the stability of cell-free produced STM3476. Several reconstitution 
trials by the rapid dilution methods were also carried out with purified STM3476. The 
success of the reconstitution attempts needs to be verified.  
 
3.3.3 Production and characterization of SulP and RhtB proteins 
 
STM1781 is a SulP family protein which showed extensive degradation when tried to 
produce  in  vivo.  This  is  a  relatively  large  protein  with  11  predicted  transmembrane 
helices and a calculated mass of 58.6 kD. On the other hand, RhtB family proteins are 
small with 6 predicted transmembrane helices and a calculated mass between 22-23 kD. 
Five members of the RhtB family from S. typhimurium were cloned and screened for in 
vivo production but without any success (see Appendix 1). So, proteins of these two 
families were ideal candidates for cell-free expression trials. 
I was able to express STM1781 of SulP family in the PCF mode and could resolubilize 
the  protein  using  FOS12  detergent.  A  large  scale  production  and  subsequent  IMAC 
purification resulted in purified STM1781 without any degradation as evident from the 
Coomassie stained SDS-PAGE (Fig. 2.25B). The protein showed a better elution profile 
in gel filtration chromatography when purified in βLM rather FOS12. However, the yield 
of the final purified protein remained below 100 µg per 1 mL reaction mix, making 
further characterization difficult and expensive. The low yield could be because of its 
large size and the  high  number of transmembrane  helices  in agreement with another 
report (Savage et al. 2007). 
STM3959 of the RhtB family could also be produced by cell-free system in PCF mode. 
The precipitate was solubilized by FOS12 and purified by IMAC while changing the 
detergent  from  FOS12  to  βLM.  At  pH 8,  the  protein  eluted  as a  broad peak  in  gel                                                                                                                        DISCUSSION 
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filtration chromatography (Fig.2.26). The purified STM3959 lacked long term stability 
and  needs  to  be  characterized  further  to  improve  the  stability  in  order  to  perform 
functional and structural studies. 
 
3.4 MBP fusion and its effect on production 
 
Several  factors,  such  as  protein  length,  number  of  transmembrane  helices,  source 
organism, function, presence and position of fusion partners (His-tag) and membrane 
topology of transporters have been suggested to play a role in the successful production 
of integral membrane proteins (Sachdev et al. 1998; Surade et al. 2006; Gordon et al. 
2008).  
I  examined  the  effect  of  full  length  MBP  and  His-tag  as    fusion  partners  on  the 
expression of three different secondary active transporters from two different families 
(Table 2.8). Out of these three, two transporters from RhtB family were not expressed as 
mentioned before. So, my aim was to check whether usage of a MBP fusion could result 
in  full  length  proteins.  But  unfortunately,  the  RhtB  family  proteins  STM0365  and 
STM3959 could not produced as MBP fusion proteins.  
On the other  hand, STM0758, predicted to have both N- and C- terminus inside the 
cytoplasm, was produced well as MBP fusion proteins. The whole cell lysate expression 
screening and detection by anti-His antibody (Western blot) showed that the production 
of STM0758 was slightly better with MBP when His-tag was present at the N-terminus, 
but the effect was opposite when the His-tag was present at the C-terminus. However, 
heterologously produced proteins are often not efficiently inserted into the membrane in 
E.  coli,  despite  the  presence  of  a  signal  peptide.  Instead,  they  readily  fold  into  a 
translocation incompetent conformation and accumulate as aggregates in the cytoplasm 
(Lee and Bernstein 2001; Korepanova et al. 2007).  Since regular expression screening is 
performed on whole cell lysate, it does not distinguish between signals contributed by 
aggregated  and  properly  membrane  integrated  proteins.  So,  I  checked  the  actual 
expression level of membrane integrated protein by preparing membranes from 1 liter 
culture  volume  and  subsequent  protein  purification.  It  was  found  that  the  actual 
production or integration of STM0758 into the membrane upon MBP fusion was lowered 
by 3.4 times and 5.9 times when a His-tag was present at N-terminus and C-terminus, 
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Probably the placement of MBP at the N-terminus of a protein having its ends in the 
cytoplasm  interferes with  correct  insertion  into the  membrane  and results  in reduced 
production. This observation also supports the predicted topology of STM0758 with both 
ends in cytoplasm. It is interesting that other transporters with the N- terminus predicted 
outside showed an opposite effect (enhanced production) upon MBP fusion at the N-
terminus (unpublished observations). 
 
3.5 Overall discussion  
 
It is well recognized that structural studies of membrane proteins is very challenging. Not 
many proteins are well abundant in their native membrane. So, the success of membrane 
protein structural endeavor lies in getting sufficient amounts of heterologously produced 
protein. I tried several approaches, both in vivo and in vitro to address this core problem 
associated with membrane protein. In the following paragraphs, I want to discuss briefly 
several important factors to be considered when working with membrane proteins. 
The  most  important  criterion  is  to  choose  the  suitable  protein.  But  this  is  hardly 
predictable. However, one can select a target protein family and chose multiple proteins 
of  that  family  from  different  organism.  In  addition,  selecting  multiple  vectors  and 
corresponding host cells for initial expression screening are beneficial. Together these 
factors are reported to increase the expression space coverage and in turn the chance of 
success (Surade et al. 2006). My approach to select 4 CDF targets from two different 
organisms proved advantageous as I found that though STM0758 was functionally active 
in vivo, Aq_2073 of A. aeolicus was more suitable as a crystallization target because of 
its unique stability in a range of buffer conditions. 
After a successful purification it is necessary to perform a stability check of the protein 
over time in addition to a detergent compatibility test. These initial screenings reveal the 
potential of that particular protein as crystallization target. Moreover, these also help to 
design conditions for crystallization trials.  
Lipid plays an important role in membrane protein folding, stability and function. So, 
often it is necessary to add lipid during purification steps or to reduce the volume of 
washing buffer as every added washing step depletes the lipid attached to the protein. If 
the protein is pure and homogeneous after a single IMAC purification step, it can be 
directly  subjected  to  crystallization  trials  after  a  dialysis  step  to  remove  imidazole.                                                                                                                        DISCUSSION 
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Sometimes, an extra  gel filtration step to polish the protein may be detrimental as it 
removes lipid molecules necessary for crystallization.  
Detergent is another important factor for membrane protein stability. Besides choosing 
the  right  detergent,  choosing  the  optimum  concentration  is  also  important.  While 
concentrating  the  protein,  free  detergent  micelles  also  get  concentrated.  These 
concentrated micelles often produce detergent crystals in crystallization drops. So, while 
concentrating protein, one should consider the molecular mass of free detergent micelles 
and probably select the highest possible molecular weight cutoff. 
Getting a well diffracting membrane protein crystal demands a lot of optimizations with 
all possible factors until one reaches the optimum condition. One attractive approach is to 
generate  several truncated  versions of the protein  to  find  out the crystallization  core 
construct and performing crystallization trials simultaneously. Many recent reports in 
literature on successful crystallization of membrane proteins indicate the success of this 
approach (Huang et al. 2003; Ressl et al. 2009; Wang et al. 2009). 
I tried cell-free expression with targets from four different families and found that this 
method  aptly  complements  the  cell  based  production  approach.  Targets  from  RhtB 
family were not expressed in vivo but could be expressed and purified using CECF. 
STM1781 of SulP family was expressed and purified while the cell based production 
resulted  in  extensive  degradation.  PF0780  of  MOP  family  was  also  purified  to 
homogeneity and its stability was comparable to in vivo produced protein. However, I 
found the final yield of the cell-free produced protein as one of the major concern for 
structural  studies.  All  my  targets  were  large  membrane  proteins  with  6-12 
transmembrane helices. The observed yields of the purified proteins went down with an 
increase of the number of transmembrane helices. Savage et al. (2007) also reported a 
similar observation in a large scale study carried out with 120 membrane proteins. They 
also suggested that CF is a robust expression system and capable of producing more 
proteins than in vivo systems.  
So, both in vitro and in vivo expression strategies that complement each other expands 
the overall expression space coverage and hence increases the chance of success of a 
structural genomics styled project. 
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4.1 Materials 
 
4.1.1 Chemicals 
 
1,4-Dithiothreitol         Serva Elektrophoresis GmbH, Heidelberg 
5-Bromo-4-chloro-3-indolylphosphate 4-  Biomol Feinchemikalien GmbH, Hamburg 
toluidine salt 
Acrylamide 30% for PAGE       Carl Roth GmbH & Co. KG, Karlsruhe 
Agarose, electrophoresis grade   Bethesda  Research  Laboratories  GmbH, 
Neu Isenburg 
Ammonium persulfate       Serva Elektrophoresis GmbH, Heidelberg 
Ampicillin, sodium salt       Carl Roth GmbH & Co. KG, Karlsruhe 
L-Arabinose           Sigma-Aldrich Chemie GmbH, Deisenhofen 
Bacto Agar           Difco Laboratories, Detroit, Michigan, USA 
Bacto Tryptone         Difco Laboratories, Detroit, Michigan, USA 
Bacto Yeast Extract         Difco Laboratories, Detroit, Michigan,USA 
Bovine serum albumin       Sigma-Aldrich Chemie GmbH, Deisenhofen 
Bromophenol blue         Sigma-Aldrich Chemie GmbH,Deisenhofen 
Charcoal           Carl Roth GmbH&Co. KG, Karlsruhe 
Coomassie Brilliant Blue R-250     Serva Elektrophoresis GmbH, Heidelberg 
Deoxynucleotide-5’-triphosphates, 
(dATP, dGTP, dTTP, dCTP)     Pharmacia Biotech, USA 
Ethidium bromide         Bio-Rad Laboratories GmbH, Munich 
Ethylenediamine tetraacetic acid    GERBU Biotechnik GmbH, Gaiberg 
Glutaraldehyde         Sigma-Aldrich Chemie GmbH, Deisenhofen 
Glycine           Serva Elektrophoresis GmbH, Heidelberg 
Kanamycin           Carl Roth GmbH & Co. KG, Karlsruhe 
N,N,N,’N,’-tetramethylethylenediamine   Sigma-Aldrich Chemie GmbH, Deisenhofen 
Nitrobluetetrazolium, toluidine salt     Biomol Feinchemikalien GmbH, Hamburg 
Other polyethylene glycols       Fluka chemie GmbH, Steinheim 
Peptone           Sigma-Aldrich Chemie GmbH, Deisenhofen 
Phenol           Carl Roth GmbH&Co. KG, Karlsruhe 
N-(2-Hydroxyethyl)-piperazine-N'-2- 
ethanesulfonic acid         Carl Roth GmbH&Co. KG, Karlsruhe 
Polyethyleneglycol 6000       Serva Elektrophoresis GmbH, Heidelberg 
Silver nitrate           Sigma-Aldrich Chemie GmbH, Deisenhofen 
Streptavidine-AP conjugate   Amersham  Buchler  GmbH  &  Co.  KG, 
Braunschweig 
Tetracycline-hydrochloride       Sigma-Aldrich Chemie GmbH, Deisenhofen 
Tris-(hydroxymethyl)-aminomethane   Carl Roth GmbH&Co. KG, Karlsruhe 
Polyethyleneimine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
 
4.1.2 Detergents 
 
Sodium dodecylsulfate       Carl Roth GmbH&Co. KG, Karlsruhe 
n-Dodecyl-α-D-maltoside       Glycon Biochemicals, Luckenwalde 
n-Dodecyl-β-D-maltoside       Glycon Biochemicals, Luckenwalde 
n-Decyl-β-D-maltoside       Glycon Biochemicals, Luckenwalde 
n-Octyl-β-D-glucopyranoside     Glycon Biochemicals, Luckenwalde                                                                                         MATERIALS AND METHODS 
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n-dodecylphosphocholine       Anatrace, Maumee, OH, USA 
Tween® 20           Koch-Light Ltd., Haverhill, England 
Dodecyl nonaoxyethylene ether                     Sigma-Aldrich Chemie GmbH, Deisenhofen 
1-myristoyl-2-hydroxy-sn-glycero-3-  
[phospho-rac-(1-glycerol)].      Avanti Polar Lipids Inc. 
1-palmitoyl-2-hydroxy-sn-glycero-3- 
[phospho-rac-(1-glycerol)]      Avanti Polar Lipids Inc. 
1-myristoyl-2-hydroxy-sn-glycero-3- 
Phosphocholine        Avanti Polar Lipids Inc. 
Polyoxyethylene-(23)-lauryl-ether     Sigma-Aldrich Chemie GmbH, Deisenhofen 
Polyoxyethylene-(10)-cetyl-ether    Sigma-Aldrich Chemie GmbH, Deisenhofen 
Polyoxyethylene-(20)-cetyl-ether    Sigma-Aldrich Chemie GmbH, Deisenhofen 
Polyoxyethylene-(2)-stearyl-ether    Sigma-Aldrich Chemie GmbH, Deisenhofen 
Polyoxyethylene-(20)-stearyl-ether    Sigma-Aldrich Chemie GmbH, Deisenhofen 
Polyoxyethylene-(20)-oleyl-ether    Sigma-Aldrich Chemie GmbH, Deisenhofen 
Digitonin          Sigma-Aldrich Chemie GmbH, Deisenhofen 
 
4.1.3 Lipids 
 
E. coli total lipid extract      Avanti Polar Lipids Inc. 
E. coli polar lipid extract      Avanti Polar Lipids Inc. 
 
4.1.4 Protease inhibitors 
 
Benzamidine   Sigma-Aldrich Chemie GmbH, Deisenhofen 
Phenylmethylsulfonylfluoride     Carl Roth GmbH & Co. KG, Karlsruhe 
 
4.1.5 Chromatographic matrices, pre-packed columns and instruments 
 
Hi-Trap column (1ml)       GE Healthcare, Munich 
Ni-NTA matrix         Qiagen GmbH, Hilden 
SP sepharose FF        GE Healthcare, Munich 
Superdex 200 HR 10/30       GE Healthcare, Munich 
Superdex 200 PC 3.2/30       Amersham Pharmacia Biotech, Freiburg 
SMART System         Amersham Pharmacia Biotech, Freiburg 
ÄKTA Prime          GE Healthcare, Munich 
ÄKTA Purifier        GE Healthcare, Munich 
 
4.1.6 Enzymes 
 
Lysozyme          AppliChem GmbH 
Benzonase           Merck KGaA, Darmstadt 
Restriction endonucleases                              MBI Fermentas GmbH, St. Leon-Rot and  
New England Biolabs GmbH, Schwalbach 
T4 DNA ligase         New England Biolabs GmbH, Schwalbach 
T4 DNA polymerase        MBI Fermentas GmbH, St. Leon-Rot 
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4.1.7 Antibodies 
 
Monoclonal anti-polyHistidine antibody   Sigma-Aldrich Chemie GmbH, Deisenhofen 
Anti-MBP antibody        New England Biolabs GmbH, Schwalbach 
 
4.1.8 Kits 
 
Qiagen Plasmid Miniprep kit      Qiagen GmbH, Hilden 
QIAquick Gel Extraction kit      Qiagen GmbH, Hilden 
QIAquick PCR Purification kit     Qiagen GmbH, Hilden 
BCA Protein Assay Kit       Pierce, Rockford, USA 
LMW and HMW calibration kit     GE healthcare, Munich 
Crystallization screening kits   Jena Biosciences GmbH, Jena, Germany, 
Hampton Research, Aliso Viejo, CA, USA  
  Qiagen GmbH, Hilden 
 
4.1.9 Marker probes 
 
Prestained protein marker (broad range)   New England Biolabs GmbH, Schwalbach 
SeeBlue
® Plus2 Pre-Stained Standard  Invitrogen, Karlsruhe 
DNA ladder           New England Biolabs GmbH, Schwalbach 
Positope          Invitrogen, Karlsruhe 
 
4.1.10 Buffers, solutions and culture- media composition 
 
Agarose gel (1%) 
Agarose         1 g 
TAE buffer 1X       100 ml 
Ethidium bromide (10 mg/ml)   2.5  L 
 
AP buffer 
Tris buffer pH 9.5       100 mM 
Sodium chloride       100 mM 
Magnesium chloride       5 mM 
 
DNA Loading buffer (4X) 
Tris buffer pH 7.4       50 mM 
EDTA          5 mM 
Glycerol         50% (v/v) 
Bromophenol blue       0.05% (w/v) 
 
LB medium 
Bacto tryptone       10 g/L 
Bacto yeast extract       5 g/L 
Sodium chloride       10 g/L 
 
Transformation buffer for E. coli 
Calcium chloride       150 mM                                                                                         MATERIALS AND METHODS 
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Manganese chloride       55 mM 
Potassium chloride       250 mM 
PIPES Buffer pH 6.7      10 mM 
Sterilised by filtration through 0.2 µm filter 
 
5X SDS gel running buffer 
Tris buffer pH 7.5       50 mM 
Glycine         190 mM 
Sodium dodecyl sulphate     0.5% 
 
5X SDS-PAGE sample buffer 
Sodium dodecyl sulphate     10% w/v 
Tris buffer pH 6.8       250 mM 
Dithiothritol         500 mM 
Glycerol         50% w/v 
Bromophenol Blue       1 mg/ml 
 
Transfer buffer 
Tris buffer pH 8.0       25 mM 
Glycine         100 mM 
Methanol         10% 
 
10X TBST buffer 
Tris buffer pH 8.0       100 mM 
Sodium chloride          1.5 M 
Tween 20               0.5% 
 
1X AP buffer 
Tris buffer pH 9.5       100 mM 
Sodium chloride       100 mM 
Magnesium chloride       5 mM 
 
4X Lower Tris buffer 
Tris buffer pH 8.8       3 M 
Sodium dodecyl sulphate     0.4% (w/v) 
 
4X Upper Tris buffer 
Tris buffer pH 6.      8.3 M 
Sodium dodecyl sulphate     0.4% (w/v) 
 
Fixing solution 
Methanol         50% 
Glacial acetic acid       10% 
Water          q.s. 
 
Staining solution 
Coomassie Brilliant Blue R-250   0.1% 
Methanol         50% 
Glacial acetic acid       10%                                                                                         MATERIALS AND METHODS 
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Water          q.s. 
 
Destaining solution 
Methanol         40% 
Glacial acetic acid       10% 
Water          q.s. 
 
Gel storage solution 
Glacial acetic acid       5% 
Water          q.s. 
 
Cell lysis buffer 
HEPES buffer pH 8.0       50 mM 
Sodium chloride       150 mM 
Benzonase         1 U/ml 
Magnesium chloride       1 mM 
Lysozyme         200  g/ml 
PMSF          1 mM 
EDTA          1 mM 
 
Membrane re-suspension buffer 
HEPES buffer pH 8.0       20 mM 
Sodium chloride       20 mM 
 
Other stock solutions 
Ampicillin (1000X)       100 mg/ml in water 
Chloramphenicol (1000X)     34 mg/ml in ethanol 
Carbenicillin (1000X)     50 mg/ml in water 
APS solution        10 % (w/v) in water 
Benzamidine (100x)       100 mM in water 
PMSF stock solution (100X)    200 mM in isopropanol 
Protogel         30% as purchased 
TEMED solution       As purchased 
APS solution        30% Ammonium persulphate in water 
BCIP-solution       50 mg BCIP/ml in dimethylformamide 
NBT solution        50 mg NBT/ml in 70% dimethylformamide 
 
4.1.11 Apparatus and consumables 
 
General 
Electroporation device     Biorad, Munich 
I-blot          Invitrogen, Karlsruhe 
Snap ID        Millipore 
Shaker         Infors AG, Bottmingen, Switzerland 
Spectrophotometer       Thermo Spectronic, Cambridge, UK 
Vortex machine       Bender & Hobein AG, Zürich, Switzerland 
Thermomixer 5436       Eppendorf GmbH, Hamburg 
LiposoFast         Avestin Europe GmbH, Mannheim 
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Centrifuges         
Sorvall         RC-5B Sorvall, Bad Homburg 
Avanti J-20 XPI       Beckman-Coulter, Fullerton, CA, USA 
Optima LE-80K       Beckman-Coulter, Fullerton, CA, USA 
Tabletop ultracentrifuge     Beckman Instruments Inc., Palo Alto, USA 
Sigma 3K 12         Sigma-Aldrich Chemie GmbH, Deisenhofen 
 
Consumables 
15 ml/ 50 ml culture tubes     Greiner bio-one 
Disposable pipets       Sarstedt, Nuembrecht 
Glass bottles         Schott AG 
Microfuge tubes       Eppendorf GmbH, Hamburg 
Pipette tips         Sarstedt, Nuembrecht 
Syringe filters        Sarstedt, Nuembrecht 
 
4.1.12 Microorganisms 
 
E. coli DH5α        Invitrogen, Karlsruhe 
E. coli NM554        Stratagene, La Jolla, USA 
E. coli TOP10       Invitrogen, Karlsruhe 
E. coli BL21-CodonPlus(DE3)-RP  Stratagene, La Jolla, USA 
 
4.1.13 Plasmids 
 
pTTQ18         Kind gift from Prof. Henderson, University 
of Leeds 
pBAD          Invitrogen, Karlsruhe 
pQE   Kind gift from Prof. Essen, University of 
Marburg 
pMAL-p2X         New England Biolabs GmbH, Schwalbach 
pJET1         Fermentas 
 
4.1.14 Components for cell-free productions 
 
pET 21a  Kind gift from Prof. Volker Dötsch, 
University of Frankfurt 
E. coli K12 A19 strain  Kind gift from Prof. Volker Dötsch, 
University of Frankfurt 
D tube dialyzer  Novagen 
 
Chemicals 
HEPES        AppliChem, Darmstadt 
DTT          AppliChem, Darmstadt 
Potassium acetate      AppliChem, Darmstadt 
Magnesium acetate      AppliChem, Darmstadt 
PMSF         AppliChem, Darmstadt 
Tris-Acetate        AppliChem, Darmstadt 
Polyethylene Glycol 8000    AppliChem, Darmstadt 
Sodium azide        AppliChem, Darmstadt                                                                                         MATERIALS AND METHODS 
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Sodium chloride      AppliChem, Darmstadt 
Potassium hydroxide      AppliChem, Darmstadt 
Sodium hydroxide      AppliChem, Darmstadt 
ATP, CTP, GTP, UTP    Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Alanine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Arginine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Aspartate        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Asparagine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Cysteine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Glutamine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Glutamic acid      Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Histidine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Isoleucine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Leucine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Lysine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Methionine       Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Proline        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Phenylalanine      Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Serine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Threonine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Tryptophan       Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Tyrosine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
L-Valine        Sigma-Aldrich Chemie GmbH, Deisenhofen 
Phosphoenolpyruvate     Sigma-Aldrich Chemie GmbH, Deisenhofen 
Acetylphosphate      Fluka GmbH, Deisenhofen 
Glycine        Fluka GmbH, Deisenhofen 
5-Formyl-5,6,7,8-     
tetrahydrofolic acid      Fluka GmbH, Deisenhofen   
Complete (Protease inhibitor)   Roche, Mannheim 
E.coli tRNA        Roche, Mannheim 
Pyruvate Kinase      Roche, Mannheim 
RiboLock
TM        Fermentas 
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4.2 Methods 
 
4.2.1 Selection of families and targets 
 
Target families and target proteins were selected based on the bioinformatic analysis 
presented  at  the  TransportDB  website  (www.membranetransport.org).  Priorities  were 
given to families without an atomic structure  
 
4.2.2 General molecular biological techniques 
 
4.2.2.1 DNA isolation 
Isolation of plasmid DNA from E. coli cells and extraction of DNA  fragments from 
agarose  gel  were  carried  out  by  using  suitable  Qiagen  kits.  Protocols  and 
recommendations provided by the manufacturer were followed. 
 
4.2.2.2 DNA restriction digestion 
Restriction digestion, incubation temperature and time were followed as recommended 
for the individual restriction enzyme by the manufacturers. 
 
4.2.2.3 Ligation 
Digested DNA fragments were purified by PCR purification kit by Qiagen in order to 
remove the protein  and nucleotide  impurities  and to  improve the ligation  efficiency. 
Ligation of the DNA fragments was carried out in the presence of T4 DNA ligase either 
overnight at 16 °C or for 4 hrs at room temperature. 
 
4.2.2.4 Vector modification 
In  order  to  be  applicable  for  the  high-throughput  cloning,  all  of  the  vectors  were 
modified. The existent multiple cloning site (MCS) was modified in such a way that all 
of the vectors had a comparable multiple cloning site. To allow parallel cloning of a 
single PCR product digested with appropriate restriction enzymes, into all vectors. 
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Table 4.1 Details of restriction enzymes and oligonucleotides used for vector modification 
 
Vector 
Version 
Parent 
Vector 
Restriction 
enzyme 
I             II 
Oligonucleotide for 
hybridization
a 
Oligonucleotide mix 
used for colony PCR 
pTTQ18A2  pTTQ18  EcoRI       HindIII  pTTQ18-32     pTTQ18-33  1: pTTQ18-21,  2: pTTQ18-22 
pTTQ18C3  pTTQ18  EcoRI       HindIII  pTTQ18-38     pTTQ18-39  1: pTTQ18-21,  2: pTTQ18-22 
pQEA2  pQE  EcoRI       HindIII  pQ-1              pQ-2  1: pQ-5,             2: pQ-6 
pQEC3  pQE  EcoRI       HindIII  pQ-3              pQ-4  1: pQ-5,             2: pQ-6 
pBADA2  pBAD  NcoI         HindIII  pBAD-1           pBAD-2  1: pBAD-7,        2: pBAD-8 
pBADC3  pBAD  NcoI         HindIII  pBAD-3           pBAD-4  1: pBAD-7,        2: pBAD-8 
a: Please refer to the appendices for oligonucleotide sequence 
Generation  of  pTTQ18A2  and  C3  from  parental  pTTQ18  vector  involves  an  intermediate 
pTTQ18A1 stage. 
Figure 4.1 Schematic representation of vector modification. 
 
Generally,  5 µg vector (as obtained  from  the  supplier  or  as  a kind gift)  was  double 
digested  with  restriction  enzymes  I  and  II  of  table  4.1  and  purified  by  agarose  gel 
extraction. This digestion was performed in the absence of any alkaline phosphatase so 
that the 5’ phosphate group remains intact which could be exploited for ligation. This 
step destroyed the existent multiple cloning site from the vector. In order to introduce a 
new  cloning  site,  “Oligonucleotide  I”  and  “Oligonucleotide  II”  were  hybridised  by 
heating a 10 µM mixture of them at 92 °C for 2 minutes. This reaction mixture was then 
allowed  to  cool  down  to  room  temperature  for  the  purpose  of  annealing.  This  was                                                                                         MATERIALS AND METHODS 
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achieved by putting off the heating block and let it cool to room temperature. Different 
dilutions of hybridised oligonucleotides were made by diluting it with sterile water from 
1:1 to 1:1000 parts in water. Of this diluted oligo, 1 µl was then ligated to the purified 
and  double  digested  vector  (3  µl)  with  T4  DNA  ligase  following  the  manufactures 
recommendations with proper controls. The total ligation reaction was performed in a 15 
µl volume and 3 µl of this reaction mix was used for the transformation into chemically 
competent DH5α cells. Positive clones were identified by isolating plasmid DNA and 
subsequent restriction digestion followed by DNA sequencing of the modified part of the 
plasmid. 
 
4.2.2.5 Cloning for MBP fusion work 
The coding sequence for MBP with signal peptide (malE gene) was amplified by PCR 
from the commercially available pMAL-p2X vector (New England BioLabs), with both 
primers harboring BamHI sites allowing 5’ and 3’ in-frame fusion with promoter and 
target proteins. The PCR product coding for MBP was first cloned into the pJET1 vector 
and then subcloned via BamHI  sites into the particular expression vectors (pTTQ18) 
carrying the target  genes.  Correct orientation  and fusion with  the  target partner  was 
verified by restriction analysis and sequencing.  
 
4.2.3 General cell culture techniques for E. coli  
 
4.2.3.1 Preparation of chemically competent E. coli cells 
Appropriate E. coli strains like DH5α, BL21(DE3), NM554 or TOP10 were streaked on a 
LB-agar plate without antibiotic and incubated at 37 °C overnight. From this plate a 
single colony was used for inoculating 2 ml LB medium and incubated with shaking at 
200 RPM at 37 °C overnight. On next day, 100 µl of this stationary phased E. coli culture 
was used to inoculate 100 ml LB medium containing 10 mM magnesium chloride. The 
flask  was  kept  at  18  °C  with  shaking  at  100  RPM  until  an  OD600  of  0.1  reached. 
Typically, it took 14-18 hrs to reach this growth phase. The culture was cooled on ice and 
centrifuged in a Sigma centrifuge at 5000 RPM at 4 °C for 10 minutes. The cell pellet 
was suspended in 33 ml of chilled transformation buffer and kept on ice for 15 minutes. 
This  suspension  was  again  centrifuged  as  before.  The  cell  pellet  was  then  finally 
suspended  in  8  ml  of  transformation  buffer  and  600  µl  of  DMSO  was  added  as                                                                                         MATERIALS AND METHODS 
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cryoprotectant.  The  cell suspension  was  aliquoted and  flash-frozen  in  liquid  nitrogen 
before storing at –80 °C. 
 
4.2.3.2 Transformation of competent E. coli cells 
An  aliquot  of  competent  E.  coli  cells  was  thawed  on  ice.  Typically  for  a  single 
transformation 50  L of the competent cell suspension was transferred into a sterile and 
cooled microcentrifuge tube. To this fraction about 50 ng of plasmid DNA was added, 
the suspension was mixed and kept on ice for 10 minutes. Competent cells were heat 
shocked  for  90  s  at  42  °C.  Immediately  afterwards,  the  microcentrifuge  tube  was 
transferred to ice and kept on ice for additional 10 minutes. This suspension was directly 
plated onto a LB Agar plate with a suitable antibiotic to screen transformed E. coli cells.  
 
4.2.4 Detection of protein production and protein visualization 
 
4.2.4.1 Protein production screening in E. coli 
For screening of gene expression in E. coli, only freshly transformed E. coli cells were 
used. LB medium was used as a culture medium for E. coli. The expression constructs 
were transformed into E. coli strains C43 (DE3) for pTTQ18 and pQE vectors, NM554 
for pTTQ18 and pQE vectors, BL21 (DE3) for MBP fusion work and TOP10 for pBAD 
vector. Transformants were selected on LB agar plates containing 50  g/ml carbenicillin. 
For protein production,  E.  coli cells from  overnight cultures of single  colonies  were 
transferred into 2 ml fresh LB medium in 24-well plates using a 1:40 dilution and were 
grown  at  37  °C  until  the  cultures  reached  an  OD600  of 0.6.  Then  the  cultures  were 
induced with 0.5 mM isopropyl-β-1-thiogalactoside (IPTG; for pTTQ18 and pQE) or 
0.02% L-arabinose (for pBAD) and incubated for 3 hours. The cells from 1 ml fractions 
were  harvested  by  centrifugation  and  finally  stored  at  –20  °C.  This  cell  pellet  was 
resuspended in 70 µl of lysis Buffer (50 mM Tris-Cl, pH 7.9, 100 mM NaCl, 10 mM 
MgSO4, 1x  Complete  protease  inhibitor  cocktail,  1  mg/ml  lysozyme,  1U  benzonase. 
After 10 minutes incubation at room temperature, 5 µl of 10% SDS and 25 µl of 4x SDS-
PAGE loading buffer were added to the mixture to make it ready for analysis by SDS-
PAGE. 
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4.2.4.2 Western blot procedure 
In order to detect recombinant proteins, produced with fusion tags, protein samples were 
separated by SDS-PAGE. Either home made 10 or 12% gels or commercially available 
pre-cast gels (Invitrogen) were used.  After a proper run, protein transfer from the SDS 
gel to a PVDF membrane was achieved by semi-dry blotting. PVDF membranes were 
activated by soaking the appropriately sized membrane in methanol (1 minute) followed 
by thorough washing with de-ionized water (5 minutes) and soaking in transfer buffer. 
The transfer was achieved by applying a current of 1 mA/cm
2 for 1 hr. A broad range 
molecular weight ladder (NEB, P7708L or Invitrogen LC5925) was used as a reference. 
Upon successful transfer the PVDF membrane was blocked for about an hour with 1% 
BSA solution in TBST. All washing and incubation steps were done on a rocker at room 
temperature. The membrane was washed with TBST buffer 3 times each with duration of 
5 minutes. The membrane was further incubated with anti-His antibody coupled to an 
alkaline phosphatase (1:2000 dilution with 1% BSA in TBST). For the detection of Strep 
tag-II, the PVDF membrane was incubated with 2  g/ml of avidin in TBST buffer to 
block all the biotin, for about 15-30 minutes. Upon blocking biotin, the PVDF membrane 
was  incubated  with  streptavidin,  a  Strep  tag  binding  protein,  coupled  to  alkaline 
phosphatase enzyme (1:2000 dilution in TBST) for about 1-2 hr. After incubation, the 
excess antibody solution was removed, and the PVDF membrane was washed 3 times for 
5 minutes each with TBST buffer. It was followed by a wash with AP buffer 3 times for 
5  minutes.  The  enzymatic  activity  of  alkaline  phosphatase  was  used  to  detect  the 
recombinant protein indirectly. Alkaline phosphatase activity was detected by addition of 
a  colour-developing  reagent,  5-Bromo-4-chloro-3-indolyl  phosphate  (BCIP)  as 
recommended by the manufacturer. 
Occasionally, “I blot” (Invitrogen) and “Snap ID” (milipore) was used for transferring 
and blotting respectively, according to manufacturer’s protocol. 
 
4.2.4.3 Coomassie staining procedure 
For the purpose of direct protein visualization after SDS-PAGE, the gels were transferred 
to Coomassie staining solution for about 20 minutes. Upon staining, the gel background 
was  de-stained  by  putting  the  gels  in  Coomassie  destaining  solution  until  the 
backgrounds become clear and protein bands become clearly visible. 
                                                                                         MATERIALS AND METHODS 
  95
4.2.5 Protein purification 
 
4.2.5.1 Protein production in large-scale cultures 
For isolating membranes for protein purification trials, E. coli cells were grown in large 
quantities (12-24 L). A small 5 ml LB medium was inoculated with a single colony with 
appropriate antibiotics and incubated in a shaker at 30 °C for about 8 hrs. This 5 ml 
culture was then used to inoculate 500 ml of LB medium for the preculture with proper 
antibiotics, and kept at 37 °C and shaken at 200 RPM overnight. This overnight culture 
was used as inoculum for the main expression culture. An inoculation ratio of 1:40 was 
used to inoculate LB medium with  antibiotic for proper selection. E .coli cells were 
grown at 37 °C with shaking at 190 RPM until an OD600 of 0.5-0.7 was reached. At this 
stage,  cultures  were  induced  with  an  appropriate  concentration  of  inducer  (final 
concentration of 0.2 to 1 mM IPTG and 0.0002 to 0.02 % L-arabinose). 
 
4.2.5.2 Membrane isolation in large scale 
For large-scale membrane isolation, cells were harvested by centrifuging the culture at 
6000 RPM (with Avanti centrifuge, JLA-8.1000 rotor, Beckman) for 10 minutes. The 
cells were washed with a buffer containing 10 mM Tris or HEPES buffer, pH 8.0, with 
150  mM  sodium  chloride.  Harvested  cells  were  stored  at  –20  °C  or  –80  °C  for  a 
maximum of one month. For membrane isolation, cells were suspended in the cell lysis 
buffer in a ratio of 1g of cells (wet weight of cells) per 10 ml of cell lysis buffer. The cell 
suspension was made homogeneous and filtered through a porous membrane so as to 
separate cell clumps from the uniformly suspended cells. The cell suspension was passed 
through a microfluidizer (Microfluidics Corp.) operated at 12000 PSI for 3-5 times. The 
lysis chamber was cooled by keeping it in ice. After lysis the cell lysate was centrifuged 
for 8000 RPM (Sorvall centrifuge, Sorval SLA-3000 rotor) at 4 °C for 30 minutes. The 
supernatant was then collected and ultracentrifuged at 43000 RPM (Beckman Coulter 
ultracentrifuge with 45 Ti rotor) for 1hr 30 minutes to spin down the membrane fraction. 
The  membrane  fraction  was  collected  and  suspended  in  the  membrane  resuspension 
buffer to a final protein concentration of 10 mg/ml. 
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4.2.5.3 Solubilization screen of membrane proteins with various detergents 
For  the  solubilization  trials,  50   L  of  the  membrane  suspension  buffer  additionally 
containing 2% of different detergents (β-LM, DM, OG, NG, LDAO, C12E5, FOS12) were 
added to 50  L of the membrane suspension. The extraction was carried out at 4 °C for 1 
hr.  It  was  followed  by  another  ultracentrifugation  to  separate  solubilizate  from 
unsolubilized  material.  10   l  of  the  supernatant  were  analysed  by  Western  blot. 
Solubilization of the membrane proteins for purification was carried out in the same way 
except that the scale of solubilization was higher. Mostly for purification β-LM was used 
as the detergent of choice unless found unsuitable. 
 
4.2.5.4 Protein purification with affinity chromatography  
In order to purify proteins, the solubilizate was loaded onto an Amersham HP Hi-trap 1 
ml column. Usually 10 ml of solubilizate were loaded onto a 1 ml column. In cases 
where protein production was low, higher amounts of solubilizate were loaded with the 
help of a peristaltic pump. The unbound protein was washed off with the buffer in which 
solubilization had been carried out. Non-specifically bound protein was then removed by 
washing the column with washing buffer by applying a gradient of imidazole from 10 
mM to 600 mM in a volume of 35-40 ml. The tagged protein of interest eluted as a last 
peak. In the batch method purification, the solubilizate was allowed to bind to the Ni-
NTA beads (Qiagen) manually. Bound beads were poured into an empty column and 
purification was done under gravity flow. After usual washing steps with 20-60 mM 
imidazole,  proteins  were  finally  eluted  with  350  mM  of  imidazole.  When  detergent 
exchange was necessary during purification, the batch method was preferred over the 
automated method using Aekta Prime. 
 
4.2.5.5 TEV protease digestion  
All our C3 version constructs have a TEV cleavage site preceding the  His-tag. TEV 
cleavage was used to remove the His-tag. For this purpose imidazole was removed from 
the affinity purified protein by an additional buffer exchange step with a PD10 column. 
The protein was concentrated to 3 - 10 mg/ml using an Amicon ultra-15 centrifugal filter 
device (Millipore). The S219V mutant of TEV protease fused with a polyHis-tag was 
used  for  digestion.  This  mutated  protease  was  purified  and  stored  according  to  the 
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to 50:1 was used. The digestion reaction was carried out in a buffer containing 50 mM 
HEPES buffer, pH 8.0, 150 mM sodium chloride or potassium chloride, 1 mM EDTA, 4 
mM 2-mercapto-ethanol. The mixture was incubated overnight at 16 °C. After digestion, 
the reaction mixture was passed through a Ni-NTA matrix and the flow through and the 
wash  fraction  equivalent  to  two  column  volumes  was  collected.  The  bound  fraction 
contained undigested protein, small peptides with polyHis-tag and a TEV protease, which 
could then be eluted with higher concentrations of imidazole. Completion of the reaction 
was monitored by a Western blot developed with anti-His antibody coupled to alkaline 
phosphatase. 
 
4.2.5.6 Gel filtration chromatography 
Gel  filtration  chromatography  was  routinely  used  for  protein  preparation  quality 
assessment as well as to “polish” the final preparations just before crystallization set-ups. 
Superdex-200 matrix was used for gel filtration. For analytical purposes a Superdex-200 
PC 3.2/30 was used in a SMART system. For preparative purposes Superdex-200 HR 
10/30 was used with an Aekta purifier or Aekta prime system. Gel filtration was carried 
out in a suitable buffer (HEPES pH 8.0; Tris pH 8.0; acetate buffer pH 4.0), salts (sodium 
chloride, potassium chloride), with detergent (1.5 – 4 times of CMC). The columns were 
calibrated using marker mixtures of the LMW and HMW column calibration kits (GE 
healthcare). Only portions representing a non-void volume fraction of the peaks were 
used for crystallization purposes. 
 
4.2.6 Cell-free production of membrane proteins 
 
4.2.6.1 S30 extract preparation 
The  following  buffers  and  components  were  prepared  prior  to  the  actual  extract 
preparation. 
YPTG medium 
Yeast extract (60gm), trypton (96 gm) and NaCl (30 gm) were mixed in 4.5 L Millipore  
water and autoclaved in the fermenter. Later, KH2PO4 (17.94 gm) and K2HPO4 (54.73 
gm) were dissolved in 1 L water and glucose (118.8 gm) in 500 ml water and autoclaved 
separately. These were then poured into the autoclaved fermenter with rest of the media, 
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Buffers 
S30 buffer A----------- 10 mM     Tris-acetate 
      14 mM     Mg(OAc)2 
      60 mM     KCl 
      6 mM                β-Mercaptoethanol (added freshly) 
S30 bufferB------------ 10 mM     Tris-Acetate 
      14 mM     Mg(OAc)2 
      60 mM     KCl 
      1 mM                DTT (added freshly) 
      0.1 mM              PMSF (added freshly) 
S30 buffer C-----------10 mM   Tris-Acetate 
      14 mM     Mg(OAc)2 
      60 mM     KOAc 
      0.5 mM  DTT (added freshly) 
4M NaCl stock solution 
 
Strain: Escherichia coli K12 A19, a kind gift from Volker Dötsch, Frankfurt University. 
 
E. coli A19 strain was freshly streaked onto an antibiotic free plate from glycerol stock 
and incubated overnight at 37 °C. A single colony was inoculated into 5 ml LB media, 
grown for 10-12 hrs at 37 °C with shaking at 200 RPM and used as an inoculum for 60 
ml LB culture. This 60 ml culture was grown overnight at 37 °C with shaking and used to 
inoculate the 6 L YPTG media in the fermenter (1:100). The culture in the fermenter was 
grown until an OD595 of 4-4.5 was reached. The fermenter was then cooled down to 10 
°C using ice cold water passing through a rubber tube wrapped around the fermenter for 
40 minutes. All centrifugation bottles and buffers were pre-chilled to 4 °C. Cells were 
harvested by centrifugation for 20 minutes at 6000 RPM (Avanti centrifuge, JLA-8.1000 
rotor, Beckman). The pellet was resuspended into 300 ml S30 buffer A and centrifuged 
twice for 10 minutes at 8000 RPM (Sorvall centrifuge, Sorvall SLA-3000 rotor). After 
another centrifugation at 8000 RPM using same rotor for 30 minutes, the cell pellet was 
weighed,  resuspended  in  an  appropriate  volume  of  S30  buffer  B  (110%  weight  by 
volume) and subjected to cell breakage by French press at 20000 psi. The broken cells 
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ultracentrifuge) for 30 minutes and the upper 2/3
rds of the supernatant was transferred to a 
fresh centrifuge tube and the centrifugation step was repeated. Again the upper 2/3
rds of 
the supernatant was collected. After adjusting the final concentration of NaCl to 400 mM 
using a 4 M stock solution, the supernatant was incubated at 42 °C for 45 minutes. The 
solution turned turbid. This turbid extract was dialyzed (12-14 kD cutoff membrane) in at 
least 60x volume of S30 buffer C for 2-4 hrs and then overnight after a buffer change. 
This dialyzed extract was centrifuged at 16000 RPM (~30,000g using a 45Ti rotor in a 
Beckman  Coulter  ultracentrifuge)  for  30  minutes  and  the  upper  2/3
rds  of  non-turbid 
supernatant was collected. This extract was then aliquoted, snap-frozen in liquid N2 and 
stored at -80 °C for future use. 
 
4.2.6.2 T7 RNA polymerase preparation 
pAR1219, the plasmid encoding T7 RNA polymerase, was a kind gift of Prof. Volker 
Dötsch, University of Frankfurt. The plasmid was freshly transformed into BL21(DE3) 
cells and a single colony was inoculated into 50 ml LB with ampicilin (50 µg/ml final 
concentration) and grown at 37 °C overnight. This culture was used to inoculate 2L LB 
in 1:100 dilution and grown at 37 °C with shaking. The induction was done at OD600 0.5-
0.6 with 0.5 mM IPTG. The culture was grown 3 more hours after induction and the cells 
were harvested by centrifugation at 6000 RPM (Avanti centrifuge, JLA-8.1000 rotor, 
Beckman) for 15 minutes. The pellet was washed with washing buffer (50 mM Tris 
buffer, pH 8, 2 mM EDTA, 20 mM NaCl), centrifuged at 4000 RPM using same rotor for 
20 minutes and resuspended into 24 ml of resuspension buffer (composition same as 
wash buffer but with 0.25 mm PMSF and 1x Complete 
protease inhibitor cocktail). To this 24 ml volume, 6 ml 
of lysozyme (final conc. 0.3 gm/L) solution was added 
and incubated for 20 minutes on ice. To this, 2.5 ml of 
0.8% deoxycholate was added and incubated further 20 
minutes  on  ice.  This  mixture  was  then  subjected  to 
sonication (3x 30 seconds, 5 mm tip, 50% duty cycle 
and  output  5)  while  cooling  on  ice.  5  ml  of  2  M 
ammonium sulfate was added and the final volume was 
made up to 50 ml by resuspension buffer. Next, 5 ml of 
10% Polyethyleneimine (sigma) was slowly added and 
Figure 4.2: 
Commassie 
stained SDS- 
PAGE showing 
purified T7 
RNA 
polymerase. 
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the mixture was stirred on ice for 20 minutes. The whole mixture was then centrifuged at 
22000  RPM  (Sorvall  centrifuge,  Sorval  SLA-3000  rotor)  for  20  minutes  and  the 
supernatant was recovered. To this supernatant, 0.82x volume of saturated ammonium 
sulfate solution (4.1 M) was added and the mixture was stirred on ice for 20 minutes. 
Afterwards, centrifugation was performed at 13400 RPM for 20 minutes using the same 
rotor and the pellet recovered was resuspended into 15 ml of buffer C-50 (20 mM sodium 
phosphate, pH 7.7, 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 5% glycerol, 1x complete 
protease inhibitor, 0.25 mM PMSF). This suspension was dialyzed for 3 hrs followed by 
12 hr in 1 L buffer C-50 each. After dialysis, the suspension was centrifuged at 10000 
RPM  (Beckman  Coulter  ultracentrifuge  with  a  45  Ti  rotor)  for  15  minutes,  the 
supernatant was recovered and loaded onto a SP sepharose FF column. This column of 
50 ml bed volume had been manually prepared, fixed to a Aekta purifier system and pre-
equilibrated with 1 column volume (CV) of C-50 buffer. After washing with 2CV of C-
50 buffer, the protein was eluted with a linear gradient of 50-500 mM NaCl over 5CV. 
The  flow  rate  was  kept  constant  at  2  ml/minute.  The  fractions  containing  T7  RNA 
Polymerase were  collected  and  pooled together.  The  pooled  fractions (~25 ml)  were 
dialyzed against 2 L of buffer C-0 (composition same as C-50 except no NaCl present) 
overnight with a buffer exchange after 4-6 hrs. The dialysate was centrifuged at 13000 
RPM for 20 minutes, the pellet was recovered and resuspended in 4 ml of C-100 buffer 
(100 mM NaCl). 4 ml of 100% glycerol was added to this, rendering the final purified T7 
RNA  polymerase  concentration  to be 3.8  g/L.  Aliquots of  appropriate  volumes  were 
stored at -80 °C. The purity of the purified T7 RNA polymerase was analyzed by SDS-
PAGE (Fig. 4.2). 
 
4.2.6.3 Cell-free expression reaction mixture 
Cell-free  expressions  were  performed  mostly  in  a  70  µl  reaction  mix  volume  for 
analytical purposes and either 1 ml or its multiple (2, 4, 10 ml) for scaling up. The 
feeding mixture (FM) volumes were kept 17-19 times higher than the reaction mixture 
(RM) volume. The Mg
2+ and K
+ concentration always varied with the particular S30 
extract batch and a prior titration for determination of the optimum concentration was 
necessary for every new S30 extract preparation. Table 4.2 describes the components and 
the concentration used for a typical analytical or scaled-up reaction. 
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Table 4.2: Components and their typical concentration in FM and RM of  cell-free reaction 
Components  Concentration 
in feeding 
mixture  
(FM) 
Concentration 
in reaction 
mixture  
(RM) 
Components 
only in 
reaction 
mixture  
(RM) 
Concentration 
in reaction 
mixture (RM) 
NaN3  0.10 %(W/V)  0.10 %(W/V)  Pyruvat Kinase  0.04 mg/ml 
PEG 8000  3.99 %(W/V)    3.99 %(W/V)    tRNA    0.56 mg/ml 
KOAc  320 mM  320 mM  RNAsin  0.4 U/µl 
Mg(OAc)2  27 mM  27 mM  S30 Extrakt  0.3 to 0.4 % of 
total volume 
HEPES pH 8  175 mM  175 mM  T7 RNA 
Polymerase 
0.01 mg/ml 
 
Complete   1x  1x  Plasmid (target 
gene) 
0.015 µg/µl 
Folinic acid  0.4 mM  0.4 mM     
DTT  2.5 mM  2.5 mM     
NTP mix  1x  1x     
PEP    40 mM  40 mM     
AcP  40 mM  40 mM     
Amino Acid mix  1.76 mM  1 mM     
RCWMDE mix
a  1.8 mM  1.8 mM     
 
a RCWMDE is a mixture of Arginine, Cysteine, Tryptophan, Methionine, Aspartic acid and 
Glutamic acid. 
 
In case of DCF reactions, detergents were typically used in the following concentrations: 
βLM (0.2-0.4%), Digitonin (0.4%), Brij-35 (0.1%), Brij-58 (1.5%), Brij-78 (1%), Brij-98 
(0.2%), Triton X-100 (0.1-0.2%). However, the detergent concentration was also varied 
to find out the optimal expression condition. 
 
4.2.6.4 Purification of cell-free produced protein 
In  case  of  DCF  production,  the  reaction  mixture  was  centrifuged  at  14000  RPM 
(Eppendorf  centrifuge  5417R)  for  15  minutes  and  the  supernatant  was  collected 
carefully. This supernatant was diluted 5 to 10 times with wash buffer (20 mM HEPES, 
pH 8, NaCl 300 mM) for purification, preferably  containing purification detergent at 
higher  CMC  (typically  βLM  with  0.1%  final  concentration)  and  loaded  onto  pre-
equilibrated Ni-NTA column/matrix. After an initial 10 column volume wash with this 
higher detergent concentration (10x CMC), further washing (20-30 CV) and elution (5 to 
10 CV) were performed at 2x-3x CMC (0.02% or 0.03%). This procedure was followed 
to ensure maximum detergent replacement as almost always the purification detergent 
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For PCF production, the reaction mixture was centrifuged at 14000 RPM for 15 minutes 
and the recovered pellet was solubilized in a suitable buffer (typically 20 mM HEPES, 
pH 8, 150 mM NaCl, 2 mM β-mercaptoethanol and 1% LMPG or FOS12) for 1-2 hrs at 
30 ºC. Before scaling up, solubililization was always optimized for the most efficient 
detergent.  The  solubilizate  was  centrifuged  at  14000  RPM  for  15  minutes  and  the 
supernatant was collected. This supernatant was subjected to purification similarly as 
DCF products. 
 
4.2.7 Determination of the oligomerization state 
 
4.2.7.1 Cross-linking of proteins with glutaraldehyde 
For  cross-linking  experiment,  glutaraldehyde  was  used  as  a  chemical  cross-linking 
reagent. Protein Aq_2073 was purified with IMAC as discussed before. However, the 
buffer was chosen to be 20 mM HEPES, pH 8.0. Glutaraldehyde was added to the protein 
sample in concentrations of 20, 50, and 100 mM with a final protein concentrations of 
0.1 mg/ml. A sample with 1% final concentration of SDS and 50 mM glutaraldehyde was 
also tested. Treated samples were kept at room temperature for 1 hr. At the end of the 
incubation period, Tris buffer was added to the samples at a final concentration of 100 
mM to quench the un-reacted glutaraldehyde. Proteins  samples were then run over a 
SDS-PAGE and proteins bands were visualized by Coomassie staining. 
 
4.2.7.2 Blue native (BN) gel electrophoresis 
BN gel elecrophoresis was performed using the Invitrogen NativePAGE
TM Novex Bis- 
Tris  gel  system.  The  NativePAGE™  Novex®  Bis-Tris  Gel  System  consists  of  the 
followings: 
 
Components  Details Composition 
NativePAGE™ Novex® Bis-
Tris  Mini Gels 
(4-16%) gels, 10x10 cm 
NativePAGE™ Sample Buffer 
(4X)  
 
For 1x, BisTris buffer (50 mM), NaCl (50 mM), 
glycerol (10% w/v) and Ponceau S (0.001%), 
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Components  Details Composition 
NativePAGE™ 5% G-250 
Sample additive 
5% concentrated stock solution of Coomassie® 
G-250 
NativePAGE™ Running 
Buffer (20X) 
50 mM Bis Tris, 50 mM Tricin for 1x 
NativePAGE™ Cathode 
Buffer additive (20x)  
0.4% Coomassie® G-250 
 
Using the above mentioned components, 1x running buffers were made as below 
Reagents             Amount  
 
Cathode buffer  NativePAGE™ Running Buffer (20X)     10 ml  
NativePAGE™ Cathode Additive (20X)     10 ml  
Deionized Water           180 ml  
_______________________________________________ 
Total Volume           200 ml 
 
Anode buffer   NativePAGE™ Running Buffer (20X)     50 m 
Deionized Water           950 ml 
________________________________________________ 
Total Volume           1000 ml 
 
After buffer preparation, loading samples were prepared on ice, as below. 
 
Reagent           Amount  
Protein sample         x  l  
NativePAGE™ sample buffer (4X)     2.5  l  
NativePAGE™ 5% G-250 sample additive   0.25-1  l 
Deionized water to         10  l  
 
The gel cassette was marked outside with a marker pen to denote the wells. After setting 
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carefully. Sample was loaded and the run was carried out at 4º C for 1hr at 150 volt and 
then 250 volt for 1-2 hrs. After the completion of the run, the gel was immersed into 
fixing solution (40% methanol and 10% acetic acid), microwaved for 45 seconds and 
shaken  at room temperature  for 15 minutes.  The  same procedure  was  repeated  with 
destaining solution (40% methanol and 8% acetic acid) until the desired band became 
clearly visible. 
 
4.2.8 Reconstitition of membrane protein into liposome 
 
4.2.8.1 Preparation of the lipid stock 
Lipids were obtained from Avanti Polar Lipids as stocks in chloroform. Lipid was dried 
under constant flow of nitrogen for 2 hours. For 2D crystallization, dried lipids were 
dissolved  in  buffers  containing  1-1.5%  detergents  (βLM,  DM  or  OG)  to  a  final 
concentration of 4 mg/ml, sonicated till homogeneity and stored in aliquots at -80º C.
   
For SSM studies  lipid was resuspended in reconstitution buffer A (typically, 50 mM 
HEPES-Tris, pH 7.5, 100 mM NaCl) to a final concentration of 10 mg/ml and sonicated 
till a clear solution was obtained. This was then extruded through a 400nM filter using 
the  LiposoFast  liposome extruder  (Avestin). The liposome diameter  was  checked  by 
using dynamic light scattering. Aliquots of liposomes were stored at -80º C. 
 
4.2.8.2 Reconstitution procedure 
An aliquot of the liposome suspension (200 µl, 10 mg/ml) was mixed with 22.5 µl of 
15% OG and the mixture was left on ice for 5-10 minutes. 0.2 mg of protein (for LPR 10) 
was added to the mixture and incubated on ice for 10 minutes. This lipid-detergent-
protein mixture was diluted into 100 ml of pre-chilled reconstitution buffer B (typically 
50 mM  HEPES-Tris,  pH 7.5, 300 mM NaCl) with moderate  stirring  and  left  for 10 
minutes at 4 ºC. The reconstituted proteoliposomes were precipitated with a Ti 60 rotor at 
60000  RPM  (Beckman  Coulter  ultracentrifuge)  for  1  hr  at  4  ºC.  The  pellet  was 
resuspended in reconstitution buffer B and centrifuged again. The obtained pellet was 
finally resuspended in storage buffer C (typically 50 mM HEPES-Tris, pH 7.5, 1 mM 
DTT or 2 mM β mercaptoethanol). 
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4.2.9 Functional and biophysical characterization 
 
4.2.9.1 Functional complementation of GG48 strain with CDF transporters 
GG48 is an E. coli strain devoid of  ZntA and ZitB. ZntA is a zinc ATPase and  ZitB is a 
secondary transporter responsible for efflux of zinc out of the cells. GG51 is a strain, 
which is devoid of ZitB only. It has been shown that the GG48 strain is sensitive to 
moderate concentrations of zinc. Chemically competent GG48 cells were transformed 
with  the  pTTQ18-C plasmid carrying  genes  of  the  CDF  family.  Transformation was 
followed by an expression  screen to detect the  expression of these genes under  new 
experimental conditions (GG48 as host cells, 0.2 mM IPTG at 30 °C). First, a standard 
curve of zinc sensitivity to GG48 was determined by incubating GG48 with  varying 
concentrations of zinc (0 to 200  M of zinc chloride in  LB medium) at 30 °C with 
shaking at 200 RPM for several hours. In the case of transformed cells, a pre-culture was 
made  inoculating  a  single  colony  in  2  ml  of  LB  medium  and  incubating  at  30  °C 
overnight. The next day, this culture was used to inoculate expression medium containing 
a varying amount of zinc chloride and 0.2 mM IPTG. Care was taken in this experiment 
to make an initial OD600 of 0.05 and allowed the cell culture to grow at 30 °C at 200 
RPM for several hours. At the end of the experiment, the sensitivity to zinc ion was 
determined by measuring the OD600. 
 
4.2.9.2 Solid supported membrane (SSM) experiments 
The SSM measurement was performed according to Garcia-Celma et al. (2009).  Briefly, 
40 µl of proteoliposomes at a protein concentration of 1 mg/ml were allowed to adsorb 
for 1 hr to an octadecanethiol/phosphatidylcholine hybrid bilayer on a gold surface (the 
sensor). The solution exchange protocol consisted in 3 phases each lasting 0.5 seconds(s). 
The nonactivating  solution flows through the cuvette during the first and third phase 
(from 0 to 0.5 s, and from 1 to 1.5 s), whereas the activating solution flows during the 
second phase (from 0.5 to 1 s). The non-activating solution always contained 1 mM 
NaCl, and the activating solution contained 1 mM KCl. All solutions were buffered in 50 
mM HEPES-TRIS at given pH values plus 1 mM DTT (Table 2.7 of result section). 
Currents were recorded throughout the entire time, and amplified with a current amplifier 
set to a gain of 10
9-10
10 V/A and low pass filtering set to 300–1,000 Hz. 
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4.2.9.3 Differential scanning calorimetry 
The DSC measurements were performed using a VP-Capillary DSC system (Microcal, 
Inc., Northampton, MA) equipped with tantalum 61 cells, each with an active volume of 
137 µl. Protein samples were diluted to 0.5-1 mg/ml while the corresponding buffer was 
used as a reference. In most cases, the protein samples were dialyzed in the buffer prior 
to the experiment and this same buffer was used as a reference buffer. Both the sample 
and buffer were filtered routinely using a 20 µm filter before the injection. The samples 
were scanned at a scan rate of 90 °C/hr unless otherwise stated, with an initial 15 minutes 
of equilibration at the starting temperature. Data were analyzed using Origin 7.0 software 
(OriginLab®  Corporation,  Northampton,  MA).  Thermograms  were  corrected  by 
subtraction of buffer-only blank scans. The corrected thermograms were normalized for 
protein concentration. 
 
4.2.10 2D crystallization, negative staining and screening by EM 
 
Protein typically at 1 mg/ml final concentration was mixed at the desired lipid to protein 
ratio (LPR) with lipid, incubated at room temperature for 1hr before being transferred to 
dialysis  bags  for  two  dimensional  crystallization.  Protein  concentration  or  the  pre 
incubation time before dialysis was varied.  The temperature and time period for dialysis 
were 30 ºC and 10 days but these criteria also varied with different detergents. 
2 µl of the dialyzed sample was placed on a carbon coated copper grid (400 mesh size). 
The sample was allowed to adsorb for a minute. The grid was stained by drops of 1.5% 
uranyl acetate. After soaking the excess solution, another drop of uranyl acetate was 
added on the grid. This ensured that any ingredients (phosphate, glycerol) in the sample 
buffer  were  removed  in  the  first  drops,  resulting  in  better  staining.  The  grids  were 
screened in a Philips CM120 microscope equipped with a LaB6 filament and operated at 
120KV. Images were recorded in low dose mode typically at a magnification of 45,000 x 
with an exposure resulting in 20 electrons per Å
2. 
 
4.2.11 3D crystallization 
 
Three dimensional crystallization trials were done with IMAC and gel filtration purified 
proteins. Drops of varying sizes (100 nl, 200 nl, 300 nl, 400 nl, 1 µl) were set either by                                                                                         MATERIALS AND METHODS 
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using Cartesian, Honey bee (Zinsser Analytic), Mosquito (TTP Labtech), Crystalmation 
(Rigaku)  or  manually.  Different  commercial  crystallization  screens  (Hampton,  Jena 
Bioscience, Qiagen etc.) were used along with lab-made buffers to generate or improve 
crystals. Hanging drops or sitting drops were mostly used for crystallization. Protein to 
buffer ratio was mostly 1:1 though other ratios were also tried. Protein concentrations 
were varied from 2 mg/ml to 10 mg/ml. 
Crystallization drops were inspected using a Leica M165 C stereomicroscope and image 
capture system.  
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Appendix 1 
 
Cloning and expression screening of RhtB family members 
 
Resistance  to  homoserine/threonine(RhtB)  family  proteins  are  involved  in  exporting 
different amino acids and conferring resistance to these amino acids. Very few proteins 
of this family are functionally characterized. I selected five RhtB family proteins from S. 
thphimurium, cloned them in to various vectors and tried to heterologously overproduce 
them in E. coli host cells. However, none of the constructs showed detectable expression 
when  the  expression  screening  and  subsequent  Western  blots  were  developed  as 
described in Materials and Methods.  Table A1 shows the cloning and expression results 
in details. 
 
Table A1 : Details of RhtB family members expression screening 
Protein  AA  MW 
(kD) 
TM 
p
I
 
 
P
T
T
Q
1
8
A
2
 
P
T
T
Q
1
8
C
3
 
p
Q
E
A
2
 
p
Q
E
C
3
 
p
B
A
D
A
2
 
p
B
A
D
C
3
 
STM0365  210  23.13  6  11.28  C, NE  C, NE  C, NE  C, NE  C, NE  C, NE 
STM1270  212  22.94  6  9.75  C, NE  C, NE  C, NE  C, NE  C, NE  CF 
STM2645  195  21.29  6  9.78  C, NE  C, NE  C, NE  C, NE  C, NE  C, NE 
STM3959  206  22.49  6  10.01  C, NE  C, NE  C, NE  C, NE  C, NE  C, NE 
STM3960  206  22.32  6  10.62  C, NE  C, NE  C, NE  C, NE  C, NE  C, NE 
AA:  Number  of  amino  acids,  MW(kD):  calculated  molecular  weight  in  kilo  Dalton,  TM: 
predicted transmembrane helices, pI: theoretical Isoelectrial point 
C: cloned, CF: cloning failed, NE: not expressed 
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Appendix 2 
Cloning, expression and purification of PNaS family protein from S. typhimurium 
 
STM4189, the only PNaS family member of S. typhimurium was cloned into pBAD, 
pTTQ18 and pQE vectors, each having two different constructs (A2 and C3) based on tag 
position.  These  6  constructs  were  subjected  to  expression  screening  and  only  the 
pBADA2 construct was found to be expressing when checked in Western blot. In order 
to  purify  the  protein,  membrane  was  prepared  from  6  L  LB  culture.  Solubilization 
screeing revealed FOS12 to be the preferred detergent while βLM could solubilize the 
protein  moderately.  However,  the  purification  of  the  protein  using  IMAC  was  not 
successful. The elution fraction always contained a lot of impurities as  evident from 
Coomassie stained SDS- PAGE. It became hard to distinguish the protein band from 
other  impurities  in  SDS-  PAGE.  Several  optimizations  with  buffer  pHs  and  other 
additives did not improve the elution profile. One probable reason could be that the 
protein was folded in such a way, that the His-tag remained inaccessible by the affinity 
column matrices. Hence, the protein failed to bind properly with the column and eluted 
with impurities (Fig A1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1: Expression screening and purification of STM4189 
 
 
47.5kD- 
Western blot of expression 
screening using pBADA2 construct 
Eluted fraction in Coomassie stained SDS-PAGE 
1,2,3,4 different fraction of the elution peak 
47.5kD- 
M      1      2      3       4                                                                                                                           APPENDIX 
  124
Appendix 3 
Analytical gel filtration profiles of Aq_2073 at different pHs 
A superdex 200 column in SMART system was used for gel filtration analysis. 
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Appendix 4 
Schematic representation of the vectors used for this thesis work 
Basic vector system; vectors were than modified based on purpose. 
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Appendix 5  
Oligonucleotide sequences for vector modification 
 
pTTQ18-21   5’   TTTGCGCCGACATCATAACG   3’ 
pTTQ18-22   5’   TGTGCTGCAAGGCGATTAAG   3’ 
pTTQ18-32     5’   ATTCCGAAAACCTGTACTTTCAAGGTGGCCGTGGTTCCCACCATCACCATCACCATCACCATCACCATTA   3’                           
pTTQ18-33   5’   AGCTTAATGGTGATGGTGATGGTGATGGTGATGGTGGGAACCACGGCCACCTTGAAAGTACAGGTTTTCGG   3’       
pTTQ18-38    5’   AATTTGCACCATCACCATCACCATCACCATCACCATGAAAACCTGTACTTTCAAGGTGGGATCCG 
      CCGGCGAATTCCAGCGCTTGGAGCCACCCGCAGTTCGAAAAATA   3’ 
pTTQ18-39   5’   AGCTTATTTTTCGAACTGCGGGTGGCTCCAAGCGCTGGAATTCGCCGGCGGATCCCACCTTGAAAGTA 
                 CAGGTTTTCATGGTGATGGTGATGGTGATGGTGATGGTGCA   3’ 
pBAD-1   5’   CATGGGGGGTTCTGAGATCTGCCGGCGAATTCCGAAAACCTGTACTTTCAAGGTGGCCGTG 
      GTTCCCACCATCACCATCACCATCACCATCACCATT   3’ 
pBAD-2   5’   AGCTTAATGGTGATGGTGATGGTGATGGTGATGGTGGGAACCACGGCCACCTTGAAA 
      GTACAGGTTTTCGGAATTCGCCGGCAGATCTCAGAACCCCC   3’ 
pBAD-3   5’   CATGGGGGGTTCTCACCATCACCATCACCATCACCATCACCATGAAAACCTGTACTTTCAAGGTGA 
      GATCTGCCGGCGAATTCCAGCGCTTGGAGCCACCCGCAGTTCGAAAAAT   3’ 
pBAD-4   5’   AGCTTATTTTTCGAACTGCGGGTGGCTCCAAGCGCTGGAATTCGCCGGCAGATCTCACCTTGAAAGTA 
      CAGGTTTTCATGGTGATGGTGATGGTGATGGTGATGGTGAGAACCCCC   3’ 
pBAD-7   5’   AGATTAGCGGATCCTACCTG   3’ 
pBAD-8   5’   CAGACCGCTTCTGCGTTCTG   3’ 
pQ-1     5’   AATTTATTAAAGAGGAGAAATTAACCATGGGAGGGATCCGCCGGCGAATTCCGAAAACCTGTAC 
      TTTCAAGGTGGCCGTGGTTCCCACCATCACCATCACCATCACCATCACCATTA   3’ 
pQ-2     5’   AGCTTAATGGTGATGGTGATGGTGATGGTGATGGTGGGAACCACGGCCACCTTGAAAGTACAGGTTT 
      TCGGAATTCGCCGGCGGATCCCTCCCATGGTTAATTTCTCCTCTTTAATA   3’ 
pQ-3     5’   AATTTATTAAAGAGGAGAAATTAACCATGGGACACCATCACCATCACCATCACCATCACCATGAAAA 
                                 CCTGTACTTTCAAGGTGGGATCCGCCGGCGAATTCCAGCGCTTGGAGCCACCCGCAGTTCGAAAAATA   3’ 
pQ-4               5’   AGCTTATTTTTCGAACTGCGGGTGGCTCCAAGCGCTGGAATTCGCCGGCGGATCCCACCTTGAAAGTACAGGTT 
           TTCATGGTGATGGTGATGGTGATGGTGATGGTGTCCCATGGTTAATTTCTCCTCTTTAATA   3’ 
pQ-5     5’    TGAGCGGATAACAATTTCAC   3’ 
pQ-6     5’    GAGTTCTGAGGTCATTACTG   3’ Acknowledgements 
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